{
  "002932.SZ": {
    "city": "Wuhan",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Wuhan Easy Diagnosis Biomedicine Co.,Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "WUHAN EASY DIAGNOS",
    "state": null,
    "summary": "Wuhan EasyDiagnosis Biomedicine Co.,Ltd. engages in the development, production, and sale of in vitro and POCT rapid diagnostic reagents and related equipment in China and internationally. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics and gynecology, and eugenics diseases, as well as health inspection and other products; and chemiluminescence detection kit and analyzers, blood gas analyzers, mobile electrocardiography, and molecular diagnosis products. The company is based in Wuhan, China.",
    "website": "http://www.mdeasydiagnosis.com",
    "zipcode": "430074"
  },
  "004080.KS": {
    "city": "Seoul",
    "country": "South Korea",
    "currency": "KRW",
    "exchange": "KSC",
    "industry": "Medical Devices",
    "long_name": "Shinhung Co., Ltd",
    "market": "kr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Shinhung",
    "state": null,
    "summary": "Shinhung Co., Ltd. manufactures and sells dental products and supplies in South Korea. Its products include implant systems; dental units, chairs, operatories, and implants; autoclaves and X-ray equipment; disposable needles; dental porcelain powder and laboratory products; dental alloys; cabinets, such as drawer cabinets, equipment cabinets, soap dispensers, sink cabinets, lateral panels, insert cabinets, and mobile cabinets; and other equipment, which include compressors and mixers. The company also offers loan services for dentists. Shinhung Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.",
    "website": "http://www.shinhung.co.kr",
    "zipcode": "100-858"
  },
  "0853.HK": {
    "city": "Shanghai",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "MicroPort Scientific Corporation",
    "market": "hk_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MICROPORT",
    "state": null,
    "summary": "MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment provides coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment offers reconstructive joints, spine and trauma, and other professional implants and equipment. The company's Cardiac Rhythm Management Business segment develops, manufactures, and markets defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment provides products and services for neurovascular diseases, such as cerebral aneurysms, intracranial atherosclerotic diseases, carotid artery diseases, and other neurovasculature related diseases. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. The company's Heart Valve Business segment engages in the research and development, manufacture, and sale of VitaFlow Transcatheter aortic valve and delivery system for the treatment of valvular heart diseases. Its Surgical Robot Business segment provides research and technology integration in the fields of robot, intelligent control, and information to provide medical products. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.",
    "website": "http://www.microport.com",
    "zipcode": "201203"
  },
  "0I1.F": {
    "city": "Cardiff",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MyHealthChecked Plc",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MYHEALTHCHECKED  LS -,001",
    "state": null,
    "summary": "MyHealthChecked Plc, a women's healthcare company, develops and commercializes mobile health diagnostics medical devices in the United Kingdom. Its products help women with unexplained infertility to concieve. The company offers myLotus, a dual purpose monitoring system that allows both ovulation (LH) and pregnancy (hCG) testing. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked Plc in December 2020. MyHealthChecked Plc was incorporated in 2008 and is based in Cardiff, the United Kingdom.",
    "website": "http://myhealthcheckedplc.com",
    "zipcode": "CF24 5EA"
  },
  "0I3.F": {
    "city": "Irvine",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Axonics, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "AXONICS INC.",
    "state": "CA",
    "summary": "Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.",
    "website": "http://www.axonics.com",
    "zipcode": "92618"
  },
  "0P8.F": {
    "city": "Alameda",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Penumbra, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "PENUMBRA INC.",
    "state": "CA",
    "summary": "Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; immersive virtual reality and display system that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.",
    "website": "http://www.penumbrainc.com",
    "zipcode": "94502"
  },
  "0WF.F": {
    "city": "Nashville",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "SmileDirectClub, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SMILEDIRECTC. A  DL-,0001",
    "state": "TN",
    "summary": "SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, Spain, and Austria. It offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.",
    "website": "http://www.smiledirectclub.com",
    "zipcode": "37219"
  },
  "0WF.MU": {
    "city": "Nashville",
    "country": "United States",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "SmileDirectClub, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SMILEDIRECTC. A  DL-,0001",
    "state": "TN",
    "summary": "SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, Spain, and Austria. It offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.",
    "website": "http://www.smiledirectclub.com",
    "zipcode": "37219"
  },
  "0ZM.F": {
    "city": "Beverly",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Hamilton Thorne Ltd.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "HAMILTON THORNE LTD. O.N.",
    "state": "MA",
    "summary": "Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers laser products used in a range of scientific applications and in vitro fertilization (IVF) procedures; and image analysis systems used in the studies of reproductive cells in the human fertility, animal sciences, and reproductive toxicology fields. The company also provides a line of air filtration products to enhance air quality in the laboratory under the ZANDAIR brand; incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand; and reproductive medicine, including clinical and laboratory equipment, and disposables, as well as installations of ART clinics under the Gynemed brand. In addition, it offers test laboratory providing services to the assisted reproductive technologies industry and laboratories under the Embryotech brand. Further, the company provides precision laser devices, imaging systems, micromanipulation systems, control rate freezers, and lab monitoring systems. It sells its products through direct sales force and distributors to pharmaceutical and biotechnology companies, animal breeding facilities, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. The company is headquartered in Beverly, Massachusetts.",
    "website": "http://www.hamiltonthorne.ltd",
    "zipcode": "01915"
  },
  "111N.F": {
    "city": "Salt Lake City",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Sintx Technologies, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SINTX TECHS INC.  DL-,01",
    "state": "UT",
    "summary": "Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.",
    "website": "http://www.sintx.com",
    "zipcode": "84119"
  },
  "1302.HK": {
    "city": "Shenzhen",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "LifeTech Scientific Corporation",
    "market": "hk_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "LIFETECH SCI",
    "state": null,
    "summary": "LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; import and export business; development, manufacture, and sale of medical polymer materials and products; manufacturing and trading of materials for hemp; investment in medical projects; staff training and internal personnel management business; information consulting for investors; and import and export, sale, and distribution of medical and paramedical devices, including software and accessories and related services, as well as technical consultation, technology transfer, technical, consulting, and technology services. It has operations in the People's Republic of China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.",
    "website": "http://www.lifetechmed.com",
    "zipcode": "518057"
  },
  "1612.HK": {
    "city": "Hung Hom",
    "country": "Hong Kong",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Vincent Medical Holdings Limited",
    "market": "hk_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "VINCENT MED",
    "state": null,
    "summary": "Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, and anesthesia systems. The company's orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People's Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.",
    "website": "http://www.vincentmedical.com",
    "zipcode": null
  },
  "1696.HK": {
    "city": "Caesarea",
    "country": "Israel",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Sisram Medical Ltd",
    "market": "hk_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SISRAM MED",
    "state": null,
    "summary": "Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers a portfolio of treatment systems for non-invasive medical aesthetic treatments, including hair removal, skin rejuvenation, skin resurfacing, vascular and pigmented lesions treatment, body contouring, skin tightening, tattoo removal, acne treatment, and cellulite reduction; and minimally invasive treatments, such as minimally invasive treatments, such as laser assisted liposuction and fat grafting, and feminine health, as well as treatment of varicose veins and ear, nose, and throat procedures. The company also provides beauty product line treatment systems, such as Rejuve and Spadeep; and manufactures, distributes, and sells medical equipment. It offers its products under the Alma, Soprano, Harmony, ClearLift, Accent, BeautiFill, and FemiLift brands. The company sells its products directly to treatment providers and treatment recipients; and through distributors and direct sales. Sisram Medical Ltd was incorporated in 2013 and is headquartered in Caesarea, Israel.",
    "website": "http://www.sisram-medical.com",
    "zipcode": "38900"
  },
  "16E.F": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Episurf Medical AB (publ)",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EPISURF MEDICAL AB B",
    "state": null,
    "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers ÂµiFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.",
    "website": "http://episurf.com",
    "zipcode": "114 49"
  },
  "1799.TWO": {
    "city": "Hsinchu City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Easywell Biomedicals, Inc.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EASYWELL BIOMEDICAL INC",
    "state": null,
    "summary": "Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. The company offers pharmaceutical products, which include high-barrier generics for the treatment of anti-cough, anti-urinary incontinence, breast cancer in PMS women, anti-depression, prevention of pneumocystis pneumonia, epilepsy, chronic angina, and inflammatory lesions of rosacea; and 505(b)(2) drugs for the treatment of Parkinson's, urinary, and pneumonia diseases. It also provides medical devices, including digital clinical, infrared ear, and non-contact forehead infrared thermometers. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.",
    "website": "http://www.easywellbio.com",
    "zipcode": "30076"
  },
  "1858.HK": {
    "city": "Beijing",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Beijing Chunlizhengda Medical Instruments Co., Ltd.",
    "market": "hk_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CHUNLI MEDICAL",
    "state": null,
    "summary": "Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. It primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. The company also exports its products to 38 countries and regions in Asia, South America, Africa, Oceania, and Europe. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorporated in 1998 and is headquartered in Beijing, China.",
    "website": "http://www.clzd.com/tc/index.php",
    "zipcode": null
  },
  "1I4.F": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "HeraMED Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HERAMEDLTD",
    "state": "NSW",
    "summary": "HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Sydney, Australia.",
    "website": "http://www.hera-med.com",
    "zipcode": "2000"
  },
  "1MK.F": {
    "city": "Paris",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Mauna Kea Technologies SA",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MAUNA KEA TECHNOL.EO -,04",
    "state": null,
    "summary": "Mauna Kea Technologies SA develops and markets medical devices for the diagnosis and treatment of cancers and other diseases in Europe, the Middle East, Africa, the United States, Latin America, China, and Japan. Its flagship product is Cellvizio, a multidisciplinary probe and needle-based confocal laser endomicroscopy platform, which provides physicians and researchers with images of tissues at the cellular level. The company was founded in 2000 and is headquartered in Paris, France.",
    "website": "http://www.maunakeatech.com",
    "zipcode": "75010"
  },
  "1N7.F": {
    "city": "Redwood City",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Nevro Corp.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "NEVRO CORP.  DL-,001",
    "state": "CA",
    "summary": "Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. In addition, the company provides HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.",
    "website": "http://www.nevro.com",
    "zipcode": "94065"
  },
  "1P4.F": {
    "city": "Wilder",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Protech Home Medical Corp.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PROTECH HOME MEDICAL NEW",
    "state": "KY",
    "summary": "Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.",
    "website": "http://www.protechhomemedical.com",
    "zipcode": "41076"
  },
  "1P5.F": {
    "city": "New York",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "PAVmed Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "PAVMED INC  DL-,001",
    "state": "NY",
    "summary": "PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.",
    "website": "http://www.pavmed.com",
    "zipcode": "10165"
  },
  "1P5.SG": {
    "city": "New York",
    "country": "United States",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "PAVmed Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "PAVmed Inc. Registered Shares D",
    "state": "NY",
    "summary": "PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.",
    "website": "http://www.pavmed.com",
    "zipcode": "10165"
  },
  "1RC.SG": {
    "city": "Chepstow",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Creo Medical Limited",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Creo Medical Group PLC Register",
    "state": null,
    "summary": "Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Speedboat RS2, a medical instrument through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.",
    "website": "http://creomedical.com",
    "zipcode": "NP16 5UH"
  },
  "2160.HK": {
    "city": "Shanghai",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "MicroPort CardioFlow Medtech Corporation",
    "market": "hk_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CARDIOFLOW-B",
    "state": null,
    "summary": "MicroPort CardioFlow Medtech Corporation, a medical device company, focuses on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases in the People's Republic of China. Its products include Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, which targets aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China. MicroPort CardioFlow Medtech Corporation is a subsidiary of Shanghai MicroPort Limited.",
    "website": "http://www.cardioflowmedtech.com",
    "zipcode": "201203"
  },
  "2393.HK": {
    "city": "Shanghai",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Yestar Healthcare Holdings Company Limited",
    "market": "hk_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "YESTAR HEALTH",
    "state": null,
    "summary": "Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. The company also distributes in vitro diagnostic products. In addition, it engages in the biotechnology development activities; management of supply chain; and freight transportation services. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.",
    "website": "http://www.yestarcorp.com",
    "zipcode": "201199"
  },
  "24OA.F": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Obalon Therapeutics, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OBALON THERAPEUT. DL-,001",
    "state": "CA",
    "summary": "Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.",
    "website": "http://www.obalon.com",
    "zipcode": "92008-4410"
  },
  "24PA.F": {
    "city": "Sylmar",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Second Sight Medical Products, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SECOND SIGHT MED.PRODUCT.",
    "state": "CA",
    "summary": "Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.",
    "website": "http://www.secondsight.com",
    "zipcode": "91342"
  },
  "2500.HK": {
    "city": "Hangzhou",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Venus Medtech (Hangzhou) Inc.",
    "market": "hk_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "VENUS MEDTECH-B",
    "state": null,
    "summary": "Venus Medtech (Hangzhou) Inc. develops and sells transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of cerebral damage during TAVR and other structural heart procedures. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.",
    "website": "http://www.venusmedtech.com",
    "zipcode": null
  },
  "26HA.F": {
    "city": "Newtown",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Helius Medical Technologies, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HELIUS MEDICAL TECHNOLOG.",
    "state": "PA",
    "summary": "Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product is Portable Neuromodulation Stimulator (PoNS), a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.",
    "website": "http://heliusmedical.com",
    "zipcode": "18940"
  },
  "2FV.F": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ScandiDos AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SCANDIDOS AB (PUBL)",
    "state": null,
    "summary": "ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation; and Delta4 Trolley, an ergonomic solution. The company is headquartered in Uppsala, Sweden.",
    "website": "http://scandidos.com",
    "zipcode": "751 83"
  },
  "2HJ.F": {
    "city": "Kista",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Brighter AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BRIGHTER AB (PUBL)",
    "state": null,
    "summary": "Brighter AB (publ), a health-tech company, develops data-driven solutions for the treatment of chronic condition in Sweden. It is developing Actiste, a mobile-connected device to remotely monitor and treat insulin-dependent diabetes; and The Benefit Loop, a cloud-based platform that gathers, processes, analyzes, and organizes real-life data. The company offers its products to consumers and patients, mobile network operators, healthcare providers, governments/authorities, insurance companies, consumers, companies/employers, clinical research organizations, pharmaceutical companies, research and development organizations, authorities, and academic bodies. Brighter AB (publ) was founded in 2007 and is based in Kista, Sweden.",
    "website": "http://brighter.se",
    "zipcode": "164 32"
  },
  "2M6.DE": {
    "city": "Dublin",
    "country": "Ireland",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Medtronic plc",
    "market": "de_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MEDTRONIC PLC  DL-,0001",
    "state": null,
    "summary": "Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.",
    "website": "http://www.medtronic.com",
    "zipcode": "2"
  },
  "2M6.F": {
    "city": "Dublin",
    "country": "Ireland",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Medtronic plc",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MEDTRONIC PLC  DL-,0001",
    "state": null,
    "summary": "Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.",
    "website": "http://www.medtronic.com",
    "zipcode": "2"
  },
  "2OK.F": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "SpectraCure AB (publ)",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SPECTRACURE AB",
    "state": null,
    "summary": "SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.",
    "website": "http://www.spectracure.com",
    "zipcode": "222 29"
  },
  "2QM.SG": {
    "city": "Omer",
    "country": "Israel",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Medigus Ltd.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Medigus Ltd. Reg.Shares(Spon.AD",
    "state": null,
    "summary": "Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel.",
    "website": "http://www.medigus.com",
    "zipcode": "8496500"
  },
  "2RW.F": {
    "city": "Yokneam Illit",
    "country": "Israel",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ReWalk Robotics Ltd.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "REWALK ROBOTICS  IS -,01",
    "state": null,
    "summary": "ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.",
    "website": "http://www.rewalk.com",
    "zipcode": "2069203"
  },
  "2SE.SG": {
    "city": "Gent",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Sequana Medical NV",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Sequana Medical NV Actions Nom.",
    "state": null,
    "summary": "Sequana Medical NV, a commercial stage medical device company, focuses on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure in Switzerland, Germany, and internationally. Its products include alfapump, a treatment solution for the management of liver refractory ascites and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with volume overload due to heart failure. The company was founded in 2006 and is headquartered in Ghent, Belgium.",
    "website": "http://www.sequanamedical.com",
    "zipcode": "9052"
  },
  "2TX.F": {
    "city": "Durham",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Asensus Surgical, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ASENSUS SURGICAL  DL-,001",
    "state": "NC",
    "summary": "Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera; and SurgiBot System, a single-port robotically enhanced laparoscopic surgical platform. Its products also comprise instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Durham, North Carolina.",
    "website": "http://www.asensus.com",
    "zipcode": "27703"
  },
  "2X7.F": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "OrthoPediatrics Corp.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ORTHOPEDIATRICS DL-,00025",
    "state": "IN",
    "summary": "OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.orthopediatrics.com",
    "zipcode": "46582"
  },
  "300003.SZ": {
    "city": "Beijing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Lepu Medical Technology (Beijing) Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "LEPU MEDICAL TECHN",
    "state": null,
    "summary": "Lepu Medical Technology (Beijing) Co., Ltd. develops, produces, and sells medical devices and equipment. The company offers cardiovascular interventional products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, tourniquets, inflation devices, and PCI accessories; structural heart diseases products, including occluders, vascular plugs, delivery systems, and mechanical heart valves; cardiac rhythm management products, which include pacemakers, equipment, leads, and electrophysiology; off-pump coronary artery bypass grafting surgical cardiology products; and PTA balloons and guide wires peripheral interventional products. It also provides critical care products, such as vascular access products, needle free connectors, blood samplers, and pressure transducers; floor and suspended type digital subtraction angiography systems; in vitro diagnostic equipment and biomarkers; hemodialysis catheters and hollow fiber dialyzers; and general surgery products, including surgical staplers and endo surgery accessories. In addition, the company offers cardiovascular system drugs, such as antithrombotic, hypolipidemic, antihypertensive, antianginal, and heart failure treatment; Ã-lactamase antibiotics and antifungal antimicrobial drugs; central nervous system drugs comprises painkillers and antidepressants; gastric/duodenal ulcer and chronic liver disease treatment drugs; respiratory system drugs; hypoproteinemia drugs; and activating blood circulation drugs. Further, it provides precision medicine, ECG telemonitoring, and cardiovascular disease consulting and management center services; medical S&T incubation and equity investment, and medical financial services; consultation, online pharmacy, and household medical equipment services; smart devices; and specialized hospital services for cardiovascular diseases, as well as involved in the co-construction of Cath lab. The company was founded in 1999 and is headquartered in Beijing, China.",
    "website": "http://en.lepumedical.com",
    "zipcode": "102200"
  },
  "300206.SZ": {
    "city": "Shenzhen",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Edan Instruments, Inc.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "EDAN INSTRUMENTS I",
    "state": null,
    "summary": "Edan Instruments, Inc. engages in the research, development, manufacture, and sale of medical equipment worldwide. The company offers diagnostic electrocardiograph (ECG) products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as vital signs, transport, and central monitoring systems, as well as high acuity cares, acute and sub-acute cares, telemetry, and pulse oximetry products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, and video colposcopes. It also provides ultrasound imaging systems that include color doppler ultrasound and B/W digital ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers. In addition, the company offers point-of-care testing systems, including blood gas and chemistry, magnetic immunoassay, and colloidal gold-labeled immunoassay analyzers; and veterinary ultrasound, ECG, ABG, and monitoring products. Edan Instruments, Inc. is headquartered in Shenzhen, the People's Republic of China.",
    "website": "http://www.edan.com.cn",
    "zipcode": "518122"
  },
  "300246.SZ": {
    "city": "Zhuhai",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Guangdong Biolight Meditech Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "GUANGDONG BIOLIGHT",
    "state": null,
    "summary": "Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. It offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. The company operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.",
    "website": "http://www.blt.com.cn",
    "zipcode": null
  },
  "300273.SZ": {
    "city": "Zhuhai",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Zhuhai Hokai Medical Instruments Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ZHUHAI HOKAI MEDIC",
    "state": null,
    "summary": "Zhuhai Hokai Medical Instruments Co., Ltd. provides medical equipment in China. The company offers minimally invasive tumor, medical imaging, and rehabilitation and conventional equipment; tumor and interventional discipline, and rehabilitation discipline construction services; artificial intelligence system solutions; and medical gas, clean, and auxiliary engineering services. It also provides in-hospital and regional medical information, and telemedicine services, as well as hospital construction; medical supply chain and logistics management; and financial leasing services. Zhuhai Hokai Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Zhuhai, China.",
    "website": "http://www.hokai.com",
    "zipcode": "519030"
  },
  "300289.SZ": {
    "city": "Beijing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Beijing Leadman Biochemistry Co.,Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "BEIJING LEADMAN BI",
    "state": null,
    "summary": "Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products in the People's Republic of China. The company offers biochemical raw materials, such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemistry diagnostic and companion reagents. In addition, the company offers medical instruments, such as EnigmaML, an automated molecular test platform for use in clinical laboratory and at the point-of-care, including clinics, doctor's surgeries, and pharmacies; DiaSys InnovaStar, an automatic compact POCT analyzer to deliver result quality comparable to measurements on laboratory analyzers; DiaSys Respons, a random access bench top analyzer; CI1000 automatic chemiluminescence immunoassay analyzers; and IDS-isys, an instrument to enhance performance and productivity. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.",
    "website": "http://www.leadmanbio.com",
    "zipcode": "100176"
  },
  "300298.SZ": {
    "city": "Changsha",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Sinocare Inc.",
    "market": "cn_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SINOCARE INC",
    "state": null,
    "summary": "Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.",
    "website": "http://www.sinocare.com",
    "zipcode": "410205"
  },
  "300314.SZ": {
    "city": "Ningbo",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Ningbo David Medical Device Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "NINGBO DAVID MEDIC",
    "state": null,
    "summary": "Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and distribution of medical equipment in China and internationally. The company primarily provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It also offers other products, such as infusion pumps, ultrasonic doppler fetal heartbeat detectors, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, breath resuscitation bags, infant oxygen hoods, far infrared heaters, mother-infant beds, and infant head fixing units. The company offers its products under David brand name. Ningbo David Medical Device Co., Ltd. was founded in 1992 and is headquartered in Ningbo, China.",
    "website": "http://www.nbdavid.com",
    "zipcode": "315712"
  },
  "300318.SZ": {
    "city": "Beijing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Beijing Bohui Innovation Biotechnology Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "BEIJING BOHUI INNO",
    "state": null,
    "summary": "Beijing Bohui Innovation Biotechnology Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, fluorescence immunochromatography analyzer, and human body element detection system; and chemical analysis products, such as atomic fluorescence spectrometer, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, life sciences related consumables, and ICP spectrum. The company was formerly known as Beijing Bohui Innovation Technology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Co., Ltd. in July 2018. Beijing Bohui Innovation Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.",
    "website": "http://www.bohui-tech.com",
    "zipcode": null
  },
  "300529.SZ": {
    "city": "Zhuhai",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Jafron Biomedical Co.,Ltd.",
    "market": "cn_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "JAFRON BIOMEDICAL",
    "state": null,
    "summary": "Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biomaterials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatoid immune diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as disinfectants, online hemodialysis B powder bags/buckets, hemodialysis concentrates, PGA absorbable sutures with needles, and resin bandages. The company offers its products in Germany, Austria, Greece, Turkey, Vietnam, India, Thailand, Iran, Malaysia, Bangladesh, Bulgaria, the Philippines, Sweden, Uganda, Ethiopia, and internationally. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.",
    "website": "http://www.jafron.com",
    "zipcode": "519085"
  },
  "300562.SZ": {
    "city": "Zhongshan",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Guangdong Transtek Medical Electronics Co., Ltd",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "GUANGDONG TRANSTEK",
    "state": null,
    "summary": "Guangdong Transtek Medical Electronics Co., Ltd designs, manufactures, and sells medically approved products, connected healthcare devices, and smart wearables in China. The company offers wearable devices, such as mambo 2, ziva, bonbon, mambo HR, and mambo watches; blood pressure monitors; and electronic scales. Guangdong Transtek Medical Electronics Co., Ltd was founded in 2002 and is based in Zhongshan, China.",
    "website": "http://www.transtek.cn",
    "zipcode": null
  },
  "300633.SZ": {
    "city": "Shenzhen",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "SonoScape Medical Corp.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SONOSCAPE MEDICAL",
    "state": null,
    "summary": "SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.",
    "website": "http://www.sonoscape.com",
    "zipcode": null
  },
  "300642.SZ": {
    "city": "Shanghai",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Tellgen Corporation",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "TELLGEN CORPORATIO",
    "state": null,
    "summary": "Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.",
    "website": "http://www.tellgen.com",
    "zipcode": "201203"
  },
  "300760.SZ": {
    "city": "Shenzhen",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Shenzhen Mindray Bio-Medical Electronics Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "SHENZHEN MINDRAY B",
    "state": null,
    "summary": "Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in the People's Republic of China. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a subsidiary of Mindray Medical International Limited.",
    "website": "http://www.mindray.com",
    "zipcode": "518057"
  },
  "300813.SZ": {
    "city": "Hangzhou",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Zhejiang Tailin BioEngineering Co.,Ltd",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ZHEJIANG TAILIN BI",
    "state": null,
    "summary": "Zhejiang Tailin BioEngineering Co.,Ltd manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. The company offers sterility testing equipment, microbiological testing equipment, TOC analyzers, sterile isolation systems, hydrogen peroxide sterilization systems, sterile delivery system, and filters, as well as technical services. Its products are primarily used in bio-pharmaceutical, medical, disease control, food, environmental protection, electronics, and other fields, as well as in bio-security equipment manufacturing industries. The company was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. Zhejiang Tailin BioEngineering Co.,Ltd was founded in 1993 and is based in Hangzhou, China.",
    "website": "http://www.tailingood.com",
    "zipcode": "310052"
  },
  "300869.SZ": {
    "city": "Qinhuangdao",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHZ",
    "industry": "Medical Devices",
    "long_name": "Contec Medical Systems Co.,Ltd",
    "market": "cn_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CONTEC MEDICAL SYS",
    "state": null,
    "summary": "Contec Medical Systems Co.,Ltd engages in the research, manufacture, and distribution of medical instruments. The company's products include electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, monitors, stethoscopes, simulators, analyzers, nebulizers, ultrasound equipment, oxygen concentrators, predictive thermometers, syringe and infusion pumps, and EMG/EP systems; ECG monitors and workstations; and EEG, pulmonary function, home, telemedicine, veterinary, electronic colposcopy, and Capnography related products. It sells its products through distributors in China and internationally. The company was founded in 1992 and is based in Qinhuangdao, China.",
    "website": "http://www.contecmed.com",
    "zipcode": "066004"
  },
  "3079.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "DVx Inc.",
    "market": "jp_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "DVX INC.",
    "state": null,
    "summary": "DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.",
    "website": "http://www.dvx.jp",
    "zipcode": "171-0033"
  },
  "308.F": {
    "city": "Billerica",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Conformis, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CONFORMIS INC.  DL-,00001",
    "state": "MA",
    "summary": "Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee; and iTotal Identity, a knee system. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Argentina, the United Arab Emirates, the Sultanate of Oman, Italy, San Marino, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.",
    "website": "http://www.conformis.com",
    "zipcode": "01821"
  },
  "3373.TWO": {
    "city": "Hsinchu City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Radiant Innovation Inc.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RADIANT INNOVATION INC",
    "state": null,
    "summary": "Radiant Innovation Inc. designs and develops infrared technology products. It offers medical infrared thermometers, industrial use infrared thermometers, and CO2 monitors. The company also provides infrared ear and forehead thermometers, multi-function thermometers, disposable probe covers, and TMS products. Radiant Innovation Inc. was founded in 2000 and is based in Hsinchu City, Taiwan.",
    "website": "http://www.radiantek.com.tw",
    "zipcode": "300"
  },
  "36M.F": {
    "city": "Santa Clara",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ShockWave Medical, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SHOCKWAVE MEDICAL DL-,001",
    "state": "CA",
    "summary": "ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.",
    "website": "http://www.shockwavemedical.com",
    "zipcode": "95054"
  },
  "37S.F": {
    "city": "Ecully",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Spineway Société Anonyme",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SPINEWAY  EO-,0001",
    "state": null,
    "summary": "Spineway SociÃ©tÃ© Anonyme engages in the design, manufacture, and marketing of implant lines and surgical equipment for treating spinal column pathologies. The company offers Ayers Rock, an anterior cervical interbody fusion cage; Blue Mountain, an anterior cervical interbody fusion plate; Mont Blanc, a posterior thoracolumbar system; Mont Blanc Baby, a posterior thoracolumbar pediatric system; Mont Blanc 3D+, a posterior for direct correction; Kili, an anterior lumbar interbody fusion cage; Twin peaks PLIF bullet shaped posterior lumbar interbody fusion cages; Twin peaks OLIF oblique lumbar interbody fusion cages; Twin peaks TLIF transforaminal lumbar interbody fusion cages; and Mont Blanc MIS, a mini-invasive thoracolumbar system. It also provides Sonora and Neve bone substitutes; Rift lumbar and Rift cervical instrumentation for spinal surgery; and Rift invasive solution. In addition, the company exports its products to approximately 50 countries through distributors. Spineway SociÃ©tÃ© Anonyme was founded in 2005 and is headquartered in Ecully, France.",
    "website": "http://www.spineway.com",
    "zipcode": "69130"
  },
  "37S.SG": {
    "city": "Ecully",
    "country": "France",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Spineway Société Anonyme",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Spineway Actions au Port. EO -,",
    "state": null,
    "summary": "Spineway SociÃ©tÃ© Anonyme engages in the design, manufacture, and marketing of implant lines and surgical equipment for treating spinal column pathologies. The company offers Ayers Rock, an anterior cervical interbody fusion cage; Blue Mountain, an anterior cervical interbody fusion plate; Mont Blanc, a posterior thoracolumbar system; Mont Blanc Baby, a posterior thoracolumbar pediatric system; Mont Blanc 3D+, a posterior for direct correction; Kili, an anterior lumbar interbody fusion cage; Twin peaks PLIF bullet shaped posterior lumbar interbody fusion cages; Twin peaks OLIF oblique lumbar interbody fusion cages; Twin peaks TLIF transforaminal lumbar interbody fusion cages; and Mont Blanc MIS, a mini-invasive thoracolumbar system. It also provides Sonora and Neve bone substitutes; Rift lumbar and Rift cervical instrumentation for spinal surgery; and Rift invasive solution. In addition, the company exports its products to approximately 50 countries through distributors. Spineway SociÃ©tÃ© Anonyme was founded in 2005 and is headquartered in Ecully, France.",
    "website": "http://www.spineway.com",
    "zipcode": "69130"
  },
  "39I.F": {
    "city": "Pinkenba",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ImpediMed Limited",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMPEDIMED LTD",
    "state": "QLD",
    "summary": "ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.",
    "website": "http://www.impedimed.com",
    "zipcode": "4008"
  },
  "3E0.F": {
    "city": "Alajuela",
    "country": "Costa Rica",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Establishment Labs Holdings Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ESTABLISHMENT LABS HLDGS",
    "state": null,
    "summary": "Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.",
    "website": "http://www.establishmentlabs.com",
    "zipcode": null
  },
  "3L3.F": {
    "city": "Minneapolis",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Tactile Systems Technology, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "TACTILE SYS TECH. DL-,001",
    "state": "MN",
    "summary": "Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.",
    "website": "http://www.tactilemedical.com",
    "zipcode": "55416"
  },
  "4104.TW": {
    "city": "New Taipei City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TAI",
    "industry": "Medical Devices",
    "long_name": "Excelsior Medical Co., Ltd.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EXCELSIOR MEDICAL CO LTD",
    "state": null,
    "summary": "Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.",
    "website": "http://www.excelsiormedical.com.tw",
    "zipcode": "235"
  },
  "4121.TWO": {
    "city": "Taipei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Rossmax International Ltd.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ROSSMAX INTERNATIONAL",
    "state": null,
    "summary": "Rossmax International Ltd. develops and supplies healthcare products and solutions in Taiwan. The company offers activity monitor, a device for monitoring and tracking fitness-related metrics, such as distance walked or run, counting steps, and calories burned; body fat monitors that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pad for therapy; and anti-decubitus mattresses. In addition, the company operates rossmax healthstyle app, which offers distributors the possibility to manage their store locations, product promotions, and local events; and health station for pharmacies, doctors, and public places. It provides healthcare products in the fields of cardiovascular, diabetes, respiratory, fever, and wound healing diseases. The company also exports its products. Rossmax International Ltd. was incorporated in 1988 and is headquartered in Taipei City, Taiwan.",
    "website": "http://www.rossmax.com",
    "zipcode": "114"
  },
  "4129.TWO": {
    "city": "New Taipei City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "United Orthopedic Corporation",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "UNITED ORTHOPEDIC CORPORATION",
    "state": null,
    "summary": "United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and orthopedic surgical instruments. It offers orthopedic surgical equipment and its manufacturing equipment; and special metal and plastics materials, as well as education, service, and support for surgeons and hospital. The company's products portfolio includes artificial hip joints, including partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine products consisting of vertebral fixation devices. It Corporation also provides injury and other orthopedic products comprise orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws; and OEM products, such as orthopedic internal fixation. In addition, the imports and exports its products. It serves in Taiwan, Asia, the United States, Europe, Africa, and Australia. The company was founded in 1993 and is headquartered in New Taipei City, Taiwan. United Orthopedic Corporation is a subsidiary of Chi-Yi Investment Co. Ltd.",
    "website": "http://www.uoc.com.tw",
    "zipcode": "23452"
  },
  "4129A.TWO": {
    "city": "New Taipei City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "United Orthopedic Corporation",
    "market": "tw_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "UNITED ORTHOPEDIC CORPORATION",
    "state": null,
    "summary": "United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and orthopedic surgical instruments. It offers orthopedic surgical equipment and its manufacturing equipment; and special metal and plastics materials, as well as education, service, and support for surgeons and hospital. The company's products portfolio includes artificial hip joints, including partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine products consisting of vertebral fixation devices. It Corporation also provides injury and other orthopedic products comprise orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws; and OEM products, such as orthopedic internal fixation. In addition, the imports and exports its products. It serves in Taiwan, Asia, the United States, Europe, Africa, and Australia. The company was founded in 1993 and is headquartered in New Taipei City, Taiwan. United Orthopedic Corporation is a subsidiary of Chi-Yi Investment Co. Ltd.",
    "website": "http://www.uoc.com.tw",
    "zipcode": "23452"
  },
  "4161.TWO": {
    "city": "Zhunan",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Bioptik Technology Incorporation",
    "market": "tw_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BIOPTIK TECH INC",
    "state": null,
    "summary": "Bioptik Technology Incorporation researches, develops, produces, and sells medical devices and reagents in Taiwan and internationally. The company offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. It also provides skin care products and dietary supplements, as well as biodiesel products. The company was founded in 1999 and is headquartered in Zhunan, Taiwan.",
    "website": "http://www.bioptik.com.tw",
    "zipcode": "35057"
  },
  "4188.TWO": {
    "city": "Taipei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "AmCad BioMed Corporation",
    "market": "tw_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AMCAD BIOMED CORPORATION",
    "state": null,
    "summary": "AmCad BioMed Corporation develops computer-assisted detection and diagnosis (CAD) software devices primarily in Taiwan. Its products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO, a solution for obstructive sleep apnea detection. The company is also developing AmCAD-CA, a software designed for analyzing digital cytological images; AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UV, a software device that is used for quantifying and classifying the ultrasonic color intensity data acquired from FDA-cleared ultrasound systems and displaying the noise-reduced color-coded pulsatile signals. The company was founded in 2008 and is based in Taipei City, Taiwan.",
    "website": "http://amcad.com.tw",
    "zipcode": "104"
  },
  "4548.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Seikagaku Corporation",
    "market": "jp_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SEIKAGAKU CORP",
    "state": null,
    "summary": "Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. The company operates in two segments, Pharmaceuticals and LAL. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN, OPEGAN Hi, and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and cross-linked hyaluronate hydrogel for knee osteoarthritis under the brand name Gel-One, as well as HERNICORE for the treatment of lumbar disc herniation. The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics. In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals, biological products, medical devices, manufacturing processes, and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Further, the company develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for osteoarthritis; SI-613-ETP to treat enthesopathy; and SI-449, a powdered adhesion barrier. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.",
    "website": "http://www.seikagaku.co.jp",
    "zipcode": "100-0005"
  },
  "4549.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Eiken Chemical Co., Ltd.",
    "market": "jp_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "EIKEN CHEMICAL CO",
    "state": null,
    "summary": "Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.",
    "website": "http://www.eiken.co.jp",
    "zipcode": "110-8408"
  },
  "46K.F": {
    "city": "Winter Springs",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "IRadimed Corporation",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "IRADIMED CORP.  DL-,0001",
    "state": "FL",
    "summary": "IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.",
    "website": "http://www.iradimed.com",
    "zipcode": "32708"
  },
  "46K.SG": {
    "city": "Winter Springs",
    "country": "United States",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "IRadimed Corporation",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "iRadimed Corp. Registered Share",
    "state": "FL",
    "summary": "IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.",
    "website": "http://www.iradimed.com",
    "zipcode": "32708"
  },
  "46L.SG": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "SeaSpine Holdings Corporation",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SeaSpine Holdings Corp. Registe",
    "state": "CA",
    "summary": "SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and demineralized bone matrices. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive surgery, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical spine. The company has development and licensing agreement with restor3d, Inc. and 7D Surgical, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.",
    "website": "http://www.seaspine.com",
    "zipcode": "92008"
  },
  "4735.TWO": {
    "city": "New Taipei City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "AViTA Corporation",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "AVITA CORPORATION",
    "state": null,
    "summary": "AViTA Corporation manufactures and sells home healthcare products for clinical and personal use. It offers various OEM/ODM solutions. The company's products include non-contact thermometers, infrared/forehead thermometers, arm and wrist type blood pressure monitors, and electronic lice combs. AViTA Corporation was founded in 1996 and is headquartered in New Taipei City, Taiwan.",
    "website": "http://www.avita.com.tw",
    "zipcode": "24158"
  },
  "4736.TWO": {
    "city": "New Taipei City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "TaiDoc Technology Corporation",
    "market": "tw_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "TAIDOC TECHNOLOGY CORPORATION",
    "state": null,
    "summary": "TaiDoc Technology Corporation manufactures and markets medical devices worldwide. It offers diagnostics products, including blood glucose and multiple parameters monitoring systems, point of care testing devices, lancet and lancing devices, and vet health care products comprise blood glucose and calcium meters, non-contact forehead thermometers, and blood ketone meters; and medical devices, such as nebulizers, thermometers, blood pressure monitors, vital sign monitors, medical kiosk, pulse oximeters, and weight scale. The company also provides telehealth remote monitoring devices and smartphone applications; and Covid-19 antigen rapid test kits. In addition, it offers services for regulatory professionals, as well as in the areas of clinical suggestions, engineering resources, and manufacturing systems. The company was founded in 1998 and is headquartered in New Taipei City, Taiwan.",
    "website": "http://www.taidoc.com",
    "zipcode": "24888"
  },
  "4745.TWO": {
    "city": "Shanghai",
    "country": "China",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Cowealth Medical Holding Co., Ltd.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "COWEALTH MEDICAL HOLDING CO LTD",
    "state": null,
    "summary": "Cowealth Medical Holding Co., Ltd. operates as a medical distribution company primarily in the diagnostic clinical laboratory field in Greater China market. It also specializes in reagent, cross-strait hospital department cooperation, and radiotherapy fields. In addition, the company undertakes the Summit project, which consolidates outside procurement of diagnostic reagents at prices as before; and provides related with related logistics management services. The company was founded in 1997 and is based in Shanghai, China.",
    "website": "http://www.cowealthholding.com",
    "zipcode": "200233"
  },
  "49Z.F": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cellink AB (publ)",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CELLINK AB AK B  O.N.",
    "state": null,
    "summary": "Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. In addition, the company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. Further, it offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It has strategic partnership with Made In Space for advancing bioprinting technology in space. The company also offers products online. Cellink AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.cellink.com",
    "zipcode": "413 46"
  },
  "4G8.F": {
    "city": "Villepinte",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Guerbet SA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "GUERBET SA INH.  EO 1",
    "state": null,
    "summary": "Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide. Its products for the CT and Cath Lab examinations include Optiray, a low osmolar contrast medium; Xenetix, a low-osmolar iodinated agent; Telebrix, a high osmolar contrast medium; Conray and MD high osmolar contrast medium products; Hexabrix, an ionic low osmolar contrast medium agent; and Micropaque/ Microtrast, a diagnostic imaging interconnected solution. The company's products for the magnetic resonance imaging examinations comprise Dotarem, a non-specific gadolinium-based contrast medium; Artirem products; and Optimark, a contrast medium. In addition, it provides products for interventional imaging, including Lipiodol ethyl esters of iodinated fatty acids of poppy seed oil; Vectorio, a classic transarterial chemoembolization mixing and injection system; Patent Blue V, an injectable medium; and SeQure and DraKon, a microcatheters. Further, the company offers delivery systems and services comprising injectors; consumables for various types of injectors; Contrast&Care, a patient data management software; Dose&Care, an operational solution for monitoring patient exposure to ionizing radiation; and Hydra Vision, a digital imaging system for urological, gastroenterological, gynecological treatment, and planning and diagnostic procedures. The company distributes its products directly, as well as through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France.",
    "website": "http://www.guerbet.com",
    "zipcode": "93420"
  },
  "4HG.F": {
    "city": "Helsingborg",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Qlife Holding AB (publ)",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "QLIFE HOLDING AB",
    "state": null,
    "summary": "Qlife Holding AB (publ), a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. It offers Egoo Home System, an integrated platform consisting of a small home device and disposable capsules each of that test for a specific biomarker, as well as a digital infrastructure that shares data with patient journal or hospital platform. The company has a research agreement with NordsjÃ¦llands Hospital to continue the validation of the Egoo Sars-CoV-2 virus test. The company was founded in 2019 and is based in Helsingborg, Sweden.",
    "website": "http://qlifeholding.com/en",
    "zipcode": "252 21"
  },
  "4KM.SG": {
    "city": "Sedgefield",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Kromek Group plc",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Kromek Group PLC Registered Sha",
    "state": null,
    "summary": "Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for medical imaging, nuclear detection, and security screening markets in the United Kingdom, North America, Asia, Europe, and Australasia. Its solutions provide high-resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and EV-CPG compact gamma ray detectors, as well as quant GR1 shielded gamma detectors, multichannel analyzers, CZT-based gamma ray imagers, quant air, scalable x-ray CZR linear array, gamma-ray spectroscopy software, gamma ray radionuclide detectors, and voltage to frequency converters. In addition, it offers medical imaging products, including CZT gamma detector for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT. Further, the company provides security products, such as D3 PRD high accuracy, D3M, and D3S PRD personal radiation detectors; D3S wearable RIID gamma neutron detectors; D3S NET networked radiation detectors and static node; static radiation detector; vehicle mounted radiation detectors; UAV radiation mapping drone and AARM system; liquid explosive detection algorithm; and Identifier liquid explosive detectors. Additionally, it engages in scientific research and development activities. The company sells its products through distributors, OEM, and direct sales. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.",
    "website": "http://www.kromek.com",
    "zipcode": "TS21 3FD"
  },
  "4PC.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Perimeter Medical Imaging AI, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PERIMETER MED.IMAG.AI",
    "state": "ON",
    "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.perimetermed.com",
    "zipcode": "M5E 1E6"
  },
  "4WO.F": {
    "city": "Suzhou",
    "country": "China",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Peijia Medical Limited",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "PEIJIA MEDICAL  HD -,01",
    "state": null,
    "summary": "Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. Its product candidates include transcatheter aortic valve replacement (TAVR) products, such as TaurusOne, a transcatheter aortic valve replacement system, including prosthetic aortic valve, delivery catheter system, and LS; TaurusElite, a second-generation TAVR device; and TaurusNXT, a third-generation TAVR device. The company is also developing transcatheter mitral valve replacement devices for the treatment of mitral regurgitation; and transcatheter tricuspid valve replacement devices for the treatment of tricuspid regurgitation. In addition, it is developing lithotripsy and balloon aortic valvuloplasty catheters, introducer sheaths, guidewires, and mitral repair devices. Further, the company is developing neurointerventional procedural products, such as stent retrievers; balloon guide and dilatation, distal access, intermediate, and aspiration catheters; and balloon microcatheter, heat-fusion detachable coils, intracranial stents, and detachable coils. Peijia Medical Limited was founded in 2012 and is headquartered in Suzhou, the People's Republic of China.",
    "website": "http://www.peijiamedical.com",
    "zipcode": "215028"
  },
  "4Z7.F": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "IRRAS AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IRRAS AB",
    "state": null,
    "summary": "IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. It also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include Hummingbird Quad ICP monitoring with drainage (H610), and Hummingbird Solo ICP monitoring (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was incorporated in 2011 and is headquartered in Stockholm, Sweden.",
    "website": "http://www.irras.com",
    "zipcode": "111 20"
  },
  "5187.T": {
    "city": "Yokohama",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Create Medic Co., Ltd.",
    "market": "jp_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CREATE MEDIC CO",
    "state": null,
    "summary": "Create Medic Co., Ltd. researches, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products. The company also provides other products, such as CLINY tracheostomy tubes, endotracheal tubes, tracheostomy tubes, and micro catheters. In addition, it offers OEM products comprising multi-lumen tubes, ultrathin-walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was founded in 1974 and is headquartered in Yokohama, Japan.",
    "website": "http://www.createmedic.co.jp",
    "zipcode": "224-0037"
  },
  "569.SI": {
    "city": "Singapore",
    "country": "Singapore",
    "currency": "SGD",
    "exchange": "SES",
    "industry": "Medical Devices",
    "long_name": "Vicplas International Ltd",
    "market": "sg_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Vicplas Intl",
    "state": null,
    "summary": "Vicplas International Ltd, an investment holding company, engages in the medical devices, and pipes and pipe fittings businesses in Singapore, Malaysia, and China. It manufactures and distributes piping systems for various industries, including waste and potable water systems for residential homes, schools, and commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies. The company also designs, develops, manufactures, and assembles sterile and non-sterile medical devices; sells pharmaceutical products; and provides project design and engineering services. The company was founded in 1993 and is based in Singapore. Vicplas International Ltd is a subsidiary of Venner Capital S.A.",
    "website": "http://www.vicplas.com",
    "zipcode": "629110"
  },
  "5HJ0.F": {
    "city": "Irvine",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Hancock Jaffe Laboratories, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "HANC. JAFFE LAB.DL-,00001",
    "state": "CA",
    "summary": "Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.",
    "website": "http://www.hancockjaffe.com",
    "zipcode": "92618"
  },
  "5I0.SI": {
    "city": "Singapore",
    "country": "Singapore",
    "currency": "SGD",
    "exchange": "SES",
    "industry": "Medical Devices",
    "long_name": "QT Vascular Ltd.",
    "market": "sg_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "$ QT Vascular",
    "state": null,
    "summary": "QT Vascular Ltd., together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation; and Glider PTCA balloon catheter for the treatment of various complex lesions. It also provides Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for atraumatic dilatation in the treatment of blocked arteries; Chocolate Touch PTA balloon catheter to treat peripheral vascular disease; GliderfleX PTA balloon catheter for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature. It has operations in the United States, Europe, and Singapore. The company was incorporated in 2005 and is based in Singapore.",
    "website": "http://www.qtvascular.com",
    "zipcode": "609966"
  },
  "5J3.F": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "SciBase Holding AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SCIBASE HOLDING AB",
    "state": null,
    "summary": "SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.",
    "website": "http://www.scibase.com",
    "zipcode": "172 63"
  },
  "5J6.F": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "OssDsign AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OSSDSIGN AB",
    "state": null,
    "summary": "OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage, as well as nanosynthetic bone graft substitute for treating skeletal defect. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.",
    "website": "http://www.ossdsign.com",
    "zipcode": "754 50"
  },
  "5JE.F": {
    "city": "Tullinge",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Bactiguard Holding AB (publ)",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "BACTIGUARD HLDG B",
    "state": null,
    "summary": "Bactiguard Holding AB (publ), a medical device company, engages in the research and development, production, marketing, and sale of infection prevention solutions. Its infection prevention solutions prevent healthcare associated infections caused by medical devices. The company's products portfolio reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube that reduces the risk of infection; BIP Endotracheal Tube Evac, which is used to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that combines surveillance and infection prevention. The company's products also include Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for chronic and acute wounds; surgical sutures comprise of non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement for use in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. The company serves in the United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zealand, and internationally. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.",
    "website": "http://www.bactiguard.com",
    "zipcode": "146 21"
  },
  "5NXA.F": {
    "city": "Helsinki",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Nexstim Plc",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NEXSTIM OYJ",
    "state": null,
    "summary": "Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression order or chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.",
    "website": "http://www.nexstim.com",
    "zipcode": "00510"
  },
  "5TX.F": {
    "city": "Boca Raton",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Sensus Healthcare, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SENSUS HEALTHCARE  DL-,01",
    "state": "FL",
    "summary": "Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary modulated robotic brachytherapy oncology therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.",
    "website": "http://www.sensushealthcare.com",
    "zipcode": "33487"
  },
  "5V7.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "VentriPoint Diagnostics Ltd.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VENTRIPOINT DIAGNOSTICS",
    "state": "ON",
    "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
    "website": "http://www.ventripoint.com",
    "zipcode": "M2N 5Y7"
  },
  "5XS2.F": {
    "city": "Beverly",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "LexaGene Holdings Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "LEXAGENE HLDGS",
    "state": "MA",
    "summary": "LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.",
    "website": "http://www.lexagene.com",
    "zipcode": "01915"
  },
  "600055.SS": {
    "city": "Beijing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Beijing Wandong Medical Technology Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "BEIJING WANDONG MEDICAL TECHNOL",
    "state": null,
    "summary": "Beijing Wandong Medical Technology Co., Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic equipment. The company offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, general and mobile X-ray, and C-arm equipment; and veterinary imaging solutions. It operates in approximately 70 countries worldwide. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. The company was founded in 1955 and is headquartered in Beijing, China.",
    "website": "http://www.wandong.com.cn",
    "zipcode": "100015"
  },
  "600587.SS": {
    "city": "Zibo",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Shinva Medical Instrument Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SHINVA MEDICAL INSTRUMENT CO LT",
    "state": null,
    "summary": "Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers dental devices, diagnostic equipment, environmental protection equipment, laboratory instruments, OR equipment, and air disinfectors; and radiation oncology products, such as linear accelerators, simulators, brachytherapy systems, Cobalt 60 therapy units, 3D treatment planning systems, radiotherapy networking information systems, and radiotherapy accessories. The company also provides infection control equipment and consumables; pharmaceutical equipment, including washing, sterilization, IV solution, packing, lyophilization, solid, extraction, package material, automatic ampoule impurity detecting, vials sterile filling, biological reaction tank equipment, as well as process information system; and integrated solutions and medical medicine services. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is based in Zibo, the People's Republic of China.",
    "website": "http://www.shinva.com",
    "zipcode": "255086"
  },
  "603387.SS": {
    "city": "Nanjing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Getein Biotech, Inc",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "GETEIN BIOTECH INC",
    "state": null,
    "summary": "Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally. The company provides diagnostic reagents and analyzers; calibrators; reagent raw materials, such as monoclonal and polyclonal antibodies, antigen, antiserum, and microsphere; and cardiac marker, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus products. It also offers products in the area of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and others. The company was founded in 2002 and is headquartered in Nanjing, China.",
    "website": "http://www.bio-gp.com.cn",
    "zipcode": "211505"
  },
  "6118.HK": {
    "city": "Beijing",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Austar Lifesciences Limited",
    "market": "hk_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AUSTAR",
    "state": null,
    "summary": "Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, in-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Beijing, China.",
    "website": "http://www.austar.com.hk",
    "zipcode": null
  },
  "61LA.F": {
    "city": "LinkÃ¶ping",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Sectra AB (publ)",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SECTRA AB B(P.S.)SK 0,125",
    "state": null,
    "summary": "Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company's Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society's critical operations. The company's Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in LinkÃ¶ping, Sweden.",
    "website": "http://www.sectra.com",
    "zipcode": "583 30"
  },
  "6572.TWO": {
    "city": "Taipei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "PlexBio Co., Ltd.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PlexBio",
    "state": null,
    "summary": "PlexBio Co., Ltd. designs, develops, and manufactures multiplexing platforms and assays to enable genetic research and clinical cancer diagnostics. It offers IntelliPlex SARS-CoV-2/Flu Kit, an in vitro diagnostic device; IntelliPlex SARS-CoV-2 Detection Kit, an automated solution for testing during the coronavirus disease; IntelliPlex Lung Cancer Panel-cfDNA, a molecular assay for mutations; IntelliPlex Lung Cancer Panel Â cfRNA, which detects various variants of the ALK, ROS1, RET, NTRK1, and MET genes using cell-free RNA derived from plasma of patients with NSCLC; IntelliPlex Lung Cancer Panel, which detects various DNA mutations; IntelliPlex BRAF V600 Mutation Kit, a single well solution for mutations; IntelliPlex EGFR Mutation Kit, a molecular assay for somatic mutations; IntelliPlex KRAS Mutation Plus Kit, a solution for clinically actionable mutations; IntelliPlex NRAS Mutation Kit, a single well mutation kit; IntelliPlex PIK3CA Mutation Kit, a PCR mutation kit; IntelliPlex ALK Rearrangement Kit, a single well solution for actionable ALK gene rearrangements; IntelliPlex RET/NTRK1 Rearrangement Kit, a single well RET and NTRK1 gene rearrangement kit; IntelliPlex ROS1 Rearrangement Kit, a molecular assay for clinical actionable gene rearrangements; IntelliPlex Food Testing Kit for Dairy, a single well solution for bacteria; and pCode Coupling Buffer Set, a solution for coupling process. The company also offers IntelliPlex 1000 pCode Processor, a hybridization, washing, incubation, and labeling solution; PlexBio 100 Fluorescent Analyzer, an optical imaging system; DigiPlex Thermocycler, an instrument for PCR amplification; pCode MicroDisc, a solution for multiplexing applications; PlexBio Magnetic Stand, a solution for paramagnetic pCode precipitation; pCode Coupling Buffer Set, a solution to-use buffers; and DeXipher software for data analysis and interpretation. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei City, Taiwan.",
    "website": "http://www.plexbio.com",
    "zipcode": "11491"
  },
  "6598.TW": {
    "city": "Santa Fe Springs",
    "country": "United States",
    "currency": "TWD",
    "exchange": "TAI",
    "industry": "Medical Devices",
    "long_name": "Applied BioCode Corporation",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "APPLIED BIOCODE CORPORATION",
    "state": "CA",
    "summary": "Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. It also develops assays, such as BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and BioCode sexually transmitted infections (STI) panels for detection of common infectious agents causing STDs, as well as MDx assays pipeline for various molecular tests. In addition, the company offers human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Further, it provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. The company was founded in 2016 and is based in Santa Fe Springs, California.",
    "website": "http://www.apbiocode.com",
    "zipcode": "90703"
  },
  "6633.TWO": {
    "city": "Zhubei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Somnics, Inc.",
    "market": "tw_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Somnics",
    "state": null,
    "summary": "Somnics, Inc., a medical device company, focuses on developing technologies for the treatment of obstructive sleep apnea (OSA). The company offers iNAP One and iNAP Lite sleep therapy systems, which utilize oral negative pressure technology to treat OSA, a sleep-related breathing disorder. Somnics, Inc. was founded in 2011 and is based in Zhubei, Taiwan.",
    "website": "http://www.somnics.com",
    "zipcode": "30261"
  },
  "6649.TWO": {
    "city": "Zhubei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Taiwan Biomaterial Co., Ltd.",
    "market": "tw_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "TAIWAN BIOMATERIAL CO LTD",
    "state": null,
    "summary": "Taiwan Biomaterial Co., Ltd. develops and sells medical devices in Taiwan. The company provides Foamagen, an absorbable biomaterial for dura reconstruction after surgeries; stroke interventional treatment devices; and devices for the treatment of early degenerative arthritis, and tissue repair and regeneration. Taiwan Biomaterial Co., Ltd. is based in Zhubei, Taiwan.",
    "website": "http://www.twbm.com.tw",
    "zipcode": "302"
  },
  "6734.TWO": {
    "city": "Taipei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "iXensor Co., Ltd.",
    "market": "tw_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "iXensor",
    "state": null,
    "summary": "iXensor Co., Ltd. develops, produces, and sells hardware and software systems for in-vitro diagnostic medical devices. The company's PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the biochemical test strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System for women's health management; and systems for infectious disease management, as well as PixoHealth App, which measures, records, and uploads test readings to the cloud. The company was founded in 2012 and is based in Taipei, Taiwan.",
    "website": "http://www.ixensor.com",
    "zipcode": "11492"
  },
  "6747.TWO": {
    "city": "Taipei City",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Brighten Optix Corporation",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BRIGHTEN OPTIX CORPORATION",
    "state": null,
    "summary": "Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable (GP) lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. It also provides OEM/ODM collaboration services. The company is based in Taipei City, Taiwan.",
    "website": "http://www.brightenoptix.com.tw",
    "zipcode": "11167"
  },
  "6767.TWO": {
    "city": "Zhubei",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Wiltrom Co., Ltd.",
    "market": "tw_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "WILTROM CO LTD",
    "state": null,
    "summary": "Wiltrom Co., Ltd. researches, develops, and produces a range of implantable medical devices. Its products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. The company is based in Zhubei, Taiwan.",
    "website": "http://www.wiltrom.com.tw",
    "zipcode": "30261"
  },
  "6796.TWO": {
    "city": "Hsinchu",
    "country": "Taiwan",
    "currency": "TWD",
    "exchange": "TWO",
    "industry": "Medical Devices",
    "long_name": "Medimaging Integrated Solution Inc.",
    "market": "tw_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MiiS",
    "state": null,
    "summary": "Medimaging Integrated Solution Inc. provides digital and portable diagnostic solutions. It designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. The company was founded in 2010 and is based in Hsinchu, Taiwan.",
    "website": "http://www.miis.com.tw",
    "zipcode": "30077"
  },
  "6823.T": {
    "city": "Kokubunji",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Rion Co., Ltd.",
    "market": "jp_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RION CO LTD",
    "state": null,
    "summary": "Rion Co., Ltd. manufactures, sells, and maintains hearing instruments, medical equipment, sound and vibration measuring instruments, particle counters, and related parts and equipment in Japan and internationally. The company's audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom made, and analog body aid instruments, as well as waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and accelerometers, recorders, and other products. The company's particle counters comprise air and liquid- borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.",
    "website": "http://www.rion.co.jp",
    "zipcode": "185-8533"
  },
  "6849.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Nihon Kohden Corporation",
    "market": "jp_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "NIHON KOHDEN CORP",
    "state": null,
    "summary": "Nihon Kohden Corporation develops, produces, and sells medical electronic equipment in Japan and internationally. It provides physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring systems, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. The company also offers patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables and services, such as electrodes and sensors, and maintenance services. In addition, it provides treatment equipment, which include defibrillators, automated external defibrillators (AED), pacemakers, ventilators, anesthesia machines, cochlear implants, and related consumables and services, such as AED pads and batteries. Further, the company offers other medical equipment, including hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Nihon Kohden Corporation was founded in 1951 and is headquartered in Tokyo, Japan.",
    "website": "http://www.nihonkohden.com",
    "zipcode": "161-8560"
  },
  "688016.SS": {
    "city": "Shanghai",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Shanghai MicroPort Endovascular MedTech Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SHANGHAI MICROPORT ENDOVASCULAR",
    "state": null,
    "summary": "Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company was founded in 2012 and is based in Shanghai, the People's Republic of China. Shanghai MicroPort Endovascular MedTech Co., Ltd. is a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.",
    "website": "http://www.endovastec.com",
    "zipcode": "201318"
  },
  "688085.SS": {
    "city": "Shanghai",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Shanghai Sanyou Medical Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SHANGHAI SANYOU MEDICAL CO LTD",
    "state": null,
    "summary": "Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and z-minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee system, knee system, and palm and wrist systems. Shanghai Sanyou Medical Co., Ltd. is based in Shanghai, China.",
    "website": "http://www.sanyoumed.com",
    "zipcode": null
  },
  "688139.SS": {
    "city": "Qingdao",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Qingdao Haier Biomedical Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "QINGDAO HAIER BIOMEDICAL CO LTD",
    "state": null,
    "summary": "Qingdao Haier Biomedical Co., Ltd. engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples worldwide. The company offers preservation equipment, biological safety cabinets, liquid nitrogen containers, cryogenic supplies, and CO2 incubators, as well as WHO/PQS certificated equipment. It provides storage solutions for biological sample banks and medical supplies, as well as blood, vaccine, and reagent safety. The company was founded in 2005 and is based in Qingdao, China.",
    "website": "http://www.haierbiomedical.com",
    "zipcode": "266101"
  },
  "688338.SS": {
    "city": "Beijing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Beijing Succeeder Technology Inc.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "BEIJING SUCCEEDER TECHNOLOGY IN",
    "state": null,
    "summary": "Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered in Beijing, China.",
    "website": "http://www.succeeder.com.cn",
    "zipcode": "102200"
  },
  "688580.SS": {
    "city": "Nanjing",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "Nanjing Vishee Medical Technology Co., Ltd",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "NANJING VISHEE MEDICAL TECHNOLO",
    "state": null,
    "summary": "Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.",
    "website": "http://www.vishee.com",
    "zipcode": "210012"
  },
  "688607.SS": {
    "city": "Suzhou",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "CareRay Digital Medical Technology Co., Ltd.",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CARERAY DIGITAL MEDICAL TECHNOL",
    "state": null,
    "summary": "CareRay Digital Medical Technology Co., Ltd. develops and produces digital X-ray flat panel detectors. The company offers wireless, wired, dynamic and breast flat panel, and industrial flat panel detectors, as well as accessories and tablet cases. Its products are used in medical, pet, security, and industrial imaging diagnostic products. The company was founded in 2007 and is headquartered in Suzhou, China.",
    "website": "http://www.careray.cn",
    "zipcode": "215123"
  },
  "688656.SS": {
    "city": "Suzhou",
    "country": "China",
    "currency": "CNY",
    "exchange": "SHH",
    "industry": "Medical Devices",
    "long_name": "HOB Biotech Group Corp.,Ltd",
    "market": "cn_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "HOB BIOTECH GROUP CORP LTD",
    "state": null,
    "summary": "HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.",
    "website": "http://www.hobiotech.com",
    "zipcode": "215123"
  },
  "6960.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Fukuda Denshi Co., Ltd.",
    "market": "jp_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "FUKUDA DENSHI CO",
    "state": null,
    "summary": "Fukuda Denshi Co., Ltd. develops, manufactures, and sells medical electronic equipment worldwide. It provides resting electrocardiograph products; data management software; stress test products; Holter products and software; and patient monitoring systems, including central and bedside monitors, digital transmitters, and central viewer workstations. The company also offers defibrillator monitors; and ultrasound scanners, as well as vascular screening systems. Fukuda Denshi Co., Ltd. was founded in 1948 and is based in Tokyo, Japan.",
    "website": "http://www.fukuda.co.jp",
    "zipcode": "113-8420"
  },
  "6IO.F": {
    "city": "Goleta",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Inogen, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "INOGEN INC.  DL -,001",
    "state": "CA",
    "summary": "Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.",
    "website": "http://www.inogen.com",
    "zipcode": "93117"
  },
  "6L9.F": {
    "city": "Oakwood",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ViewRay, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "VIEWRAY INC.",
    "state": "OH",
    "summary": "ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.",
    "website": "http://www.viewray.com",
    "zipcode": "44146"
  },
  "6W5.F": {
    "city": "Vincennes",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "SpineGuard SA",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SPINEGUARD  EO -,05",
    "state": null,
    "summary": "SpineGuard SA provides designs, develops, and markets medical devices used in surgical procedures worldwide. The company provides PediGuard Straight probe for screw placement; PediGuard Curved probe that includes a tapered tip to enhance the ease of penetrating through pedicle; PediGuard Cannulated probe primarily for helping surgeons reduce radiation exposure during minimally-invasive procedures; and PediGuard Threaded Device, a drilling instrument. It also offers DSG (Dynamic Surgical Guidance) Connect app, which allows collection and visualization of the signal measured at the tip of DSG connect devices during pedicle drilling; and DSG smart screw allows for one step screw placement treatment. The company serves patients, surgeons, operating room staff, and health care providers. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France.",
    "website": "http://www.spineguard.com",
    "zipcode": "94300"
  },
  "6YC.F": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Senzime AB (publ)",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SENZIME AB AK",
    "state": null,
    "summary": "Senzime AB (publ) develps and markets patient monitoring systems to monitor patients under anesthesia in Europe and the United States. The company offers TetraGraph, a TOF-monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; CliniSenz Analyzer, which detects early signs of complications; and Onzurf Probe for sampling from the surface of an organ. Senzime AB (publ) was founded in 1999 and is based in Uppsala, Sweden.",
    "website": "http://www.senzime.com",
    "zipcode": "756 51"
  },
  "72X.F": {
    "city": "Shanghai",
    "country": "China",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MicroPort CardioFlow Medtech Corporation",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "MICROPORT CARDIO.MEDTECH.",
    "state": null,
    "summary": "MicroPort CardioFlow Medtech Corporation, a medical device company, focuses on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases in the People's Republic of China. Its products include Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, which targets aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China. MicroPort CardioFlow Medtech Corporation is a subsidiary of Shanghai MicroPort Limited.",
    "website": "http://www.cardioflowmedtech.com",
    "zipcode": "201203"
  },
  "7575.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Japan Lifeline Co., Ltd.",
    "market": "jp_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "JAPAN LIFELINE CO",
    "state": null,
    "summary": "Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. Its cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, and automated external defibrillators; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. The company's cardiovascular and vascular surgery products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.",
    "website": "http://www.japanlifeline.com",
    "zipcode": "140-0002"
  },
  "7779.T": {
    "city": "Tsukuba",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "CYBERDYNE Inc.",
    "market": "jp_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CYBERDYNE INC",
    "state": null,
    "summary": "CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as non-medical HAL; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides HAL Therapy, a medical service to provide medical treatment for functional improvement of patients with cerebral, nervous, spinal cord injury, and cerebral embolism disorders; and non-medical services, such as HAL FIT and ROBO CARE training programs. The company operates 16 Neuro HALFIT service centers. CYBERDYNE Inc. has a strategic partnership with CellSource Co., Ltd. to jointly discover new treatment methods for patients with osteoarthritis of the knee caused by aging. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.",
    "website": "http://www.cyberdyne.jp",
    "zipcode": "305-0818"
  },
  "782.F": {
    "city": "VÃ¤sterÃ¥s",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Scandinavian Real Heart AB (Publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SCANDINAV. REAL HEART AB",
    "state": null,
    "summary": "Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. The company engages in developing total artificial heart that provides solutions to patients diagnosed with advanced congestive heart failure. It also develops Realheart VAD, Realheart PulsePump, and Realheart Sternal prosthetic products. The company was founded in 2007 and is based in VÃ¤sterÃ¥s, Sweden.",
    "website": "http://realheart.se",
    "zipcode": "722 13"
  },
  "7963.T": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "JPY",
    "exchange": "JPX",
    "industry": "Medical Devices",
    "long_name": "Koken Ltd.",
    "market": "jp_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "KOKEN LTD",
    "state": null,
    "summary": "Koken Ltd., together with its subsidiaries, produces and sells occupational personal protective equipment in Japan and internationally. It operates in Mask-Related Business and Other Businesses segments. The company offers clean air solutions, including KOACH, an open clean zone creator; KOKENLAMINAR, a push-pull ventilation system; and LAMIKOACH, an air ventilation system as contamination source control. It also provides IMADEZE, a copper-based lactate antibacterial agent; masks for medical facilities and general consumers; and functional water production systems, such as electrolyzed water generators, endoscope washers/disinfectors, blood stain washer kits, and portable showers, as well as magnetic water treatment systems. In addition, the company offers respirators for industrial use, including particulate respirators, powered air-purifying respirators, supplied air respirators, chemical cartridge respirators, and gas masks; respirators for general consumers; equipment for accident and disaster countermeasures; and protective clothes, ear plugs, face shields, etc. Koken Ltd. was founded in 1943 and is headquartered in Tokyo, Japan.",
    "website": "http://www.koken-ltd.co.jp",
    "zipcode": null
  },
  "7AC.F": {
    "city": "MalmÃ¶",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Acarix AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ACARIX AB",
    "state": null,
    "summary": "Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases. The company offers CADScor System for the diagnosis of coronary artery disease. It operates in Germany, Sweden, Denmark, and internationally. Acarix AB (publ) was founded in 2009 and is headquartered in MalmÃ¶, Sweden.",
    "website": "http://www.acarix.com",
    "zipcode": "211 19"
  },
  "7IN.F": {
    "city": "Menlo Park",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Intersect ENT, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "INTERSECT ENT  DL-,001",
    "state": "CA",
    "summary": "Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL and PROPEL Mini, which are steroid releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.",
    "website": "http://www.intersectent.com",
    "zipcode": "94025"
  },
  "7UD.F": {
    "city": "OzarÃ³w Mazowiecki",
    "country": "Poland",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Braster S.A.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BRASTER A,B  ZY-,10",
    "state": null,
    "summary": "Braster S.A. produces and sells at-home breast cancer examination devices worldwide. It provides Braster System, an in-home breast examination system for individual customers; and Braster Pro, a breast examination system for professional use by healthcare professionals. The company was formerly known as BRASTER spÃ³lka z ograniczona odpowiedzialnoscia and changed its name to Braster S.A. in December 2012. Braster S.A. was founded in 2008 and is headquartered in OzarÃ³w Mazowiecki, Poland.",
    "website": "http://www.braster.eu",
    "zipcode": "05-850"
  },
  "8BP.F": {
    "city": "Issoire",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Biocorp Production",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BIOCORP PRODUCTION EO-,05",
    "state": null,
    "summary": "Biocorp Production designs, develops, and manufactures medical devices and drug delivery systems in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Onejet, a motor driven disposable auto-injector designed to deliver viscosity products; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France.",
    "website": "http://biocorpsys.com",
    "zipcode": "63500"
  },
  "8C4.F": {
    "city": "Tsukuba",
    "country": "Japan",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "CYBERDYNE Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CYBERDYNE INC.",
    "state": null,
    "summary": "CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as non-medical HAL; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides HAL Therapy, a medical service to provide medical treatment for functional improvement of patients with cerebral, nervous, spinal cord injury, and cerebral embolism disorders; and non-medical services, such as HAL FIT and ROBO CARE training programs. The company operates 16 Neuro HALFIT service centers. CYBERDYNE Inc. has a strategic partnership with CellSource Co., Ltd. to jointly discover new treatment methods for patients with osteoarthritis of the knee caused by aging. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.",
    "website": "http://www.cyberdyne.jp",
    "zipcode": "305-0818"
  },
  "8CT.F": {
    "city": "Burnaby",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cannabix Technologies Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CANNABIX TECHS INC.",
    "state": "BC",
    "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
    "website": "http://www.cannabixtechnologies.com",
    "zipcode": "V5A 4R4"
  },
  "8HH.F": {
    "city": "Alpharetta",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Avanos Medical, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AVANOS MEDICAL INC.DL-,01",
    "state": "GA",
    "summary": "Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.",
    "website": "http://avanos.com",
    "zipcode": "30004"
  },
  "8IM1.F": {
    "city": "Zug",
    "country": "Switzerland",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Implantica AG",
    "market": "dr_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "IMPLANTICA AG  SDR./1",
    "state": null,
    "summary": "Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company develops RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux. It also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energising platform; AppetiteControl, an implant to treat obesity by controlling appetite; and UriControl, a remote controlled implant to treat urinary incontinence for men and women. The company was founded in 2015 and is based in Zug, Switzerland.",
    "website": "http://www.implantica.com",
    "zipcode": "6300"
  },
  "8YY.SI": {
    "city": "Singapore",
    "country": "Singapore",
    "currency": "SGD",
    "exchange": "SES",
    "industry": "Medical Devices",
    "long_name": "Biolidics Limited",
    "market": "sg_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "$ Biolidics",
    "state": null,
    "summary": "Biolidics Limited, a medical technology company, develops cell enrichment systems for cancer diagnosis, prognosis, and treatment selection and monitoring applications. The company engages in the research, experimental development, and marketing on biotechnology, life and medical science, and electronics related industrial design services. It offers ClearCell FX1 System, an automated in vitro diagnostic medical device that separates and enriches cancer cells from blood. The company has a strategic collaboration with Sysmex Corporation. It serves academic and research institutes, hospitals, and laboratories in Singapore, China, Hong Kong, Japan, the United States, and other European Union countries. The company was founded in 2009 and is based in Singapore.",
    "website": "http://www.biolidics.com",
    "zipcode": "577177"
  },
  "8ZF.F": {
    "city": "Durham",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Polarean Imaging plc",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "POLAREAN IMAG.LS-,00037",
    "state": "NC",
    "summary": "Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.",
    "website": "http://www.polarean.com",
    "zipcode": "27713"
  },
  "9996.HK": {
    "city": "Suzhou",
    "country": "China",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Medical Devices",
    "long_name": "Peijia Medical Limited",
    "market": "hk_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "PEIJIA-B",
    "state": null,
    "summary": "Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. Its product candidates include transcatheter aortic valve replacement (TAVR) products, such as TaurusOne, a transcatheter aortic valve replacement system, including prosthetic aortic valve, delivery catheter system, and LS; TaurusElite, a second-generation TAVR device; and TaurusNXT, a third-generation TAVR device. The company is also developing transcatheter mitral valve replacement devices for the treatment of mitral regurgitation; and transcatheter tricuspid valve replacement devices for the treatment of tricuspid regurgitation. In addition, it is developing lithotripsy and balloon aortic valvuloplasty catheters, introducer sheaths, guidewires, and mitral repair devices. Further, the company is developing neurointerventional procedural products, such as stent retrievers; balloon guide and dilatation, distal access, intermediate, and aspiration catheters; and balloon microcatheter, heat-fusion detachable coils, intracranial stents, and detachable coils. Peijia Medical Limited was founded in 2012 and is headquartered in Suzhou, the People's Republic of China.",
    "website": "http://www.peijiamedical.com",
    "zipcode": "215028"
  },
  "9MH.F": {
    "city": "Mississauga",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MedX Health Corp",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDX HEALTH CORP.",
    "state": "ON",
    "summary": "MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.",
    "website": "http://www.medxhealth.com",
    "zipcode": "L5T 1M2"
  },
  "A1BM34.SA": {
    "city": "Danvers",
    "country": "United States",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Abiomed, Inc.",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABIOMED INC DRN",
    "state": "MA",
    "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.",
    "website": "http://www.abiomed.com",
    "zipcode": "01923"
  },
  "A1LG34.SA": {
    "city": "Tempe",
    "country": "United States",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Align Technology, Inc.",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ALIGN TECHNODRN",
    "state": "AZ",
    "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.",
    "website": "http://www.aligntech.com",
    "zipcode": "85281"
  },
  "AAQ1.DE": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "aap Implantate AG",
    "market": "de_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AAP IMPLANTATE AG O.N.",
    "state": null,
    "summary": "aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.",
    "website": "http://www.aap.de",
    "zipcode": "12099"
  },
  "AAQ1.F": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "aap Implantate AG",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AAP IMPLANTATE AG O.N.",
    "state": null,
    "summary": "aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.",
    "website": "http://www.aap.de",
    "zipcode": "12099"
  },
  "ABL.DE": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "de_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABS",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABL.F": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABS",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABMD": {
    "city": "Danvers",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Abiomed, Inc.",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABIOMED, Inc.",
    "state": "MA",
    "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.",
    "website": "http://www.abiomed.com",
    "zipcode": "01923"
  },
  "ABMD.MX": {
    "city": "Danvers",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Abiomed, Inc.",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABIOMED INC",
    "state": "MA",
    "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.",
    "website": "http://www.abiomed.com",
    "zipcode": "01923"
  },
  "ABMT": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Advanced Biomedical Technologies, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ADVANCED BIOMEDICAL TECHNOLOGIE",
    "state": "NY",
    "summary": "Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.",
    "website": "http://abtlafleur.com",
    "zipcode": "10166"
  },
  "ABT": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "us_market",
    "market_cap": "Mega Cap",
    "sector": "Healthcare",
    "short_name": "Abbott Laboratories",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABT.BA": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "ARS",
    "exchange": "BUE",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "ar_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABS",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABT.MX": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABORATORIES",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABT.SN": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "USD",
    "exchange": "SGO",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "cl_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABS",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABT.SW": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "CHF",
    "exchange": "EBS",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "ch_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABOR",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABT.VI": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "at_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT LABORATORIES",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ABTT34.SA": {
    "city": "North Chicago",
    "country": "United States",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Abbott Laboratories",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABBOTT      DRN",
    "state": "IL",
    "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃ©niÃ¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.",
    "website": "http://www.abbott.com",
    "zipcode": "60064-6400"
  },
  "ACARIX.ST": {
    "city": "MalmÃ¶",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Acarix AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Acarix AB",
    "state": null,
    "summary": "Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases. The company offers CADScor System for the diagnosis of coronary artery disease. It operates in Germany, Sweden, Denmark, and internationally. Acarix AB (publ) was founded in 2009 and is headquartered in MalmÃ¶, Sweden.",
    "website": "http://www.acarix.com",
    "zipcode": "211 19"
  },
  "ADDV-A.ST": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "ADDvise Group AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ADDvise Group AB A",
    "state": null,
    "summary": "ADDvise Group AB (publ) develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, and Asia. The company's Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit develops, manufactures, and markets vacuum mattresses, pillows and splints, and vacuum products, as well as equipment for pilots, such as flight suits and Anti-G suits; healthcare equipment, such as bags and carrying systems, as well as equipment and consumable materials, such as intra-osseous and biopsy needles; equipment for patient positioning, primarily within urology and gynecology areas; and surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.",
    "website": "http://www.addvisegroup.se",
    "zipcode": "114 46"
  },
  "ADDV-B.ST": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "ADDvise Group AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ADDvise Group AB B",
    "state": null,
    "summary": "ADDvise Group AB (publ) develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, and Asia. The company's Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit develops, manufactures, and markets vacuum mattresses, pillows and splints, and vacuum products, as well as equipment for pilots, such as flight suits and Anti-G suits; healthcare equipment, such as bags and carrying systems, as well as equipment and consumable materials, such as intra-osseous and biopsy needles; equipment for patient positioning, primarily within urology and gynecology areas; and surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.",
    "website": "http://www.addvisegroup.se",
    "zipcode": "114 46"
  },
  "ADMT": {
    "city": "Northvale",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "ADM Tronics Unlimited, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ADM TRONICS UNLIMITED INC",
    "state": "NJ",
    "summary": "ADM Tronics Unlimited, Inc., together with its subsidiary, develops, manufactures, and sells electronics for non-invasive, electrotherapeutic, and diagnostic medical devices, veterinary, and other applications in the United States, Australia, Asia, and Europe. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. It also provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. In addition, the company offers water-based, adhesive, and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Further, it provides contract manufacturing services; and research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products. The company was founded in 1969 and is headquartered in Northvale, New Jersey.",
    "website": "http://www.admtronics.com",
    "zipcode": "07647"
  },
  "ADR.AX": {
    "city": "Auckland",
    "country": "New Zealand",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Adherium Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ADHERIUM FPO",
    "state": null,
    "summary": "Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. It offers Hailie, an asthma and COPD medication adherence solution for patients with chronic respiratory diseases. The company also provides a range of smart device sensors for respiratory medications, such as Bluetooth enabled Hailie sensors wrap around a patient's existing inhalers and automatically send usage data to their smartphone; and Hailie app that enables patients, caregivers, and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. It offers its digital health solutions to patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company has a collaboration with HGE Health in COPD. The company was founded in 2001 and is headquartered in Auckland, New Zealand.",
    "website": "http://www.adherium.com",
    "zipcode": "1010"
  },
  "AEMD": {
    "city": "San Diego",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Aethlon Medical, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Aethlon Medical, Inc.",
    "state": "CA",
    "summary": "Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.",
    "website": "http://www.aethlonmedical.com",
    "zipcode": "92123"
  },
  "AFIB": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Acutus Medical, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Acutus Medical, Inc.",
    "state": "CA",
    "summary": "Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is based in Carlsbad, California.",
    "website": "http://www.acutusmedical.com",
    "zipcode": "92008"
  },
  "AFW.F": {
    "city": "Tempe",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Align Technology, Inc.",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ALIGN TECHNOLOGY DL-,0001",
    "state": "AZ",
    "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.",
    "website": "http://www.aligntech.com",
    "zipcode": "85281"
  },
  "AHCO": {
    "city": "Plymouth Meeting",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "AdaptHealth Corp.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "AdaptHealth Corp.",
    "state": "PA",
    "summary": "AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.",
    "website": "http://www.adapthealth.com",
    "zipcode": "19462"
  },
  "AHPI": {
    "city": "Saint Louis",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Allied Healthcare Products, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Allied Healthcare Products, Inc",
    "state": "MO",
    "summary": "Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. Allied Healthcare Products, Inc. was incorporated in 1979 and is headquartered in St. Louis, Missouri.",
    "website": "http://www.alliedhpi.com",
    "zipcode": "63110"
  },
  "AIO.F": {
    "city": "Danvers",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Abiomed, Inc.",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ABIOMED INC.  DL-,01",
    "state": "MA",
    "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.",
    "website": "http://www.abiomed.com",
    "zipcode": "01923"
  },
  "ALBLU.PA": {
    "city": "Elancourt",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Bluelinea Société Anonyme",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BLUELINEA",
    "state": null,
    "summary": "Bluelinea SociÃ©tÃ© Anonyme provides healthcare solutions for elderly and disabled people in France. The company offers SERENEA, a nursing call solution; BluePhone, a mobile phone with mobile remote assistance for seniors; BlueGard, a geolocation bracelet; prevention of night fall products; home automation solution for environmental control, opening automation, intercom/videophone, etc.; and fall and smoke detectors, call watches, and key boxes options and accessories. It also provides BlueHub packs and Handi Joysticks; IP nurse call, fugue control, autonomy bracelets, baby protection products, paging, and EHPADOM counters. The company was founded in 2006 and is headquartered in Elancourt, France.",
    "website": "http://bluelinea.com",
    "zipcode": "78990"
  },
  "ALCAR.PA": {
    "city": "VÃ©lizy-Villacoublay",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Carmat SA",
    "market": "fr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CARMAT",
    "state": null,
    "summary": "Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It also develops orthotopic, bioprosthetic, self-regulating, pulsatile, and implantable systems, as well as power supply systems. The company was founded in 2008 and is based in VÃ©lizy-Villacoublay, France.",
    "website": "http://www.carmatsa.com",
    "zipcode": "78140"
  },
  "ALCOR.PA": {
    "city": "Issoire",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Biocorp Production",
    "market": "fr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BIOCORP",
    "state": null,
    "summary": "Biocorp Production designs, develops, and manufactures medical devices and drug delivery systems in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Onejet, a motor driven disposable auto-injector designed to deliver viscosity products; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France.",
    "website": "http://biocorpsys.com",
    "zipcode": "63500"
  },
  "ALEMG.PA": {
    "city": "Mouy",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Euromedis Groupe",
    "market": "fr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EUROMEDIS GROUPE",
    "state": null,
    "summary": "Euromedis Groupe, together with its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals in France. It offers disposable medical gloves; surgical products, such as sensors, pockets, scalpels, etc.; hygiene and protection equipment comprising white-coats, masks, shoes, etc.; needles, syringes, infusers, catheters, transfusion equipment, etc.; and compresses, bandages, beds, etc. The company also provides incontinence products, as well as products related to hygiene; and home care products. In addition, it distributes medical-surgical equipment through a network of outlets under the Paramat name. Further, the company leases equipment; and provides home maintenance and hospitalization services. It also exports its products to Belgium, Italy, Morocco, Ivory Coast, Gabon, Benin, Algeria, Ireland, the Netherlands, Portugal, Tunisia, Switzerland, the Czech Republic, the United Kingdom, Germany, Finland, Spain, Greece, Hungary, Lithuania, Latvia, Bulgaria, and Poland. Euromedis Groupe was founded in 1985 and is based in Mouy, France.",
    "website": "http://www.euromedis.fr",
    "zipcode": "60290"
  },
  "ALGN": {
    "city": "Tempe",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Align Technology, Inc.",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Align Technology, Inc.",
    "state": "AZ",
    "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.",
    "website": "http://www.aligntech.com",
    "zipcode": "85281"
  },
  "ALGN.MX": {
    "city": "Tempe",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Align Technology, Inc.",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ALIGN TECHNOLOGY INC",
    "state": "AZ",
    "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.",
    "website": "http://www.aligntech.com",
    "zipcode": "85281"
  },
  "ALGN.VI": {
    "city": "Tempe",
    "country": "United States",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "Align Technology, Inc.",
    "market": "at_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ALIGN TECHNOLOGY INC",
    "state": "AZ",
    "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.",
    "website": "http://www.aligntech.com",
    "zipcode": "85281"
  },
  "ALIMP.PA": {
    "city": "Martillac",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Implanet S.A.",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMPLANET",
    "state": null,
    "summary": "Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.",
    "website": "http://www.implanet.com",
    "zipcode": "33650"
  },
  "ALMD.TA": {
    "city": "Caesarea",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Allmed Solutions Ltd",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ALLMED SOLUTIONS",
    "state": null,
    "summary": "Allium Medical Solutions Ltd., a medical device company, develops, manufactures, and markets minimally invasive products in Israel and internationally. The company offers covered stents, such as ureteral, round posterior, triangular prostatic, bulbar, and biliary stents. It also provides uro-gynecology products, including EndoFast Reliant Systems for reinforcement; EndoFast Resorb kits for fixation of surgical mesh to tissues for tissue reinforcement; EndoFast Reliant MN, an implantable, sub-urethral support sling for the treatment of male stress urinary incontinence; and EndoFast Reliant SCP for fixation of surgical mesh to tissue for tissue reinforcement during laparotomy or laparoscopic Sacrocolpopexy approach. In addition, the company offers gastro-duodenal sleeves for the treatment of diabetes mellitus and obesity; and WIRION EPD system, an embolic protection system. Allium Medical Solutions Ltd. is headquartered in Caesarea, Israel.",
    "website": "http://www.allium-medical.com",
    "zipcode": "3088900"
  },
  "ALRT": {
    "city": "Richmond",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "ALR Technologies Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ALR TECHNOLOGIES INC",
    "state": "VA",
    "summary": "ALR Technologies Inc. develops compliance monitoring systems that enable health care professionals to remotely monitor patient health conditions in the United States. The company's product includes Diabetes Management System, which consists of a communications software platform that enables health professionals to monitor the health progress of patients with diabetes. Its primary business markets are the providers of health insurance and the providers of disease and case management services, including the home care industry. The company was formerly known as Mo Betta Corp. and changed its name to ALR Technologies Inc. in December 1998. ALR Technologies Inc. was founded in 1987 and is headquartered in Richmond, Virginia.",
    "website": "http://www.alrt.com",
    "zipcode": "23225"
  },
  "ALSGD.PA": {
    "city": "Vincennes",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "SpineGuard SA",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SPINEGUARD",
    "state": null,
    "summary": "SpineGuard SA provides designs, develops, and markets medical devices used in surgical procedures worldwide. The company provides PediGuard Straight probe for screw placement; PediGuard Curved probe that includes a tapered tip to enhance the ease of penetrating through pedicle; PediGuard Cannulated probe primarily for helping surgeons reduce radiation exposure during minimally-invasive procedures; and PediGuard Threaded Device, a drilling instrument. It also offers DSG (Dynamic Surgical Guidance) Connect app, which allows collection and visualization of the signal measured at the tip of DSG connect devices during pedicle drilling; and DSG smart screw allows for one step screw placement treatment. The company serves patients, surgeons, operating room staff, and health care providers. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France.",
    "website": "http://www.spineguard.com",
    "zipcode": "94300"
  },
  "ALSPW.PA": {
    "city": "Ecully",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Spineway Société Anonyme",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SPINEWAY",
    "state": null,
    "summary": "Spineway SociÃ©tÃ© Anonyme engages in the design, manufacture, and marketing of implant lines and surgical equipment for treating spinal column pathologies. The company offers Ayers Rock, an anterior cervical interbody fusion cage; Blue Mountain, an anterior cervical interbody fusion plate; Mont Blanc, a posterior thoracolumbar system; Mont Blanc Baby, a posterior thoracolumbar pediatric system; Mont Blanc 3D+, a posterior for direct correction; Kili, an anterior lumbar interbody fusion cage; Twin peaks PLIF bullet shaped posterior lumbar interbody fusion cages; Twin peaks OLIF oblique lumbar interbody fusion cages; Twin peaks TLIF transforaminal lumbar interbody fusion cages; and Mont Blanc MIS, a mini-invasive thoracolumbar system. It also provides Sonora and Neve bone substitutes; Rift lumbar and Rift cervical instrumentation for spinal surgery; and Rift invasive solution. In addition, the company exports its products to approximately 50 countries through distributors. Spineway SociÃ©tÃ© Anonyme was founded in 2005 and is headquartered in Ecully, France.",
    "website": "http://www.spineway.com",
    "zipcode": "69130"
  },
  "ALSSI.PA": {
    "city": "Aix-en-Provence",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "SuperSonic Imagine SA",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SUPERSONIC IMAGINE",
    "state": null,
    "summary": "SuperSonic Imagine SA operates as a medical technology company. The company designs, develops, and markets Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution; and Aixplorer MACH ultrasound machines. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company serves China, the United States, France, Asia, and the Europe, Middle East, and Africa. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.",
    "website": "http://www.supersonicimagine.fr",
    "zipcode": "13857"
  },
  "ALT.AX": {
    "city": "Brisbane",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Analytica Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ANALYTICA FPO",
    "state": "QLD",
    "summary": "Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.",
    "website": "http://www.analyticamedical.com",
    "zipcode": "4000"
  },
  "ALTER.PA": {
    "city": "Marne-la-VallÃ©e",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Theradiag SA",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERADIAG",
    "state": null,
    "summary": "Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis Âµ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LISA tracker, a tool for monitoring of biotherapies, as well as Elisa and rapid tests for SARS-CoV 2 serology. The company was founded in 1986 and is based in Marne La Vallee, France.",
    "website": "http://www.theradiag.com",
    "zipcode": "77435"
  },
  "ALTHE.PA": {
    "city": "Malakoff",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Theraclion SA",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERACLION",
    "state": null,
    "summary": "Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was incorporated in 2004 and is based in Malakoff, France.",
    "website": "http://www.theraclion.com",
    "zipcode": "92240"
  },
  "AMEUF": {
    "city": "Toowong",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Anteris Technologies Ltd",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ANTERIS TECHNOLOGIES LTD",
    "state": "QLD",
    "summary": "Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. It also researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.",
    "website": "http://www.anteristech.com",
    "zipcode": "4066"
  },
  "AMT.AX": {
    "city": "Lane Cove West",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Allegra Orthopaedics Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ALLEGRA FPO",
    "state": "NSW",
    "summary": "Allegra Orthopaedics Limited designs, sells, and distributes orthopaedic implant products in Australia and New Zealand. The company operates through Orthopaedics Division and Innovation Division segments. It offers adult and adolescent clavicle fixation systems; shoulder implants; ulna heads, compression screws, distal radius systems, and hand fracture systems; reconstruction prosthesis, modular tumor and revision systems, partial pelvis replacement, cementless stems, cups, and ceramic prosthesis heads for hips; and knee replacement systems and knee distal first instruments. The company also provides foot and ankle products, such as total ankle replacement systems, toe products, A-curve handles, screws, staples, and foot systems; surgical screws, sawblades, and kirschner wires and pins; NanoFx, a solution for microfracture; and face shields and mask strap holders. The company was formerly known as Advanced Surgical Design & Manufacture Limited and changed its name to Allegra Orthopaedics Limited in November 2014. Allegra Orthopaedics Limited was founded in 1994 and is based in Lane Cove West, Australia.",
    "website": "http://www.allegraorthopaedics.com",
    "zipcode": "2066"
  },
  "AOHA.F": {
    "city": "Irvine",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Rua Life Sciences Plc",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RUA LIFE SCIENCES  LS0,05",
    "state": null,
    "summary": "Rua Life Sciences Plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to Rua Life Sciences Plc in June 2020. Rua Life Sciences Plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.",
    "website": "http://www.rualifesciences.com",
    "zipcode": "KA11 5AN"
  },
  "APEN": {
    "city": "Austin",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Apollo Endosurgery, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Apollo Endosurgery, Inc.",
    "state": "TX",
    "summary": "Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.",
    "website": "http://www.apolloendo.com",
    "zipcode": "78746"
  },
  "APYX": {
    "city": "Clearwater",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Apyx Medical Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Apyx Medical Corporation",
    "state": "FL",
    "summary": "Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.",
    "website": "http://www.apyxmedical.com",
    "zipcode": "33760"
  },
  "ARAY": {
    "city": "Sunnyvale",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Accuray Incorporated",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Accuray Incorporated",
    "state": "CA",
    "summary": "Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.",
    "website": "http://www.accuray.com",
    "zipcode": "94089"
  },
  "ARCOMA.ST": {
    "city": "VÃ¤xjÃ¶",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Arcoma AB",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Arcoma AB",
    "state": null,
    "summary": "Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in VÃ¤xjÃ¶, Sweden.",
    "website": "http://www.arcoma.se",
    "zipcode": "352 46"
  },
  "ARX.AX": {
    "city": "Auckland",
    "country": "New Zealand",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Aroa Biosurgery Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "AROA BIO FPO",
    "state": null,
    "summary": "Aroa Biosurgery Limited, a regenerative medicine company, develops and manufactures medical devices for wound and tissue repair in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad, an implant and dermal procedures for soft tissue repair, reinforcement, and complex wounds; and Reinforced Bioscaffolds, a biologics and synthetics product used in surgical ventral hernia repair solutions. The company was founded in 2008 and is based in Auckland, New Zealand.",
    "website": "http://aroabio.com",
    "zipcode": "2150"
  },
  "ASAPF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Aurora Spine Corporation",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AURORA SPINE CORPORATION",
    "state": "ON",
    "summary": "Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. It also provides pain care services. The company was incorporated in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.aurora-spine.com",
    "zipcode": "M4S 3B1"
  },
  "ASG.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Aurora Spine Corporation",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AURORA SPINE CORPORATION",
    "state": "ON",
    "summary": "Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. It also provides pain care services. The company was incorporated in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.aurora-spine.com",
    "zipcode": "M4S 3B1"
  },
  "ASTI.CN": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Aquarius Surgical Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AquariusSurgTe",
    "state": "ON",
    "summary": "Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., manufactures, distributes, services, supports, and trains laser systems and consumables in various medical disciplines in Canada and the United States. Its products include Pathfinder laser for the treatment of benign prostate hyperplasia; HYPHO laser to treat urinary stone; Versafine FRx laser to address vaginal health related conditions associated with menopause; and ASTI's surgical lasers for supporting wavelengths and medical procedures. The company also offers clinical education, service, support, and maintenance services. The company was formerly known as Aquarius Coatings Inc. Aquarius Surgical Technologies Inc. was incorporated in 1986 and is based in Toronto, Canada.",
    "website": "http://aquariussurgical.com",
    "zipcode": "M5R 1G4"
  },
  "ASXC": {
    "city": "Durham",
    "country": "United States",
    "currency": "USD",
    "exchange": "ASE",
    "industry": "Medical Devices",
    "long_name": "Asensus Surgical, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Asensus Surgical, Inc.",
    "state": "NC",
    "summary": "Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera; and SurgiBot System, a single-port robotically enhanced laparoscopic surgical platform. Its products also comprise instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Durham, North Carolina.",
    "website": "http://www.asensus.com",
    "zipcode": "27703"
  },
  "AT1.AX": {
    "city": "Leichhardt",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Atomo Diagnostics Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ATOMO DIAG FPO",
    "state": "NSW",
    "summary": "Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. The company has operations in Europe, Asia, Africa, and Central and South America. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.",
    "website": "http://atomodiagnostics.com",
    "zipcode": "2040"
  },
  "ATEC": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Alphatec Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Alphatec Holdings, Inc.",
    "state": "CA",
    "summary": "Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.",
    "website": "http://www.atecspine.com",
    "zipcode": "92008"
  },
  "AVGR": {
    "city": "Redwood City",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Avinger, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Avinger, Inc.",
    "state": "CA",
    "summary": "Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.",
    "website": "http://www.avinger.com",
    "zipcode": "94063"
  },
  "AVH.AX": {
    "city": "Valencia",
    "country": "United States",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "AVITA Medical, Inc.",
    "market": "au_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AVITA MED CDI 5:1",
    "state": "CA",
    "summary": "AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.",
    "website": "http://www.avitamedical.com",
    "zipcode": "91355"
  },
  "AVHHL": {
    "city": "Valencia",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "AVITA Medical, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AVITA MEDICAL INC CDI 5:1",
    "state": "CA",
    "summary": "AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.",
    "website": "http://www.avitamedical.com",
    "zipcode": "91355"
  },
  "AVMR": {
    "city": "Orlando",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "AVRA Medical Robotics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AVRA MED ROBOTICS INC",
    "state": "FL",
    "summary": "AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.",
    "website": "http://www.avramedicalrobotics.com",
    "zipcode": "32826"
  },
  "AVNS": {
    "city": "Alpharetta",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Avanos Medical, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Avanos Medical, Inc.",
    "state": "GA",
    "summary": "Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.",
    "website": "http://avanos.com",
    "zipcode": "30004"
  },
  "AVO.L": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Advanced Oncotherapy plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ADVANCED ONCOTHERAPY PLC ORD 25",
    "state": null,
    "summary": "Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.",
    "website": "http://www.avoplc.com",
    "zipcode": "W1S 1TE"
  },
  "AVR.AX": {
    "city": "Toowong",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Anteris Technologies Ltd",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ANTERIS FPO",
    "state": "QLD",
    "summary": "Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. It also researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.",
    "website": "http://www.anteristech.com",
    "zipcode": "4066"
  },
  "AVTI": {
    "city": "Canton",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Avitar, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AVITAR INC",
    "state": "MA",
    "summary": "Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.",
    "website": null,
    "zipcode": "02021"
  },
  "AXGN": {
    "city": "Alachua",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "AxoGen, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AxoGen, Inc.",
    "state": "FL",
    "summary": "AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.",
    "website": "http://www.axogeninc.com",
    "zipcode": "32615"
  },
  "AXNX": {
    "city": "Irvine",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Axonics, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Axonics, Inc.",
    "state": "CA",
    "summary": "Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.",
    "website": "http://www.axonics.com",
    "zipcode": "92618"
  },
  "AZYO": {
    "city": "Silver Spring",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Aziyo Biologics, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Aziyo Biologics, Inc.",
    "state": "MD",
    "summary": "Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device; and cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. The company also provides FiberCel, ViBone, and OsterGro V that are designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.",
    "website": "http://www.aziyo.com",
    "zipcode": "20904"
  },
  "B3BN.F": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP.",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "B3BN.MU": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP.",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "B5G2.F": {
    "city": "Belgrade",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Lattice Biologics Ltd.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LATTICE BIOLOGICS LTD.",
    "state": "MT",
    "summary": "Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.",
    "website": "http://www.latticebiologics.com",
    "zipcode": "59714"
  },
  "BACTI-B.ST": {
    "city": "Tullinge",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Bactiguard Holding AB (publ)",
    "market": "se_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Bactiguard Holding AB ser. B",
    "state": null,
    "summary": "Bactiguard Holding AB (publ), a medical device company, engages in the research and development, production, marketing, and sale of infection prevention solutions. Its infection prevention solutions prevent healthcare associated infections caused by medical devices. The company's products portfolio reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube that reduces the risk of infection; BIP Endotracheal Tube Evac, which is used to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that combines surveillance and infection prevention. The company's products also include Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for chronic and acute wounds; surgical sutures comprise of non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement for use in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. The company serves in the United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zealand, and internationally. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.",
    "website": "http://www.bactiguard.com",
    "zipcode": "146 21"
  },
  "BBLG": {
    "city": "Burlington",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Bone Biologics Corporation",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BONE BIOLOGICS CORP",
    "state": "MA",
    "summary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.",
    "website": "http://www.bonebiologics.com",
    "zipcode": "01803"
  },
  "BFLY": {
    "city": "Guilford",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Butterfly Network, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Butterfly Network, Inc.",
    "state": "CT",
    "summary": "Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.",
    "website": "http://www.butterflynetwork.com",
    "zipcode": "06437"
  },
  "BIEL": {
    "city": "Frederick",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "BioElectronics Corporation",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BIOELECTRONICS CORP",
    "state": "MD",
    "summary": "BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain relief; Smart Insole, a heel pain solution; Allay, a drug-free micro medical device that uses electromagnetic pulse therapy to reduce menstrual pain and discomfort; RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. The company sells its products to wholesale distributors, hospitals and clinics, and consumers. BioElectronics Corporation was founded in 2000 and is headquartered in Frederick, Maryland.",
    "website": "http://www.bielcorp.com",
    "zipcode": "21704"
  },
  "BIIO": {
    "city": "Cham",
    "country": "Switzerland",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Bionovate Technologies Corp.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "BIONOVATE TECHNOLOGIES CORP",
    "state": null,
    "summary": "Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop and provide automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of September 28, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.",
    "website": null,
    "zipcode": "6330"
  },
  "BIO": {
    "city": "Hercules",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Bio-Rad Laboratories, Inc.",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Bio-Rad Laboratories, Inc.",
    "state": "CA",
    "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.",
    "website": "http://www.bio-rad.com",
    "zipcode": "94547"
  },
  "BIOL": {
    "city": "Foothill Ranch",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "BIOLASE, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Biolase, Inc.",
    "state": "CA",
    "summary": "BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.",
    "website": "http://www.biolase.com",
    "zipcode": "92610-2811"
  },
  "BIOV.TA": {
    "city": "Rehovot",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Bio-View Ltd",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "BIO VIEW",
    "state": null,
    "summary": "Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd was founded in 2000 and is headquartered in Rehovot, Israel.",
    "website": "http://www.bioview.com",
    "zipcode": "7670203"
  },
  "BIVWF": {
    "city": "Rehovot",
    "country": "Israel",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Bio-View Ltd",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BIO VIEW",
    "state": null,
    "summary": "Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd was founded in 2000 and is headquartered in Rehovot, Israel.",
    "website": "http://www.bioview.com",
    "zipcode": "7670203"
  },
  "BIZ-R.BK": {
    "city": "Bangkok",
    "country": "Thailand",
    "currency": "THB",
    "exchange": "SET",
    "industry": "Medical Devices",
    "long_name": "Business Alignment Public Company Limited",
    "market": "th_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BUSINESS ALIGNMENT PUBLIC COMPA",
    "state": null,
    "summary": "Business Alignment Public Company Limited engages in the distribution and installation of medical equipment and software system for cancer treatment through radiotherapy in Thailand. It imports and distributes radiation machine equipment. The company is also involved in the construction of building for locating medical equipment; and providing repair and maintenance services for medical equipment. It serves hospitals, ministry of public health, and public health departments and organizations. The company was founded in 2000 and is headquartered in Bangkok, Thailand.",
    "website": "http://www.bizalignment.com",
    "zipcode": "10500"
  },
  "BIZ.BK": {
    "city": "Bangkok",
    "country": "Thailand",
    "currency": "THB",
    "exchange": "SET",
    "industry": "Medical Devices",
    "long_name": "Business Alignment Public Company Limited",
    "market": "th_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BUSINESS ALIGNMENT PUBLIC COMPA",
    "state": null,
    "summary": "Business Alignment Public Company Limited engages in the distribution and installation of medical equipment and software system for cancer treatment through radiotherapy in Thailand. It imports and distributes radiation machine equipment. The company is also involved in the construction of building for locating medical equipment; and providing repair and maintenance services for medical equipment. It serves hospitals, ministry of public health, and public health departments and organizations. The company was founded in 2000 and is headquartered in Bangkok, Thailand.",
    "website": "http://www.bizalignment.com",
    "zipcode": "10500"
  },
  "BKD.F": {
    "city": "Billerica",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Bruker Corporation",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BRUKER CORP.  DL -,01",
    "state": "MA",
    "summary": "Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",
    "website": "http://www.bruker.com",
    "zipcode": "01821"
  },
  "BLO.CN": {
    "city": "Burnaby",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Cannabix Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CannabixTech",
    "state": "BC",
    "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
    "website": "http://www.cannabixtechnologies.com",
    "zipcode": "V5A 4R4"
  },
  "BLOZF": {
    "city": "Burnaby",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cannabix Technologies Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CANNABIX TECHNOLOGIES INC",
    "state": "BC",
    "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
    "website": "http://www.cannabixtechnologies.com",
    "zipcode": "V5A 4R4"
  },
  "BONEH.HE": {
    "city": "Oulu",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "BBS-Bioactive Bone Substitutes Oyj",
    "market": "fi_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BBS-Bioactive Bone Substitutes",
    "state": null,
    "summary": "BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBON, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins. The company was founded in 2003 and is headquartered in Oulu, Finland.",
    "website": "http://www.bbs-artebone.fi",
    "zipcode": "90220"
  },
  "BONES.ST": {
    "city": "Oulu",
    "country": "Finland",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "BBS-Bioactive Bone Substitutes Oyj",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BBS-Bioactive Bone Substitutes",
    "state": null,
    "summary": "BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBON, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins. The company was founded in 2003 and is headquartered in Oulu, Finland.",
    "website": "http://www.bbs-artebone.fi",
    "zipcode": "90220"
  },
  "BOV.F": {
    "city": "Clearwater",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Apyx Medical Corporation",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "APYX MEDICAL  DL-,001",
    "state": "FL",
    "summary": "Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.",
    "website": "http://www.apyxmedical.com",
    "zipcode": "33760"
  },
  "BRIG.ST": {
    "city": "Kista",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Brighter AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Brighter AB",
    "state": null,
    "summary": "Brighter AB (publ), a health-tech company, develops data-driven solutions for the treatment of chronic condition in Sweden. It is developing Actiste, a mobile-connected device to remotely monitor and treat insulin-dependent diabetes; and The Benefit Loop, a cloud-based platform that gathers, processes, analyzes, and organizes real-life data. The company offers its products to consumers and patients, mobile network operators, healthcare providers, governments/authorities, insurance companies, consumers, companies/employers, clinical research organizations, pharmaceutical companies, research and development organizations, authorities, and academic bodies. Brighter AB (publ) was founded in 2007 and is based in Kista, Sweden.",
    "website": "http://brighter.se",
    "zipcode": "164 32"
  },
  "BRKR": {
    "city": "Billerica",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Bruker Corporation",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Bruker Corporation",
    "state": "MA",
    "summary": "Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",
    "website": "http://www.bruker.com",
    "zipcode": "01821"
  },
  "BRKR.MX": {
    "city": "Billerica",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Bruker Corporation",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BRUKER CORPORATION",
    "state": "MA",
    "summary": "Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",
    "website": "http://www.bruker.com",
    "zipcode": "01821"
  },
  "BRSF": {
    "city": "Bohemia",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Brain Scientific Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "BRAIN SCIENTIFIC INC",
    "state": "NY",
    "summary": "Brain Scientific Inc. operates as a neurodiagnostic and predictive technology platform company in the United States. The company provides a platform for data acquisition and analysis of electroencephalography (EEG) data that combines medical device technologies with cloud-based telehealth services. It also offers NeuroCap, a disposable and soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional EEG systems; and NeuroEEG, a cloud-enabled data acquisition platform for electroencephalogram activity, as well as MemoryMD Cloud, a database where brain data can be stored and analyzed. Brain Scientific Inc. was founded in 2013 and is headquartered in Bohemia, New York.",
    "website": "http://www.brainscientific.com",
    "zipcode": "11716"
  },
  "BRSYF": {
    "city": "Jerusalem",
    "country": "Israel",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "BrainsWay Ltd.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BRAINSWAY LTD",
    "state": null,
    "summary": "Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.",
    "website": "http://www.brainsway.com",
    "zipcode": "9777518"
  },
  "BSGM": {
    "city": "Westport",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "BioSig Technologies, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BioSig Technologies, Inc.",
    "state": "CT",
    "summary": "BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.",
    "website": "http://www.biosig.com",
    "zipcode": "06880"
  },
  "BTCY": {
    "city": "Redwood City",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Biotricity, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BIOTRICITY INC",
    "state": "CA",
    "summary": "Biotricity, Inc., medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry technology, an integrated electrocardiogram (ECG) device and software solution. Biotricity, Inc. has a research partnership with the University of Calgary to determine the predictive value of ECG readings in preventative healthcare applications; and a strategic partnership with Verizon to develop EMS solutions for first responders by integrating its Bioflux solution. The company is based in Redwood City, California.",
    "website": "http://www.biotricity.com",
    "zipcode": "94065"
  },
  "BTH1.F": {
    "city": "Foothill Ranch",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "BIOLASE, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "BIOLASE INC.  DL -,001",
    "state": "CA",
    "summary": "BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.",
    "website": "http://www.biolase.com",
    "zipcode": "92610-2811"
  },
  "BUW.F": {
    "city": "Hercules",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Bio-Rad Laboratories, Inc.",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BIO-RAD LABS INC. B  DL 1",
    "state": "CA",
    "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.",
    "website": "http://www.bio-rad.com",
    "zipcode": "94547"
  },
  "BUWA.DE": {
    "city": "Hercules",
    "country": "United States",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Bio-Rad Laboratories, Inc.",
    "market": "de_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BIO-RAD LABS INC.DL-,0001",
    "state": "CA",
    "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.",
    "website": "http://www.bio-rad.com",
    "zipcode": "94547"
  },
  "BUWA.F": {
    "city": "Hercules",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Bio-Rad Laboratories, Inc.",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BIO-RAD LABS INC.DL-,0001",
    "state": "CA",
    "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.",
    "website": "http://www.bio-rad.com",
    "zipcode": "94547"
  },
  "BWAY": {
    "city": "Jerusalem",
    "country": "Israel",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "BrainsWay Ltd.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Brainsway Ltd.",
    "state": null,
    "summary": "Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.",
    "website": "http://www.brainsway.com",
    "zipcode": "9777518"
  },
  "BWAY.TA": {
    "city": "Jerusalem",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "BrainsWay Ltd.",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "BRAINSWAY LTD",
    "state": null,
    "summary": "Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.",
    "website": "http://www.brainsway.com",
    "zipcode": "9777518"
  },
  "C26.F": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "CellaVision AB (publ)",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CELLAVISION AB  SK -,15",
    "state": null,
    "summary": "CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.",
    "website": "http://www.cellavision.com",
    "zipcode": "223 62"
  },
  "CBL.AX": {
    "city": "Surrey Hills",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Control Bionics Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CTRLBIONIC FPO",
    "state": "VIC",
    "summary": "Control Bionics Limited designs, manufactures, and sells wireless wearable electromyography based augmentative and alternative communication technologies that allow users to operate and communicate through a computer using their thoughts and neuroelectric signals. It offers Eye Control Duo, an integrated eye tracking device for those living with paralysis and loss of speech; NeuroNode Trilogy, a solution for those living with paralysis and loss of speech; and Control Bionics Complete Communication System, an out of the box solution for those living with paralysis and loss of speech. The company also provides support and warranty services. The company's products are used by people suffering from diseases, such as motor neuron diseases, amyotrophic lateral sclerosis, cerebral palsy, multiple sclerosis, and spinal cord injuries. It operates in Australia, the United States, Japan, and internationally. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Surrey Hills, Australia.",
    "website": "http://www.controlbionics.com",
    "zipcode": "3127"
  },
  "CDX.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "CardieX Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CARDIEXLTD FPO",
    "state": "NSW",
    "summary": "CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. It also provides TeleHealth Services, which provides digital, e-commerce, and mobile tools for patients to connect online with health coaches. The company offers its devices and services to hospitals, clinics, research institutions and pharmaceutical companies. CardieX Limited has a strategic collaboration with Blumio Inc. to develop wearable sensor; and a joint development agreement with inHealth to develop hypertension and cardiovascular programs for the products. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia.",
    "website": "http://cardiex.com",
    "zipcode": "2000"
  },
  "CEVI.ST": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "CellaVision AB (publ)",
    "market": "se_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CellaVision AB",
    "state": null,
    "summary": "CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.",
    "website": "http://www.cellavision.com",
    "zipcode": "223 62"
  },
  "CFMS": {
    "city": "Billerica",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Conformis, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Conformis, Inc.",
    "state": "MA",
    "summary": "Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee; and iTotal Identity, a knee system. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Argentina, the United Arab Emirates, the Sultanate of Oman, Italy, San Marino, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.",
    "website": "http://www.conformis.com",
    "zipcode": "01821"
  },
  "CGHC": {
    "city": "Scottsdale",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Capital Group Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CAPITAL GROUP HOLDINGS INC",
    "state": "AZ",
    "summary": "Capital Group Holdings, Inc. provides health and wellness products and services in the United States. The company provides OneHealthPass, a Web-based personal health record system, which allows documents, images, and voice mail messages to be transmitted in and out of the system using various methods, including fax, voice, and file upload. It also offers patient-centric telehealth services; and operates 7 urgent care clinics located in the Phoenix, Arizona Metropolitan Area, that provide medical care services. The company was formerly known as Oasis Online Technologies, Corp. and changed its name to Capital Group Holdings, Inc. in April, 2010. Capital Group Holdings, Inc. was incorporated in 1980 and is based in Scottsdale, Arizona.",
    "website": "http://www.capitalgroupholdings.com",
    "zipcode": "85260"
  },
  "CHEOF": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "CHEOY": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "CHFS": {
    "city": "Eden Prairie",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "CHF Solutions, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CHF Solutions, Inc.",
    "state": "MN",
    "summary": "CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.",
    "website": "http://www.chf-solutions.com",
    "zipcode": "55344"
  },
  "CKMTF": {
    "city": "VÃ©lizy-Villacoublay",
    "country": "France",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Carmat SA",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CARMAT",
    "state": null,
    "summary": "Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It also develops orthotopic, bioprosthetic, self-regulating, pulsatile, and implantable systems, as well as power supply systems. The company was founded in 2008 and is based in VÃ©lizy-Villacoublay, France.",
    "website": "http://www.carmatsa.com",
    "zipcode": "78140"
  },
  "CKNTF": {
    "city": "Lod",
    "country": "Israel",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cell Kinetics Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CELL KINETICS LTD",
    "state": null,
    "summary": "Cell Kinetics Ltd. engages in the refining and commercialization of CellScan and related technology. It focuses on the development and commercialization of a cell carrier technology known as CKChip, a platform static cytometry technology that enables the simultaneous examination of various individual live cells using simple imaging methods, such as fluorescence microscopy. The company was founded in 1992 and is headquartered in Lod, Israel. Cell Kinetics Ltd. is a subsidiary of Medis Technologies Ltd.",
    "website": null,
    "zipcode": "71291"
  },
  "CLLKF": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cellink AB (publ)",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CELLINK AB",
    "state": null,
    "summary": "Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. In addition, the company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. Further, it offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It has strategic partnership with Made In Space for advancing bioprinting technology in space. The company also offers products online. Cellink AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.cellink.com",
    "zipcode": "413 46"
  },
  "CLNK-B.ST": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Cellink AB (publ)",
    "market": "se_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CELLINK AB ser. B",
    "state": null,
    "summary": "Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. In addition, the company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. Further, it offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It has strategic partnership with Made In Space for advancing bioprinting technology in space. The company also offers products online. Cellink AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.cellink.com",
    "zipcode": "413 46"
  },
  "CLPT": {
    "city": "Irvine",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "ClearPoint Neuro, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ClearPoint Neuro Inc.",
    "state": "CA",
    "summary": "ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to perform minimally invasive surgical procedures in the heart. It has license and collaboration agreements with The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Microsystems, LLC, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Irvine, California.",
    "website": "http://www.clearpointneuro.com",
    "zipcode": "92618"
  },
  "CLS-B.ST": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Clinical Laserthermia Systems AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Clinical Laserthermia Systems A",
    "state": null,
    "summary": "Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden.",
    "website": "http://www.clinicallaser.se",
    "zipcode": "223 81"
  },
  "CMP.AX": {
    "city": "Abbotsford",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Compumedics Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "COMPUMEDIC FPO",
    "state": "VIC",
    "summary": "Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; SomtÃ© PSG; Siesta 802, an ambulatory recording device; Grael PSG; and SomtÃ©, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; ProFusion neXus 360, a Web-based patient data and lab management system that provides integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, and summit IP products. Further, the company provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and a range of consumables and supplies for diagnostic and research solutions. The company was founded in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.",
    "website": "http://www.compumedics.com.au",
    "zipcode": "3067"
  },
  "CNMD": {
    "city": "Largo",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "CONMED Corporation",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CONMED Corporation",
    "state": "FL",
    "summary": "CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.",
    "website": "http://www.conmed.com",
    "zipcode": "33773-4908"
  },
  "COH.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "au_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR FPO",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "CRAD-B.ST": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "C-Rad AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "C-RAD AB ser. B",
    "state": null,
    "summary": "C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.",
    "website": "http://www.c-rad.se",
    "zipcode": "753 09"
  },
  "CREO.L": {
    "city": "Chepstow",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Creo Medical Limited",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "CREO MEDICAL GROUP PLC ORD GBP0",
    "state": null,
    "summary": "Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Speedboat RS2, a medical instrument through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.",
    "website": "http://creomedical.com",
    "zipcode": "NP16 5UH"
  },
  "CRRVF": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "CRY": {
    "city": "Kennesaw",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "CryoLife, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CryoLife, Inc.",
    "state": "GA",
    "summary": "CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.",
    "website": "http://www.cryolife.com",
    "zipcode": "30144"
  },
  "CSII": {
    "city": "Saint Paul",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Cardiovascular Systems, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Cardiovascular Systems, Inc.",
    "state": "MN",
    "summary": "Cardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.",
    "website": "http://www.csi360.com",
    "zipcode": "55112-6416"
  },
  "CSSI": {
    "city": "Tempe",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Costas, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "COSTAS INC",
    "state": "AZ",
    "summary": "Costas, Inc., a digital media company, owns and develops Web-based consumer Internet assets and communities in the United States and India. It operates ejobresource.com, an online job portal that offers recruitment and placement services. The company also provides under graduate and graduate degree courses; and systems integration and software services. It serves the media and entertainment, agency, retail, manufacturing, financial services, and various other industries. The company was founded in 1998 and is based in Tempe, Arizona.",
    "website": "http://www.costasinc.com",
    "zipcode": "85281"
  },
  "CSX.AX": {
    "city": "Artarmon",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "CleanSpace Holdings Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CLEANSPACE FPO",
    "state": "NSW",
    "summary": "CleanSpace Holdings Limited engages in the design and manufacture of respiratory protection equipment for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcare; CleanSpace ULTRA, a respirator for eye protection and water tolerance; CleanSpace2, a respirator for various working environments; and CleanSpace EX, an air purifying respirator. The company also provides accessories comprising respirators, masks, filters, cleaning and storage products, biohood system parts, and spares. It serves mining, infrastructure, energy, transport, metal, chemical, healthcare, and defense and government organizations. CleanSpace Holdings Limited was founded in 2009 and is based in Artarmon, Australia.",
    "website": "http://cleanspacetechnology.com",
    "zipcode": "2064"
  },
  "CTSO": {
    "city": "Monmouth Junction",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Cytosorbents Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Cytosorbents Corporation",
    "state": "NJ",
    "summary": "Cytosorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of post-operative complications of cardiopulmonary bypass surgery, and maintaining or improving the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; and DrugSorb, a device to remove toxic chemicals from the blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey.",
    "website": "http://www.cytosorbents.com",
    "zipcode": "08852"
  },
  "CTTC": {
    "city": "Fairfield",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Calmare Therapeutics Incorporated",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CALMARE THERAPEUTICS INC",
    "state": "CT",
    "summary": "Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.",
    "website": "http://www.calmaretherapeutics.com",
    "zipcode": "06824"
  },
  "CUTR": {
    "city": "Brisbane",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Cutera, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Cutera, Inc.",
    "state": "CA",
    "summary": "Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, myQ, and skincare products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.",
    "website": "http://cutera.com",
    "zipcode": "94005"
  },
  "CVM.V": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "CXT.F": {
    "city": "VÃ©lizy-Villacoublay",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Carmat SA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CARMAT  EO -,04",
    "state": null,
    "summary": "Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It also develops orthotopic, bioprosthetic, self-regulating, pulsatile, and implantable systems, as well as power supply systems. The company was founded in 2008 and is based in VÃ©lizy-Villacoublay, France.",
    "website": "http://www.carmatsa.com",
    "zipcode": "78140"
  },
  "CYBQF": {
    "city": "Tsukuba",
    "country": "Japan",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "CYBERDYNE Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CYBERDYNE INC",
    "state": null,
    "summary": "CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as non-medical HAL; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides HAL Therapy, a medical service to provide medical treatment for functional improvement of patients with cerebral, nervous, spinal cord injury, and cerebral embolism disorders; and non-medical services, such as HAL FIT and ROBO CARE training programs. The company operates 16 Neuro HALFIT service centers. CYBERDYNE Inc. has a strategic partnership with CellSource Co., Ltd. to jointly discover new treatment methods for patients with osteoarthritis of the knee caused by aging. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.",
    "website": "http://www.cyberdyne.jp",
    "zipcode": "305-0818"
  },
  "CYBQY": {
    "city": "Tsukuba",
    "country": "Japan",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "CYBERDYNE Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CYBERDYNE INC",
    "state": null,
    "summary": "CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as non-medical HAL; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides HAL Therapy, a medical service to provide medical treatment for functional improvement of patients with cerebral, nervous, spinal cord injury, and cerebral embolism disorders; and non-medical services, such as HAL FIT and ROBO CARE training programs. The company operates 16 Neuro HALFIT service centers. CYBERDYNE Inc. has a strategic partnership with CellSource Co., Ltd. to jointly discover new treatment methods for patients with osteoarthritis of the knee caused by aging. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.",
    "website": "http://www.cyberdyne.jp",
    "zipcode": "305-0818"
  },
  "CYC.AX": {
    "city": "Kingsgrove",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Cyclopharm Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CYCLOPHARM FPO",
    "state": "NSW",
    "summary": "Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.",
    "website": "http://www.cyclopharm.com.au",
    "zipcode": "2208"
  },
  "CYDX": {
    "city": "Boston",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "CYduct Diagnostics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CYDUCT DIAGNOSTICS INC",
    "state": "MA",
    "summary": "CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.",
    "website": "http://www.solosendoscopy.com",
    "zipcode": "02136"
  },
  "CYL.F": {
    "city": "Kennesaw",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "CryoLife, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CRYOLIFE INC.  DL-,01",
    "state": "GA",
    "summary": "CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.",
    "website": "http://www.cryolife.com",
    "zipcode": "30144"
  },
  "DCTH": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Delcath Systems, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Delcath Systems, Inc.",
    "state": "NY",
    "summary": "Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO includes the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma; and the ALIGN trial, a Phase 3 clinical trial for intrahepatic cholangiocarcinoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.",
    "website": "http://www.delcath.com",
    "zipcode": "10019"
  },
  "DEMG.L": {
    "city": "Chichester",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Deltex Medical Group plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "DELTEX MEDICAL GROUP PLC ORD 1P",
    "state": null,
    "summary": "Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers Doppler Probes that is used to measure a patient's blood flow and fluid status directly from the descending aorta during surgery and critical care; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure wave algorithm for deriving haemodynamic parameters. The company's products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.",
    "website": "http://www.deltexmedical.com",
    "zipcode": "PO19 8TX"
  },
  "DGM.PA": {
    "city": "Mauguio",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Diagnostic Medical Systems S.A.",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "DIAGNOSTIC MEDICAL",
    "state": null,
    "summary": "Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. It offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-arms, and posturology solutions. The company also exports its products. Diagnostic Medical Systems S.A. was founded in 1979 and is based in Mauguio, France.",
    "website": "http://www.dms.com",
    "zipcode": "34130"
  },
  "DGWPF": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK AG & CO KGAA",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DIGN.ST": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Dignitana AB (publ.)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Dignitana AB",
    "state": null,
    "summary": "Dignitana AB (publ.), a medical technology company, develops, produces, and markets medical cooling devices primarily in the United States. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. Dignitana AB (publ.) was incorporated in 2007 is headquartered in Lund, Sweden.",
    "website": "http://dignitana.com",
    "zipcode": "226 60"
  },
  "DIZTF": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Dignitana AB (publ.)",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "DIGNITANA AB",
    "state": null,
    "summary": "Dignitana AB (publ.), a medical technology company, develops, produces, and markets medical cooling devices primarily in the United States. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. Dignitana AB (publ.) was incorporated in 2007 is headquartered in Lund, Sweden.",
    "website": "http://dignitana.com",
    "zipcode": "226 60"
  },
  "DMTRF": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "3-D Matrix, Ltd.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "3-D MATRIX LTD",
    "state": null,
    "summary": "3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.",
    "website": "http://www.3d-matrix.co.jp",
    "zipcode": "102-0083"
  },
  "DPD3.F": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Imagin Medical Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMAGIN MEDICAL INC.",
    "state": "BC",
    "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
    "website": "http://imaginmedical.com",
    "zipcode": "V6C 1L9"
  },
  "DRW1.F": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK GEN.S.D",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW3.DE": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK VZO O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW3.F": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK VZO O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW3.VI": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "at_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK AG VZ",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW8.DE": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK ST.A.O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW8.F": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK ST.A.O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DYNT": {
    "city": "Eagan",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Dynatronics Corporation",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Dynatronics Corporation",
    "state": "MN",
    "summary": "Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.",
    "website": "http://www.dynatronics.com",
    "zipcode": "55121"
  },
  "DYXA.SG": {
    "city": "Eagan",
    "country": "United States",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Dynatronics Corporation",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Dynatronics Corp. Registered Sh",
    "state": "MN",
    "summary": "Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.",
    "website": "http://www.dynatronics.com",
    "zipcode": "55121"
  },
  "E1WL34.SA": {
    "city": "Irvine",
    "country": "United States",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Edwards Lifesciences Corporation",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "EDWARDS LIFEDRN",
    "state": "CA",
    "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",
    "website": "http://www.edwards.com",
    "zipcode": "92614"
  },
  "E2OM.F": {
    "city": "Horsham",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "STRATA Skin Sciences, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "STRATA SKIN SCIENC.DL-,01",
    "state": "PA",
    "summary": "STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.",
    "website": "http://www.strataskinsciences.com",
    "zipcode": "19044"
  },
  "E8X.DE": {
    "city": "Singen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "elexxion AG",
    "market": "de_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ELEXXION AG",
    "state": null,
    "summary": "elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. It offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. The company also provides Odobleach; and perio green, a therapy product for the photothermal therapy of periodontology and periimplantitis, as well as offers repair services. The company was founded in 2002 and is based in Singen, Germany. elexxion AG is a subsidiary of Tian Ying Medical Instrument Co., Ltd.",
    "website": "http://www.elexxion.com",
    "zipcode": "78224"
  },
  "E8X.F": {
    "city": "Singen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "elexxion AG",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ELEXXION AG",
    "state": null,
    "summary": "elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. It offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. The company also provides Odobleach; and perio green, a therapy product for the photothermal therapy of periodontology and periimplantitis, as well as offers repair services. The company was founded in 2002 and is based in Singen, Germany. elexxion AG is a subsidiary of Tian Ying Medical Instrument Co., Ltd.",
    "website": "http://www.elexxion.com",
    "zipcode": "78224"
  },
  "EAR": {
    "city": "San Jose",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Eargo, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Eargo, Inc.",
    "state": "CA",
    "summary": "Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.",
    "website": "http://eargo.com",
    "zipcode": "95110"
  },
  "EC8.F": {
    "city": "Largo",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "CONMED Corporation",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "CONMED CORP.  DL-,01",
    "state": "FL",
    "summary": "CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.",
    "website": "http://www.conmed.com",
    "zipcode": "33773-4908"
  },
  "ECGI": {
    "city": "Los Angeles",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "ECGI Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "EVENT CARDIO GROUP INC",
    "state": "CA",
    "summary": "ECGI Holdings, Inc., through its subsidiary, operates in the cardiac medical device innovation, patient monitoring, and cardiac event prediction industry. The company is developing cardiac monitoring device based on a wireless and leadless advance cardiac monitor. Its products include Now Cardio, a cardiac monitor that offers dual-functionality, including holter monitoring and event recording. The company was formerly known as Event Cardio Group Inc. and changed its name to ECGI Holdings, Inc. in August 2019. ECGI Holdings, Inc. is based in Los Angeles, California.",
    "website": "http://www.ecgiholdings.com",
    "zipcode": "90035"
  },
  "ECTE": {
    "city": "Iselin",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Echo Therapeutics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ECHO THERAPEUTICS INC",
    "state": "NJ",
    "summary": "Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community. In addition, it has a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, use, market, import, and sell CGM to medical facilities and individual consumers in South Korea; and a license, development, and commercialization agreement with Medical Technologies Innovation Asia, Ltd to research, develop, manufacture, and use CGM in the People's Republic of China, Hong Kong, Macau, and Taiwan. The company was founded in 1989 and is headquartered in Iselin, New Jersey.",
    "website": "http://www.echotx.com",
    "zipcode": "08830"
  },
  "EDA.F": {
    "city": "Lyon",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "EDAP TMS S.A.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EDAP TMS S.A. ADR EO -,13",
    "state": null,
    "summary": "EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.",
    "website": "http://www.edap-tms.com",
    "zipcode": "69120"
  },
  "EDAP": {
    "city": "Lyon",
    "country": "France",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "EDAP TMS S.A.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EDAP TMS S.A.",
    "state": null,
    "summary": "EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.",
    "website": "http://www.edap-tms.com",
    "zipcode": "69120"
  },
  "EE51.F": {
    "city": "Calenzano",
    "country": "Italy",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "EL.En. S.p.A.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "EL.EN. S.P.A.  EO 0,13",
    "state": "FI",
    "summary": "EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Italy, Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.",
    "website": "http://www.elengroup.com",
    "zipcode": "50041"
  },
  "EFNC.TA": {
    "city": "Jerusalem",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Erech Finance Cahalacha Ltd",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ERECH FINANCE",
    "state": null,
    "summary": "Erech Finance Cahalacha Ltd operates as a medical equipment company. It provides therapeutic medical devices for diabetes. The company is based in Jerusalem, Israel.",
    "website": null,
    "zipcode": "9123101"
  },
  "EJU.F": {
    "city": "San Diego",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Aethlon Medical, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "AETHLON MEDIC.NEW DL-,001",
    "state": "CA",
    "summary": "Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.",
    "website": "http://www.aethlonmedical.com",
    "zipcode": "92123"
  },
  "ELMD": {
    "city": "New Prague",
    "country": "United States",
    "currency": "USD",
    "exchange": "ASE",
    "industry": "Medical Devices",
    "long_name": "Electromed, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Electromed, Inc.",
    "state": "MN",
    "summary": "Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.",
    "website": "http://smartvest.com",
    "zipcode": "56071"
  },
  "ELN.MI": {
    "city": "Calenzano",
    "country": "Italy",
    "currency": "EUR",
    "exchange": "MIL",
    "industry": "Medical Devices",
    "long_name": "EL.En. S.p.A.",
    "market": "it_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "EL.EN.",
    "state": "FI",
    "summary": "EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Italy, Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.",
    "website": "http://www.elengroup.com",
    "zipcode": "50041"
  },
  "EMED": {
    "city": "Scottsdale",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Electromedical Technologies, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ELECTROMEDICAL TECHNOLOGIES INC",
    "state": "AZ",
    "summary": "Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. Its products include WellnessPro Plus, a bioelectronics therapy prescription device to relieve chronic and acute pain. Electromedical Technologies, Inc. is headquartered in Scottsdale, Arizona.",
    "website": "http://www.electromedtech.com",
    "zipcode": "85260"
  },
  "EMITF": {
    "city": "Petach Tikva",
    "country": "Israel",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Elbit Imaging Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ELBIT IMAGING LTD",
    "state": null,
    "summary": "Elbit Imaging Ltd., together with its subsidiaries, engages in research and development, production, and marketing of treatment-oriented medical systems; and products to treat cancer diseases. Its treatment-oriented medical systems include magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings. The company is also involved in the sale of plots in India. It has operations in the United States, Europe, and internationally. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.",
    "website": "http://www.elbitimaging.com",
    "zipcode": "4952801"
  },
  "EMITF.TA": {
    "city": "Petach Tikva",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Elbit Imaging Ltd.",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ELBIT IMAGING LTD",
    "state": null,
    "summary": "Elbit Imaging Ltd., together with its subsidiaries, engages in research and development, production, and marketing of treatment-oriented medical systems; and products to treat cancer diseases. Its treatment-oriented medical systems include magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings. The company is also involved in the sale of plots in India. It has operations in the United States, Europe, and internationally. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.",
    "website": "http://www.elbitimaging.com",
    "zipcode": "4952801"
  },
  "EMTC.TA": {
    "city": "Petah Tikva",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Elbit Medical Technologies Ltd",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ELBIT MEDICAL TECH",
    "state": null,
    "summary": "Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders. The company is based in Petah Tikva, Israel. Elbit Medical Technologies Ltd is a subsidiary of Elbit Imaging Ltd.",
    "website": null,
    "zipcode": "4900102"
  },
  "EMV.AX": {
    "city": "Macquarie Park",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "EMvision Medical Devices Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EMVISION FPO",
    "state": "NSW",
    "summary": "EMvision Medical Devices Limited engages in the research, development, and commercialization of imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, and other medical imaging needs. The company has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. EMvision Medical Devices Limited was founded in 2017 and is based in Macquarie Park, Australia.",
    "website": "http://www.emvision.com.au",
    "zipcode": "2113"
  },
  "ENCW": {
    "city": "Henderson",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Enchanted World Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ENCHANTED WORLD INC",
    "state": "NV",
    "summary": "Enchanted World Inc. engages in the development, manufacture, and distribution of health care products in the United States. The company offers fitness and weight loss equipment and products. The company offers BioFit infrared bike, a design for the use of infrared and exercise to reduce body fat. The BioFit engages 3,300 watts of infrared lights and offers detox, inch loss, weight loss, inflammation reduction, pain control, and enhanced calorie burn. It provides its products to wellness and weight loss centers, med spas, gyms, doctors' offices, and day spas. The company was formerly known as Cardio Infrared Technologies, Inc. and changed its name to Enchanted World Inc. in December 2014. Enchanted World Inc. is based in Henderson, Nevada.",
    "website": null,
    "zipcode": "89052"
  },
  "ENDY.TA": {
    "city": "Freehold",
    "country": "United States",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Endymed Ltd",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ENDYMED LTD",
    "state": "NJ",
    "summary": "Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey.",
    "website": "http://www.endymed.com",
    "zipcode": "07728"
  },
  "EO8.F": {
    "city": "Paris",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "EOS imaging SA",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EOS IMAGING  EO -,01",
    "state": null,
    "summary": "EOS imaging SA, together with its subsidiaries, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, an imaging system that provides low dose, full body, and stereo-radiographic images of patient in a functional position; EOSedge, an X-ray system that provides images quality for patients; sterEOS, a 3D modeling workstation that analyzes frontal and lateral EOS images which are captured simultaneously and registered to generate precise, patient-specific, and 3D models of the spine and/or lower limbs from weight-bearing, low dose, or Micro Dose EOS exams; and EOSapps, an online 3D surgical planning solutions based on unbiased, weight-bearing EOS images, and an accurate 2D/3D patient-specific data set. The company also develops knee and hip surgery planning software, as well as manufactures patient-specific cutting guides for orthopedic surgeries. It sells its products in Europe, the Middle East, Africa, North America, the Asia-Pacific, and Latin America. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS imaging SA was founded in 1989 and is headquartered in Paris, France.",
    "website": "http://www.eos-imaging.com",
    "zipcode": "75011"
  },
  "EOSI.PA": {
    "city": "Paris",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "EOS imaging SA",
    "market": "fr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EOS IMAGING",
    "state": null,
    "summary": "EOS imaging SA, together with its subsidiaries, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, an imaging system that provides low dose, full body, and stereo-radiographic images of patient in a functional position; EOSedge, an X-ray system that provides images quality for patients; sterEOS, a 3D modeling workstation that analyzes frontal and lateral EOS images which are captured simultaneously and registered to generate precise, patient-specific, and 3D models of the spine and/or lower limbs from weight-bearing, low dose, or Micro Dose EOS exams; and EOSapps, an online 3D surgical planning solutions based on unbiased, weight-bearing EOS images, and an accurate 2D/3D patient-specific data set. The company also develops knee and hip surgery planning software, as well as manufactures patient-specific cutting guides for orthopedic surgeries. It sells its products in Europe, the Middle East, Africa, North America, the Asia-Pacific, and Latin America. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS imaging SA was founded in 1989 and is headquartered in Paris, France.",
    "website": "http://www.eos-imaging.com",
    "zipcode": "75011"
  },
  "EPIS-B.ST": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Episurf Medical AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Episurf Medical AB B",
    "state": null,
    "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers ÂµiFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.",
    "website": "http://episurf.com",
    "zipcode": "114 49"
  },
  "EPSFF": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Episurf Medical AB (publ)",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EPISURF MEDICAL AB",
    "state": null,
    "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers ÂµiFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.",
    "website": "http://episurf.com",
    "zipcode": "114 49"
  },
  "EQUR": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "E-Qure Corp.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "E-QURE CORP",
    "state": "NY",
    "summary": "E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers down to complete closure and/or cure. E-Qure Corp. is based in New York, New York.",
    "website": "http://www.e-qure.com",
    "zipcode": "10023"
  },
  "ESMC": {
    "city": "Wayne",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Escalon Medical Corp.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ESCALON MEDICAL CORP",
    "state": "PA",
    "summary": "Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.",
    "website": "http://www.escalonmedical.com",
    "zipcode": "19087"
  },
  "ESTA": {
    "city": "Alajuela",
    "country": "Costa Rica",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Establishment Labs Holdings Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Establishment Labs Holdings Inc",
    "state": null,
    "summary": "Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.",
    "website": "http://www.establishmentlabs.com",
    "zipcode": null
  },
  "EUZ.DE": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Eckert & Ziegler Strahlen- und Medizintechnik AG",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ECKERT+ZIEGLER AG O.N.",
    "state": null,
    "summary": "Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment's products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.",
    "website": "http://www.ezag.com",
    "zipcode": "13125"
  },
  "EUZ.F": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Eckert & Ziegler Strahlen- und Medizintechnik AG",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "ECKERT+ZIEGLER AG O.N.",
    "state": null,
    "summary": "Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment's products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.",
    "website": "http://www.ezag.com",
    "zipcode": "13125"
  },
  "EVARF": {
    "city": "Didcot",
    "country": "United Kingdom",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Lombard Medical, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LOMBARD MED INC",
    "state": null,
    "summary": "Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.",
    "website": "http://www.lombardmedical.com",
    "zipcode": "OX11 7HJ"
  },
  "EW": {
    "city": "Irvine",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Edwards Lifesciences Corporation",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Edwards Lifesciences Corporatio",
    "state": "CA",
    "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",
    "website": "http://www.edwards.com",
    "zipcode": "92614"
  },
  "EW.MX": {
    "city": "Irvine",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Edwards Lifesciences Corporation",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "EDWARDS LIFESCIENCES CORP",
    "state": "CA",
    "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",
    "website": "http://www.edwards.com",
    "zipcode": "92614"
  },
  "EWL.DE": {
    "city": "Irvine",
    "country": "United States",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Edwards Lifesciences Corporation",
    "market": "de_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "EDWARDS LIFESCIENCES",
    "state": "CA",
    "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",
    "website": "http://www.edwards.com",
    "zipcode": "92614"
  },
  "EWL.F": {
    "city": "Irvine",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Edwards Lifesciences Corporation",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "EDWARDS LIFESCIENCES",
    "state": "CA",
    "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",
    "website": "http://www.edwards.com",
    "zipcode": "92614"
  },
  "EWLS.VI": {
    "city": "Irvine",
    "country": "United States",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "Edwards Lifesciences Corporation",
    "market": "at_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "EDWARDS LIFESCIENCES CORP",
    "state": "CA",
    "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.",
    "website": "http://www.edwards.com",
    "zipcode": "92614"
  },
  "EYE.AX": {
    "city": "Kent Town",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Nova Eye Medical Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NOVA EYE FPO",
    "state": "SA",
    "summary": "Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.",
    "website": "http://www.nova-eye.com",
    "zipcode": "5067"
  },
  "EYES": {
    "city": "Sylmar",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Second Sight Medical Products, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Second Sight Medical Products, ",
    "state": "CA",
    "summary": "Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.",
    "website": "http://www.secondsight.com",
    "zipcode": "91342"
  },
  "FDMDF": {
    "city": "Melbourne",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "4DMedical Limited",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "4D MEDICAL LTD",
    "state": "VIC",
    "summary": "4DMedical Limited operates as a software technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging platform that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure ventilation and perfusion; and Contrast Free Pulmonary Angiography (CFPA) products, as well as small animal ventilators and preclinical scanners. 4Dmedical Limited partners with University of Miami Health System to establish the functional lung imaging research program. The company was founded in 2012 and is based in Melbourne, Australia.",
    "website": "http://www.4dmedical.com",
    "zipcode": "3004"
  },
  "FDV.F": {
    "city": "Old Greenwich",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Star Equity Holdings, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "STAR EQ.HLDG  DL -,0001",
    "state": "CT",
    "summary": "Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to cardiologists, internal medicine physicians, family practice physicians, hospitals, IDNs, and federal institutions. It also develops, sells, and maintains solid-state gamma cameras; imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages and finances real estate assets and investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.",
    "website": "http://www.starequity.com",
    "zipcode": "06870"
  },
  "FLURF": {
    "city": "Calgary",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "FluroTech Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "FLUROTECH LTD",
    "state": "AB",
    "summary": "FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech's specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada.",
    "website": "http://www.flurotech.com",
    "zipcode": "T2L 1Y1"
  },
  "FOAA.F": {
    "city": "Melville",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "FONAR Corporation",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "FONAR CORP. NEW  DL-,0001",
    "state": "NY",
    "summary": "FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates four diagnostic imaging facilities in Florida; and manages 35 MRI scanning facilities, including 22 facilities located in New York and 13 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was founded in 1978 and is based in Melville, New York.",
    "website": "http://www.fonar.com",
    "zipcode": "11747"
  },
  "FONR": {
    "city": "Melville",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "FONAR Corporation",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Fonar Corporation",
    "state": "NY",
    "summary": "FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates four diagnostic imaging facilities in Florida; and manages 35 MRI scanning facilities, including 22 facilities located in New York and 13 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was founded in 1978 and is based in Melville, New York.",
    "website": "http://www.fonar.com",
    "zipcode": "11747"
  },
  "FZMD": {
    "city": "Richardson",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Fuse Medical, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "FUSE MEDICAL INC",
    "state": "TX",
    "summary": "Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; full spinal implants for trauma, degenerative disc disease, and deformity indications; and various osteo-biologics, and regenerative and amniotic tissues, which comprise human allografts, synthetic skin and substitute bone materials, tendons, and regenerative tissues and fluids. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.",
    "website": "http://www.fusemedical.com",
    "zipcode": "75080"
  },
  "G5Z3.F": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Neovasc Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NEOVASC INC.",
    "state": "BC",
    "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
    "website": "http://www.neovasc.com",
    "zipcode": "V6V 2J7"
  },
  "GBS": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "GBS Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "GBS Inc.",
    "state": "NY",
    "summary": "GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.",
    "website": "http://www.gbs.inc",
    "zipcode": "10017"
  },
  "GBT.PA": {
    "city": "Villepinte",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Guerbet SA",
    "market": "fr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "GUERBET",
    "state": null,
    "summary": "Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide. Its products for the CT and Cath Lab examinations include Optiray, a low osmolar contrast medium; Xenetix, a low-osmolar iodinated agent; Telebrix, a high osmolar contrast medium; Conray and MD high osmolar contrast medium products; Hexabrix, an ionic low osmolar contrast medium agent; and Micropaque/ Microtrast, a diagnostic imaging interconnected solution. The company's products for the magnetic resonance imaging examinations comprise Dotarem, a non-specific gadolinium-based contrast medium; Artirem products; and Optimark, a contrast medium. In addition, it provides products for interventional imaging, including Lipiodol ethyl esters of iodinated fatty acids of poppy seed oil; Vectorio, a classic transarterial chemoembolization mixing and injection system; Patent Blue V, an injectable medium; and SeQure and DraKon, a microcatheters. Further, the company offers delivery systems and services comprising injectors; consumables for various types of injectors; Contrast&Care, a patient data management software; Dose&Care, an operational solution for monitoring patient exposure to ionizing radiation; and Hydra Vision, a digital imaging system for urological, gastroenterological, gynecological treatment, and planning and diagnostic procedures. The company distributes its products directly, as well as through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France.",
    "website": "http://www.guerbet.com",
    "zipcode": "93420"
  },
  "GGNDF": {
    "city": "Ballerup",
    "country": "Denmark",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "GN Store Nord A/S",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "GN STORE NORD",
    "state": null,
    "summary": "GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer segments in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. The company offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.",
    "website": "http://www.gn.com",
    "zipcode": "2750"
  },
  "GHST": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "GHST World Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "GHOST TECHNOLOGY INC",
    "state": "NY",
    "summary": "GHST World Inc. engages in the marketing and sale of technologically enhanced sports equipment. It also holds a portfolio of 119 art paintings and reproductions. In addition, the company focuses on the research and development of technology and products designed to connect households and other electronic devices using the Internet. The company is based in New York, New York.",
    "website": "http://www.ghstinternational.com",
    "zipcode": "10152"
  },
  "GM0N.F": {
    "city": "Audubon",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Globus Medical, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "GLOBUS MED.A NEW DL -,001",
    "state": "PA",
    "summary": "Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.",
    "website": "http://www.globusmedical.com",
    "zipcode": "19403"
  },
  "GME.DE": {
    "city": "Geschwenda",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Geratherm Medical AG",
    "market": "de_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "GERATHERM O.N.",
    "state": null,
    "summary": "Geratherm Medical AG operates as a medical technology company in Germany. The company operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment primarily offers clinical thermometers; blood pressure monitors; and self-test diagnostic products for women, including pregnancy tests, chlamydia tests, urinary tract infection, diverse ovulation test solutions, and pH tests. The Respiratory segment develops and manufactures products under the Spirostik and Spirostik Complete names, principally for the pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment provides warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and nomag IC, an incubator system for use in magnetic resonance imaging of premature and newborn infants under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation used in preventing strokes. It markets its products through pharmacies, hospitals, and clinics. The company exports its products to Europe, South America, the Middle East, Asia, Africa, the United States, and internationally. Geratherm Medical AG is headquartered in Geschwenda, Germany.",
    "website": "http://www.geratherm.com",
    "zipcode": "99331"
  },
  "GME.F": {
    "city": "Geschwenda",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Geratherm Medical AG",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "GERATHERM O.N.",
    "state": null,
    "summary": "Geratherm Medical AG operates as a medical technology company in Germany. The company operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment primarily offers clinical thermometers; blood pressure monitors; and self-test diagnostic products for women, including pregnancy tests, chlamydia tests, urinary tract infection, diverse ovulation test solutions, and pH tests. The Respiratory segment develops and manufactures products under the Spirostik and Spirostik Complete names, principally for the pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment provides warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and nomag IC, an incubator system for use in magnetic resonance imaging of premature and newborn infants under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation used in preventing strokes. It markets its products through pharmacies, hospitals, and clinics. The company exports its products to Europe, South America, the Middle East, Asia, Africa, the United States, and internationally. Geratherm Medical AG is headquartered in Geschwenda, Germany.",
    "website": "http://www.geratherm.com",
    "zipcode": "99331"
  },
  "GMED": {
    "city": "Audubon",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Globus Medical, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Globus Medical, Inc.",
    "state": "PA",
    "summary": "Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.",
    "website": "http://www.globusmedical.com",
    "zipcode": "19403"
  },
  "GMED.MX": {
    "city": "Audubon",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Globus Medical, Inc.",
    "market": "mx_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "GLOBUS MED INC",
    "state": "PA",
    "summary": "Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.",
    "website": "http://www.globusmedical.com",
    "zipcode": "19403"
  },
  "GN.CO": {
    "city": "Ballerup",
    "country": "Denmark",
    "currency": "DKK",
    "exchange": "CPH",
    "industry": "Medical Devices",
    "long_name": "GN Store Nord A/S",
    "market": "dk_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "GN Store Nord A/S",
    "state": null,
    "summary": "GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer segments in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. The company offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.",
    "website": "http://www.gn.com",
    "zipcode": "2750"
  },
  "GNF.F": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "GenMark Diagnostics, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "GENMARK DIAGNOST.DL-,0001",
    "state": "CA",
    "summary": "GenMark Diagnostics, Inc. designs and manufactures multiplex molecular diagnostic solutions to enhance patient care, improve quality metrics, and reduce the total cost-of-care for laboratory professionals, healthcare providers, and customers in the United States and internationally. It offers ePlex systems to streamline the diagnostic workflow from physician order entry to the release of the final report, automate and accelerate order entry and results reporting, notify practitioners that test results are available, enable operation on every shift, minimize system downtime and ensure patients and physicians have access to rapid test results, and reduce avoidable medical errors; ePlex software to support the needs of laboratory and healthcare systems, streamline tasks across the diagnostic process from order-to-report, improve productivity at every level, improve order-to-report turnaround time, reduce labor costs, and eliminate potential transcription errors with bi-directional LIS capabilities; XT-8 systems for processing multiple tests; ePlex panels that include respiratory pathogen and blood culture identification (BCID) Panels to identify the viral and bacterial organisms associated with upper respiratory infection, provide broad coverage of organisms that can lead to sepsis along with the resistance genes, and aid clinicians in the identification of bacterial and fungal organisms; and XT-8 panels to provide sensitive and specific respiratory virus detection with an optimized workflow to maximize laboratory efficiency. The company serves customers through distributors. GenMark Diagnostics, Inc. was formerly known as Osmetech plc and changed its name to GenMark Diagnostics, Inc. in June 2010. The company was incorporated in 2010 and is based in Carlsbad, California. As of April 21, 2021, GenMark Diagnostics, Inc. operates as a subsidiary of Roche Holding AG.",
    "website": "http://www.genmarkdx.com",
    "zipcode": "92008-8829"
  },
  "GNN.F": {
    "city": "Ballerup",
    "country": "Denmark",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "GN Store Nord A/S",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "GN STORE NORD A/S NAM.DK1",
    "state": null,
    "summary": "GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer segments in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. The company offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.",
    "website": "http://www.gn.com",
    "zipcode": "2750"
  },
  "GNNDY": {
    "city": "Ballerup",
    "country": "Denmark",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "GN Store Nord A/S",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "GN STORE NORD",
    "state": null,
    "summary": "GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer segments in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. The company offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.",
    "website": "http://www.gn.com",
    "zipcode": "2750"
  },
  "GNSN.VI": {
    "city": "Ballerup",
    "country": "Denmark",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "GN Store Nord A/S",
    "market": "at_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "GN STORE NORD AS",
    "state": null,
    "summary": "GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer segments in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. The company offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.",
    "website": "http://www.gn.com",
    "zipcode": "2750"
  },
  "GOV.F": {
    "city": "Acton",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Insulet Corporation",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "INSULET CORP.  DL -,001",
    "state": "MA",
    "summary": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.",
    "website": "http://www.insulet.com",
    "zipcode": "01720"
  },
  "GPXMED.ST": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "GPX Medical AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "GPX Medical AB",
    "state": null,
    "summary": "GPX Medical AB operates as a medical technology company. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provide intensive care and healthier lives for preterm born infants. The company was founded in 2016 and headquartered in Lund, Sweden.",
    "website": "http://gasporox.se/medical-diagnostics/",
    "zipcode": "227 30"
  },
  "GTHP": {
    "city": "Norcross",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Guided Therapeutics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "GUIDED THERAPEUTICS INC",
    "state": "GA",
    "summary": "Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.",
    "website": "http://www.guidedinc.com",
    "zipcode": "30092"
  },
  "H9O1.F": {
    "city": "Erlangen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "HumanOptics AG",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HUMANOPTICS AG  O.N.",
    "state": null,
    "summary": "HumanOptics AG develops, manufactures, and sells intraocular implantable solutions. The company offers artificial intraocular lenses. It also provides CUSTOMFLEX ARTIFICIALIRIS, an iris prosthesis, which is used for the medical and aesthetic reconstruction of eyes with complete or partial aniridia; and implants and accessories. HumanOptics AG serves surgeons and patients. The company is headquartered in Erlangen, Germany. HumanOptics AG is a former subsidiary of Medipart AG.",
    "website": "http://www.humanoptics.com",
    "zipcode": "91054"
  },
  "HEMC.ST": {
    "city": "Karlstad",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Hemcheck Sweden AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Hemcheck Sweden AB",
    "state": null,
    "summary": "Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States. The company was founded in 2010 and is based in Karlstad, Sweden.",
    "website": "http://www.hemcheck.com",
    "zipcode": "651 88"
  },
  "HJLI": {
    "city": "Irvine",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Hancock Jaffe Laboratories, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Hancock Jaffe Laboratories, Inc",
    "state": "CA",
    "summary": "Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.",
    "website": "http://www.hancockjaffe.com",
    "zipcode": "92618"
  },
  "HMD.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "HeraMED Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HERAMED FPO",
    "state": "NSW",
    "summary": "HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Sydney, Australia.",
    "website": "http://www.hera-med.com",
    "zipcode": "2000"
  },
  "HQ8F.F": {
    "city": "Austin",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Apollo Endosurgery, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "APOLLO ENDOSURGERY DL-,01",
    "state": "TX",
    "summary": "Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.",
    "website": "http://www.apolloendo.com",
    "zipcode": "78746"
  },
  "HRTT": {
    "city": "Studio City",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Heart Tronics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HEART TRONICS INC",
    "state": "CA",
    "summary": "Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.",
    "website": null,
    "zipcode": "91607"
  },
  "HSM.TO": {
    "city": "Newtown",
    "country": "United States",
    "currency": "CAD",
    "exchange": "TOR",
    "industry": "Medical Devices",
    "long_name": "Helius Medical Technologies, Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HELIUS MEDICAL TECHNOLOGIES INC",
    "state": "PA",
    "summary": "Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product is Portable Neuromodulation Stimulator (PoNS), a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.",
    "website": "http://heliusmedical.com",
    "zipcode": "18940"
  },
  "HTL.V": {
    "city": "Beverly",
    "country": "United States",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Hamilton Thorne Ltd.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "HAMILTON THORNE LTD",
    "state": "MA",
    "summary": "Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers laser products used in a range of scientific applications and in vitro fertilization (IVF) procedures; and image analysis systems used in the studies of reproductive cells in the human fertility, animal sciences, and reproductive toxicology fields. The company also provides a line of air filtration products to enhance air quality in the laboratory under the ZANDAIR brand; incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand; and reproductive medicine, including clinical and laboratory equipment, and disposables, as well as installations of ART clinics under the Gynemed brand. In addition, it offers test laboratory providing services to the assisted reproductive technologies industry and laboratories under the Embryotech brand. Further, the company provides precision laser devices, imaging systems, micromanipulation systems, control rate freezers, and lab monitoring systems. It sells its products through direct sales force and distributors to pharmaceutical and biotechnology companies, animal breeding facilities, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. The company is headquartered in Beverly, Massachusetts.",
    "website": "http://www.hamiltonthorne.ltd",
    "zipcode": "01915"
  },
  "HTLZF": {
    "city": "Beverly",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Hamilton Thorne Ltd.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "HAMILTON THORNE LTD",
    "state": "MA",
    "summary": "Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers laser products used in a range of scientific applications and in vitro fertilization (IVF) procedures; and image analysis systems used in the studies of reproductive cells in the human fertility, animal sciences, and reproductive toxicology fields. The company also provides a line of air filtration products to enhance air quality in the laboratory under the ZANDAIR brand; incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand; and reproductive medicine, including clinical and laboratory equipment, and disposables, as well as installations of ART clinics under the Gynemed brand. In addition, it offers test laboratory providing services to the assisted reproductive technologies industry and laboratories under the Embryotech brand. Further, the company provides precision laser devices, imaging systems, micromanipulation systems, control rate freezers, and lab monitoring systems. It sells its products through direct sales force and distributors to pharmaceutical and biotechnology companies, animal breeding facilities, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. The company is headquartered in Beverly, Massachusetts.",
    "website": "http://www.hamiltonthorne.ltd",
    "zipcode": "01915"
  },
  "HUMX.TA": {
    "city": "Netanya",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Human Xtensions Ltd.",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "HUMAN XTENSIONS LT",
    "state": null,
    "summary": "Human Xtensions Ltd. develops unmediated surgical systems. It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel.",
    "website": "http://human-x.com",
    "zipcode": "4250574"
  },
  "HYBT": {
    "city": "Xiamen",
    "country": "China",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Heyu Biological Technology Corporation",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HEYU BIOLOGICAL TECHNOLOGY CORP",
    "state": null,
    "summary": "Heyu Biological Technology Corporation does not have significant operations. Previously, the company was engaged in the provision of application services; and development of business software technologies and services for business merchants and organizations. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.",
    "website": "http://heyubt.com",
    "zipcode": "361022"
  },
  "IART": {
    "city": "Princeton",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Integra LifeSciences Holdings Corporation",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Integra LifeSciences Holdings C",
    "state": "NJ",
    "summary": "Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",
    "website": "http://www.integralife.com",
    "zipcode": "08540"
  },
  "IBAB.BR": {
    "city": "Louvain-la-Neuve",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "BRU",
    "industry": "Medical Devices",
    "long_name": "Ion Beam Applications SA",
    "market": "be_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "IBA",
    "state": null,
    "summary": "Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.",
    "website": "http://www.iba-worldwide.com",
    "zipcode": "1348"
  },
  "ICO.ST": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Iconovo AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Iconovo AB",
    "state": null,
    "summary": "Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a reservoir-based dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a unit dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone. Iconovo AB (publ) was founded in 2013 and is headquartered in Lund, Sweden.",
    "website": "http://www.iconovo.se",
    "zipcode": "223 81"
  },
  "IDH.L": {
    "city": "Boldon",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Immunodiagnostic Systems Holdings PLC",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "IMMUNODIAGNOSTIC SYSTEMS HOLDIN",
    "state": null,
    "summary": "Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.",
    "website": "http://www.idsplc.com",
    "zipcode": "NE35 9PD"
  },
  "IDL.V": {
    "city": "Vaughan",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Imaging Dynamics Company Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMAGING DYNAMICS COMPANY LTD",
    "state": "ON",
    "summary": "Imaging Dynamics Company Ltd., a medical technology company, provides digital radiography equipment worldwide. The company offers imaging detectors; and flat panel detectors under Aquarius8600 and VetnovaXion names. It also provides Magellan, a medical image processing software; and Sirius, a veterinary image processing software. In addition, the company provides 1600 Plus X-Series, a DR solution with a floor mounted U-arm multi-axis positioning device that includes X-ray tube, collimator, and generator; and veterinary DR systems. Further, it provides after sales services. It offers products through dealers, distributors, and original equipment manufacturer partners. The company was formerly known as Imaging Dynamics Corporation and changed its name to Imaging Dynamics Company Ltd. in October 2001. Imaging Dynamics Company Ltd. was founded in 1995 and is headquartered in Vaughan, Canada.",
    "website": "http://www.imagingdynamics.com",
    "zipcode": "L4K 4P3"
  },
  "IGNT": {
    "city": "Riverside",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Ingen Technologies, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "INGEN TECHNOLOGIES INC",
    "state": "CA",
    "summary": "Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. The company manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease; and oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark name. Its Oxyview is a pneumatic metering device that displays and confirms the oxygen flow rate near the patient. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California.",
    "website": "http://www.ingen-tech.com",
    "zipcode": "92503"
  },
  "IHC.L": {
    "city": "Crawley",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Inspiration Healthcare Group plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "INSPIRATION HEALTHCARE GROUP PL",
    "state": null,
    "summary": "Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as Unique+ CFM, a wireless electroencephalography monitoring device; a nasal continuous positive airway pressure (nCPAP) device for treating infants, as well as a range of breathing circuits under the Inspire nCPAP name; inspiration air/oxygen blenders; and Tecotherm Neo, a servo control device for total body cooling and warming used in initial stabilization of preterm infants. Its neonatal intensive care products also include LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. In addition, the company provides adult intensive care products; AlphaCore5, a patient warming system for prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for management of body temperature in neonates. Inspiration Healthcare Group plc was founded in 1998 and is headquartered in Crawley, the United Kingdom.",
    "website": "http://www.inspiration-healthcare.com",
    "zipcode": "RH10 9NE"
  },
  "II2.F": {
    "city": "Tel Aviv",
    "country": "Israel",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "InspireMD, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "INSPIREMD 1/18 DL-,0001",
    "state": null,
    "summary": "InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.",
    "website": "http://www.inspiremd.com",
    "zipcode": "6744832"
  },
  "IKMA": {
    "city": "Citra",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "IntelaKare Marketing, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "INTELAKARE MARKETING INC",
    "state": "FL",
    "summary": "IntelaKare Marketing, Inc. provides online retail services for food products and home appliances. The company is based in Citra, Florida.",
    "website": null,
    "zipcode": "32113"
  },
  "IL3.F": {
    "city": "Princeton",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Integra LifeSciences Holdings Corporation",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "INTEGR.LIFES.HLDGS DL-,01",
    "state": "NJ",
    "summary": "Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",
    "website": "http://www.integralife.com",
    "zipcode": "08540"
  },
  "IM11.F": {
    "city": "Martillac",
    "country": "France",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Implanet S.A.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMPLANET SA  EO 0,10",
    "state": null,
    "summary": "Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.",
    "website": "http://www.implanet.com",
    "zipcode": "33650"
  },
  "IME.CN": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Imagin Medical Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ImaginMedical",
    "state": "BC",
    "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
    "website": "http://imaginmedical.com",
    "zipcode": "V6C 1L9"
  },
  "IMEXF": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Imagin Medical Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMAGIN MEDICAL INC",
    "state": "BC",
    "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
    "website": "http://imaginmedical.com",
    "zipcode": "V6C 1L9"
  },
  "IMP-A-SDB.ST": {
    "city": "Zug",
    "country": "Switzerland",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Implantica AG",
    "market": "se_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "Implantica AG SDB",
    "state": null,
    "summary": "Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company develops RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux. It also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energising platform; AppetiteControl, an implant to treat obesity by controlling appetite; and UriControl, a remote controlled implant to treat urinary incontinence for men and women. The company was founded in 2015 and is based in Zug, Switzerland.",
    "website": "http://www.implantica.com",
    "zipcode": "6300"
  },
  "IMPZY": {
    "city": "Martillac",
    "country": "France",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Implanet S.A.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMPLANET",
    "state": null,
    "summary": "Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.",
    "website": "http://www.implanet.com",
    "zipcode": "33650"
  },
  "IMR.AX": {
    "city": "Burnsville",
    "country": "United States",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Imricor Medical Systems, Inc.",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMRICOR CDI FORUS",
    "state": "MN",
    "summary": "Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.",
    "website": "http://www.imricor.com",
    "zipcode": "55337"
  },
  "INGN": {
    "city": "Goleta",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Inogen, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Inogen, Inc",
    "state": "CA",
    "summary": "Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.",
    "website": "http://www.inogen.com",
    "zipcode": "93117"
  },
  "INMD": {
    "city": "Yokne'am",
    "country": "Israel",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "InMode Ltd.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "InMode Ltd.",
    "state": null,
    "summary": "InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.",
    "website": "http://www.inmodemd.com",
    "zipcode": "2069206"
  },
  "INSP": {
    "city": "Golden Valley",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Inspire Medical Systems, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Inspire Medical Systems, Inc.",
    "state": "MN",
    "summary": "Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.",
    "website": "http://www.inspiresleep.com",
    "zipcode": "55416"
  },
  "INVO": {
    "city": "Sarasota",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "INVO Bioscience, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "INVO BioScience, Inc.",
    "state": "FL",
    "summary": "INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.",
    "website": "http://www.invobioscience.com",
    "zipcode": "34240"
  },
  "IOB.F": {
    "city": "Louvain-la-Neuve",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Ion Beam Applications SA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ION BEAM APPLICATIONS SA",
    "state": null,
    "summary": "Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.",
    "website": "http://www.iba-worldwide.com",
    "zipcode": "1348"
  },
  "IOBCF": {
    "city": "Louvain-la-Neuve",
    "country": "Belgium",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Ion Beam Applications SA",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "IBA(ION BEAM APPLICATIONS)",
    "state": null,
    "summary": "Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.",
    "website": "http://www.iba-worldwide.com",
    "zipcode": "1348"
  },
  "IPD.AX": {
    "city": "Pinkenba",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "ImpediMed Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMPEDIMED FPO",
    "state": "QLD",
    "summary": "ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.",
    "website": "http://www.impedimed.com",
    "zipcode": "4008"
  },
  "IPDQF": {
    "city": "Pinkenba",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "ImpediMed Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMPEDIMED LIMITED",
    "state": "QLD",
    "summary": "ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.",
    "website": "http://www.impedimed.com",
    "zipcode": "4008"
  },
  "IRIX": {
    "city": "Mountain View",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "IRIDEX Corporation",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IRIDEX Corporation",
    "state": "CA",
    "summary": "IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",
    "website": "http://www.iridex.com",
    "zipcode": "94043"
  },
  "IRMD": {
    "city": "Winter Springs",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "IRadimed Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "iRadimed Corporation",
    "state": "FL",
    "summary": "IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.",
    "website": "http://www.iradimed.com",
    "zipcode": "32708"
  },
  "IRME": {
    "city": "Rosh Pina",
    "country": "Israel",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "IR-Med Inc.",
    "market": "us_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "IR-MED INC",
    "state": null,
    "summary": "IR-Med Inc., a medical device company, focuses on the development of infra-red light spectroscopy (IR) and artificial intelligence (AI) combined technology solutions to address the diagnosis of medical ailments. It develops PressureSafe, a non-invasive and real-time optical monitoring device for the preemptive detection of pressure injury; and Nobiotics, an advanced otoscope that works on IR-spectrographic analysis technology providing doctors an immediate indication of the infection being viral or bacterial. The company also engages in developing a real-time noninvasive optical monitor to determine Propofol blood concentration. Its products are used for applications in pressure injury, ear inflammation, and other pharmaceutical areas. IR-Med Inc. is headquartered in Rosh Pina, Israel.",
    "website": "http://www.ir-medical.com",
    "zipcode": "1210002"
  },
  "IRRAS.ST": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "IRRAS AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IRRAS AB",
    "state": null,
    "summary": "IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. It also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include Hummingbird Quad ICP monitoring with drainage (H610), and Hummingbird Solo ICP monitoring (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was incorporated in 2011 and is headquartered in Stockholm, Sweden.",
    "website": "http://www.irras.com",
    "zipcode": "111 20"
  },
  "ITGR": {
    "city": "Plano",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Integer Holdings Corporation",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Integer Holdings Corporation",
    "state": "TX",
    "summary": "Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.",
    "website": "http://www.integer.net",
    "zipcode": "75024"
  },
  "ITMMF": {
    "city": "Caesarea",
    "country": "Israel",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Itamar Medical Ltd.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ITAMAR MEDICAL LTD",
    "state": null,
    "summary": "Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",
    "website": "http://www.itamar-medical.com",
    "zipcode": "3079883"
  },
  "ITMR": {
    "city": "Caesarea",
    "country": "Israel",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Itamar Medical Ltd.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Itamar Medical Ltd. - American ",
    "state": null,
    "summary": "Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",
    "website": "http://www.itamar-medical.com",
    "zipcode": "3079883"
  },
  "ITMR.TA": {
    "city": "Caesarea",
    "country": "Israel",
    "currency": "ILA",
    "exchange": "TLV",
    "industry": "Medical Devices",
    "long_name": "Itamar Medical Ltd.",
    "market": "il_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "ITAMAR MEDICAL LTD",
    "state": null,
    "summary": "Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",
    "website": "http://www.itamar-medical.com",
    "zipcode": "3079883"
  },
  "IUG.L": {
    "city": "Cardiff",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Intelligent Ultrasound Group plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "INTELLIGENT ULTRASOUND GROUP PL",
    "state": null,
    "summary": "Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators in the United Kingdom, North America, and internationally. It also develops clinical ultrasound software. The company's clinical AI software products include ScanNav Audit, an AI-based ultrasound software product that provides real-time support for ultrasound practitioners, which performs fetal anomaly scans; ScanNav AutoCapture, an AI-based ultrasound software product that automatically captures images; and ScanNav AnatomyGuide, an AI based ultrasound software product, which can automatically identify and highlight key anatomical structures in a live ultrasound image. Its simulator training platforms, comprises of ScanTrainer, a haptic-based ultrasound simulator for obstetrics and gynaecology training markets; HeartWorks, a manikin-based ultrasound simulator for cardiac and anaesthesiology training markets; and BodyWorks, a manikin-based ultrasound simulators for PoCUS, emergency medicine, critical care, and intensive care training markets. The company was formerly known as MedaPhor Group plc and changed its name to Intelligent Ultrasound Group plc in January 2019. Intelligent Ultrasound Group plc was founded in 2004 and is headquartered in Cardiff, the United Kingdom.",
    "website": "http://www.intelligentultrasound.com",
    "zipcode": "CF10 1DY"
  },
  "IV3.F": {
    "city": "Elyria",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Invacare Corporation",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "INVACARE CORP.",
    "state": "OH",
    "summary": "Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and KÃ¼schall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.",
    "website": "http://www.invacare.com",
    "zipcode": "44035-4190"
  },
  "IVC": {
    "city": "Elyria",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Invacare Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Invacare Corporation",
    "state": "OH",
    "summary": "Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and KÃ¼schall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.",
    "website": "http://www.invacare.com",
    "zipcode": "44035-4190"
  },
  "IX4.F": {
    "city": "Mountain View",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "IRIDEX Corporation",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IRIDEX CORP.  DL-,01",
    "state": "CA",
    "summary": "IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",
    "website": "http://www.iridex.com",
    "zipcode": "94043"
  },
  "JMD.F": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Japan Medical Dynamic Marketing, INC.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "JP.MEDICAL DY.MARK.",
    "state": null,
    "summary": "Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan. It provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. The company offers its products to medical professionals and hospitals. The company was founded in 1973 and is headquartered in Tokyo, Japan.",
    "website": "http://www.jmdm.co.jp",
    "zipcode": "162-0066"
  },
  "JNX.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Therma Bright Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "THERMA BRIGHT INC.",
    "state": "ON",
    "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
    "website": "http://thermabright.com",
    "zipcode": "M4M 3P1"
  },
  "KIDS": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "OrthoPediatrics Corp.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "OrthoPediatrics Corp.",
    "state": "IN",
    "summary": "OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.orthopediatrics.com",
    "zipcode": "46582"
  },
  "KLYG": {
    "city": "Collinsville",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Kelyniam Global, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "KELYNIAM GLOBAL INC",
    "state": "CT",
    "summary": "Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers. The company develops, manufactures, and distributes custom cranial and craniofacial fixation screws for patients requiring the reconstruction of cranial and facial structures. It serves health systems, hospitals, sales representative, and surgeons, payors, and patients. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. The company was incorporated in 2005 and is based in Collinsville, Connecticut.",
    "website": "http://www.kelyniam.com",
    "zipcode": "06019"
  },
  "KMK.L": {
    "city": "Sedgefield",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Kromek Group plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "KROMEK GROUP PLC ORD 1P",
    "state": null,
    "summary": "Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for medical imaging, nuclear detection, and security screening markets in the United Kingdom, North America, Asia, Europe, and Australasia. Its solutions provide high-resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and EV-CPG compact gamma ray detectors, as well as quant GR1 shielded gamma detectors, multichannel analyzers, CZT-based gamma ray imagers, quant air, scalable x-ray CZR linear array, gamma-ray spectroscopy software, gamma ray radionuclide detectors, and voltage to frequency converters. In addition, it offers medical imaging products, including CZT gamma detector for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT. Further, the company provides security products, such as D3 PRD high accuracy, D3M, and D3S PRD personal radiation detectors; D3S wearable RIID gamma neutron detectors; D3S NET networked radiation detectors and static node; static radiation detector; vehicle mounted radiation detectors; UAV radiation mapping drone and AARM system; liquid explosive detection algorithm; and Identifier liquid explosive detectors. Additionally, it engages in scientific research and development activities. The company sells its products through distributors, OEM, and direct sales. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.",
    "website": "http://www.kromek.com",
    "zipcode": "TS21 3FD"
  },
  "KMLXF": {
    "city": "Melbourne",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Respiri Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RESPIRI LTD",
    "state": "VIC",
    "summary": "Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.",
    "website": "http://www.respiri.co",
    "zipcode": "3004"
  },
  "L1Z1.F": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Alphatec Holdings, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ALPHATEC HOLDINGS INC.",
    "state": "CA",
    "summary": "Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.",
    "website": "http://www.atecspine.com",
    "zipcode": "92008"
  },
  "LBL.V": {
    "city": "Belgrade",
    "country": "United States",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Lattice Biologics Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LATTICE BIOLOGICS LTD",
    "state": "MT",
    "summary": "Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.",
    "website": "http://www.latticebiologics.com",
    "zipcode": "59714"
  },
  "LBLTF": {
    "city": "Belgrade",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Lattice Biologics Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LATTICE BIOLOGICS LTD",
    "state": "MT",
    "summary": "Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.",
    "website": "http://www.latticebiologics.com",
    "zipcode": "59714"
  },
  "LBT.AX": {
    "city": "Adelaide",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "LBT Innovations Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LABTECH FPO",
    "state": "SA",
    "summary": "LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. It offers MicroStreak, an automated culture-plate streaking and inoculation system; Automated Plate Assessment System, an intelligent imaging and machine learning software; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. The company was founded in 2004 and is headquartered in Adelaide, Australia.",
    "website": "http://www.lbtinnovations.com",
    "zipcode": "5000"
  },
  "LCDX": {
    "city": "Andover",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Caliber Imaging & Diagnostics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CALIBER IMAGING & DIAGNOSTICS I",
    "state": "MA",
    "summary": "Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.",
    "website": "http://www.caliberid.com",
    "zipcode": "01810"
  },
  "LIA.F": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "LivaNova PLC",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "LIVANOVA PLC  DL -,01",
    "state": null,
    "summary": "LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.",
    "website": "http://www.livanova.com",
    "zipcode": "W2 6LG"
  },
  "LIFE.OL": {
    "city": "Bergen",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Medical Devices",
    "long_name": "Lifecare AS",
    "market": "no_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LIFECARE AS",
    "state": null,
    "summary": "Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a long term implantable micro sensor for monitoring glucose levels. The company was founded in 2006 and is headquartered in Bergen, Norway.",
    "website": "http://www.lifecare.no",
    "zipcode": "5861"
  },
  "LIVN": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "LivaNova PLC",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "LivaNova PLC",
    "state": null,
    "summary": "LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.",
    "website": "http://www.livanova.com",
    "zipcode": "W2 6LG"
  },
  "LLBO": {
    "city": "Reno",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Lifeline Biotechnologies, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LIFELINE BIOTECHNOLOGIES INC",
    "state": "NV",
    "summary": "Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.",
    "website": "http://www.lbti.co",
    "zipcode": "89502"
  },
  "LLIT": {
    "city": "Beijing",
    "country": "China",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Lianluo Smart Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Lianluo Smart Limited",
    "state": null,
    "summary": "Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.",
    "website": "http://www.lianluosmart.com",
    "zipcode": "102200"
  },
  "LNSR": {
    "city": "Orlando",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "LENSAR, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "LENSAR, Inc.",
    "state": "FL",
    "summary": "LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.",
    "website": "http://www.lensar.com",
    "zipcode": "32826"
  },
  "LPTI": {
    "city": "Chadds Ford",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Longport, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LONGPORT INC",
    "state": "PA",
    "summary": "Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, clinical dermatology, and aesthetics/plastics, as well as in various other applications, including burn assessment, superficial musculoskeletal imaging, and veterinary applications. It also exports its products. The company was founded in 1993 and is based in Chadds Ford, Pennsylvania.",
    "website": "http://www.longportinc.com",
    "zipcode": "19317"
  },
  "LS6.F": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Clinical Laserthermia Systems AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CLINICAL LASERTHERM.SYS B",
    "state": null,
    "summary": "Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden.",
    "website": "http://www.clinicallaser.se",
    "zipcode": "223 81"
  },
  "LSM.F": {
    "city": "Adelaide",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "LBT Innovations Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LBT INNOVATIONS LTD.",
    "state": "SA",
    "summary": "LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. It offers MicroStreak, an automated culture-plate streaking and inoculation system; Automated Plate Assessment System, an intelligent imaging and machine learning software; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. The company was founded in 2004 and is based in Adelaide, Australia.",
    "website": "http://www.lbtinnovations.com",
    "zipcode": "5000"
  },
  "LT3.F": {
    "city": "Alachua",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "AxoGen, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AXOGEN INC.  DL -,01",
    "state": "FL",
    "summary": "AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.",
    "website": "http://www.axogeninc.com",
    "zipcode": "32615"
  },
  "LUNG": {
    "city": "Redwood City",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Pulmonx Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Pulmonx Corporation",
    "state": "CA",
    "summary": "Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.",
    "website": "http://pulmonx.com",
    "zipcode": "94063"
  },
  "LUR.F": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Luxbright AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LUXBRIGHT AB",
    "state": null,
    "summary": "Luxbright AB, a technology company, develops and commercializes X-ray tubes, generators, and other X-ray systems to system suppliers. The company was founded in 2012 and is based in Gothenburg, Sweden.",
    "website": "http://luxbright.com",
    "zipcode": "41346"
  },
  "LWX.F": {
    "city": "Boldon",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Immunodiagnostic Systems Holdings PLC",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMMUNODIAGNOSTIC  LS -,02",
    "state": null,
    "summary": "Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.",
    "website": "http://www.idsplc.com",
    "zipcode": "NE35 9PD"
  },
  "LXB.ST": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Luxbright AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Luxbright AB",
    "state": null,
    "summary": "Luxbright AB, a technology company, develops and commercializes X-ray tubes, generators, and other X-ray systems to system suppliers. The company was founded in 2012 and is based in Gothenburg, Sweden.",
    "website": "http://luxbright.com",
    "zipcode": "41346"
  },
  "LXD1.F": {
    "city": "Crawley",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Inspiration Healthcare Group plc",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "INSPIRATION HEA.GR.LS-,10",
    "state": null,
    "summary": "Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as Unique+ CFM, a wireless electroencephalography monitoring device; a nasal continuous positive airway pressure (nCPAP) device for treating infants, as well as a range of breathing circuits under the Inspire nCPAP name; inspiration air/oxygen blenders; and Tecotherm Neo, a servo control device for total body cooling and warming used in initial stabilization of preterm infants. Its neonatal intensive care products also include LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. In addition, the company provides adult intensive care products; AlphaCore5, a patient warming system for prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for management of body temperature in neonates. Inspiration Healthcare Group plc was founded in 1998 and is headquartered in Crawley, the United Kingdom.",
    "website": "http://www.inspiration-healthcare.com",
    "zipcode": "RH10 9NE"
  },
  "LXG.V": {
    "city": "Beverly",
    "country": "United States",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "LexaGene Holdings Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "LEXAGENE HOLDINGS INC",
    "state": "MA",
    "summary": "LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.",
    "website": "http://www.lexagene.com",
    "zipcode": "01915"
  },
  "LXGTF": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Registered Plan Private Investments Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LEXINGTON BIOSCIENCES INC",
    "state": "BC",
    "summary": "Lexington Biosciences, Inc. does not have significant operations. Previously, it was engaged in the development and commercialization of non-invasive diagnostic products for cardiovascular health. The company is headquartered in Vancouver, Canada.",
    "website": "http://www.lexingtonbiosciences.com",
    "zipcode": "V6E 2E9"
  },
  "LXXGF": {
    "city": "Beverly",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "LexaGene Holdings Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "LEXAGENE HOLDINGS INC",
    "state": "MA",
    "summary": "LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.",
    "website": "http://www.lexagene.com",
    "zipcode": "01915"
  },
  "MASS": {
    "city": "Boston",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "908 Devices Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "908 Devices Inc.",
    "state": "MA",
    "summary": "908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.",
    "website": "http://www.908devices.com",
    "zipcode": "02210"
  },
  "MCRPF": {
    "city": "Shanghai",
    "country": "China",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "MicroPort Scientific Corporation",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MICROPORT SCIENTIFIC CORPORATIO",
    "state": null,
    "summary": "MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment provides coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment offers reconstructive joints, spine and trauma, and other professional implants and equipment. The company's Cardiac Rhythm Management Business segment develops, manufactures, and markets defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment provides products and services for neurovascular diseases, such as cerebral aneurysms, intracranial atherosclerotic diseases, carotid artery diseases, and other neurovasculature related diseases. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. The company's Heart Valve Business segment engages in the research and development, manufacture, and sale of VitaFlow Transcatheter aortic valve and delivery system for the treatment of valvular heart diseases. Its Surgical Robot Business segment provides research and technology integration in the fields of robot, intelligent control, and information to provide medical products. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.",
    "website": "http://www.microport.com",
    "zipcode": "201203"
  },
  "MD1.F": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Medistim ASA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "MEDISTIM ASA  NK -,25",
    "state": null,
    "summary": "Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.",
    "website": "http://www.medistim.com",
    "zipcode": "0579"
  },
  "MDGS": {
    "city": "Omer",
    "country": "Israel",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Medigus Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Medigus Ltd.",
    "state": null,
    "summary": "Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel.",
    "website": "http://www.medigus.com",
    "zipcode": "8496500"
  },
  "MDT": {
    "city": "Dublin",
    "country": "Ireland",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Medtronic plc",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Medtronic plc.",
    "state": null,
    "summary": "Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.",
    "website": "http://www.medtronic.com",
    "zipcode": "2"
  },
  "MDT.BA": {
    "city": "Dublin",
    "country": "Ireland",
    "currency": "ARS",
    "exchange": "BUE",
    "industry": "Medical Devices",
    "long_name": "Medtronic plc",
    "market": "ar_market",
    "market_cap": "Mega Cap",
    "sector": "Healthcare",
    "short_name": "MEDTRONIC PLC",
    "state": null,
    "summary": "Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.",
    "website": "http://www.medtronic.com",
    "zipcode": "2"
  },
  "MDTC34.SA": {
    "city": "Dublin",
    "country": "Ireland",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Medtronic plc",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MEDTRONIC   DRN",
    "state": null,
    "summary": "Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.",
    "website": "http://www.medtronic.com",
    "zipcode": "2"
  },
  "MDTN.MX": {
    "city": "Dublin",
    "country": "Ireland",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Medtronic plc",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MEDTRONIC PLC",
    "state": null,
    "summary": "Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.",
    "website": "http://www.medtronic.com",
    "zipcode": "2"
  },
  "MDX.V": {
    "city": "Mississauga",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "MedX Health Corp",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDX HEALTH CORP",
    "state": "ON",
    "summary": "MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.",
    "website": "http://www.medxhealth.com",
    "zipcode": "L5T 1M2"
  },
  "MDXG": {
    "city": "Marietta",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "MiMedx Group, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "MiMedx Group, Inc",
    "state": "GA",
    "summary": "MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.",
    "website": "http://www.mimedx.com",
    "zipcode": "30062"
  },
  "MED.SW": {
    "city": "Basel",
    "country": "Switzerland",
    "currency": "CHF",
    "exchange": "EBS",
    "industry": "Medical Devices",
    "long_name": "Medartis Holding AG",
    "market": "ch_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "MEDARTIS N",
    "state": null,
    "summary": "Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for surgical fixation of bone fractures for upper and lower extremities, as well as for the craniomaxillofacial region. The company offers osteosynthesis systems for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.",
    "website": "http://www.medartis.com",
    "zipcode": "4057"
  },
  "MEDI.OL": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Medical Devices",
    "long_name": "Medistim ASA",
    "market": "no_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "MEDISTIM ASA",
    "state": null,
    "summary": "Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.",
    "website": "http://www.medistim.com",
    "zipcode": "0579"
  },
  "MF6.DE": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "MagForce AG",
    "market": "de_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MAGFORCE AG",
    "state": null,
    "summary": "MagForce AG operates in the field of nanotechnology-based cancer treatment in Germany and Poland. It offers NanoTherm therapy for the treatment of solid tumors; NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nano-particles that could be activated in an alternative magnetic field; NanoPlan, a therapy planning simulation software; and NanoActivator, a magnetic field applicator. The company was founded in 1997 and is headquartered in Berlin, Germany.",
    "website": "http://www.magforce.com",
    "zipcode": "12489"
  },
  "MF6.F": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MagForce AG",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MAGFORCE AG",
    "state": null,
    "summary": "MagForce AG operates in the field of nanotechnology-based cancer treatment in Germany and Poland. It offers NanoTherm therapy for the treatment of solid tumors; NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nano-particles that could be activated in an alternative magnetic field; NanoPlan, a therapy planning simulation software; and NanoActivator, a magnetic field applicator. The company was founded in 1997 and is headquartered in Berlin, Germany.",
    "website": "http://www.magforce.com",
    "zipcode": "12489"
  },
  "MFST": {
    "city": "Freehold",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Medifirst Solutions, Inc",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDIFIRST SOLUTIONS INC",
    "state": "NJ",
    "summary": "Medifirst Solutions, Inc., a development stage company, focuses on developing products within the healthcare market for consumer and professional applications. It develops a hand-held mobile laser system, The Time Machine Series lasers to treat temporary relief of minor muscle and joint pains, stiffness, minor arthritis pain, muscle spasms, temporary increase in local blood circulation, and temporary relaxation of muscles. Medifirst Solutions, Inc. was founded in 2010 and is based in Freehold, New Jersey.",
    "website": "http://www.medifirstsolutions.com",
    "zipcode": "07728"
  },
  "MGP.L": {
    "city": "Hastings",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Medica Group Plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "MEDICA GROUP PLC ORD 0.2P",
    "state": null,
    "summary": "Medica Group Plc provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom. It offers NightHawk emergency computerised tomography (CT) and MR reporting, routine cross sectional, routine plain film, and radiographer plain film services. The company also provides audit services, such as cause for concern audit, departmental quality assurance, and ongoing CT, MR, plain film, and ultrasound audit services; and multiparametric prostate magnetic resonance imaging, specialist cardiac reporting, CT colonoscopy, DXA reporting, nuclear medicine examination, tailored cancer reporting, PET-CT, and CBCT services. Medica Group Plc was incorporated in 2013 and is based in Hastings, the United Kingdom.",
    "website": "http://www.medicagroup.co.uk",
    "zipcode": "TN34 1EA"
  },
  "MHC.L": {
    "city": "Cardiff",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "MyHealthChecked Plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "MYHEALTHCHECKED PLC ORD 0.1P",
    "state": null,
    "summary": "MyHealthChecked Plc, a women's healthcare company, develops and commercializes mobile health diagnostics medical devices in the United Kingdom. Its products help women with unexplained infertility to concieve. The company offers myLotus, a dual purpose monitoring system that allows both ovulation (LH) and pregnancy (hCG) testing. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked Plc in December 2020. MyHealthChecked Plc was incorporated in 2008 and is based in Cardiff, the United Kingdom.",
    "website": "http://myhealthcheckedplc.com",
    "zipcode": "CF24 5EA"
  },
  "MHTX": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Manhattan Scientifics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MANHATTAN SCIENTIFICS INC",
    "state": "NY",
    "summary": "Manhattan Scientifics, Inc., a technology incubator, develops and commercializes life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.",
    "website": "http://www.mhtx.com",
    "zipcode": "10001"
  },
  "MICR": {
    "city": "Fitchburg",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Micron Solutions, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MICRON SOLUTIONS INC",
    "state": "MA",
    "summary": "Micron Solutions, Inc., through its subsidiary, Micron Products, Inc., operates as a contract manufacturing organization that produces medical device components requiring precision machining and injection molding in the United States and internationally. The company also manufactures components, devices, and equipment for military, law enforcement, automotive, and consumer product applications. Its products include silver/silver chloride coated and conductive resin sensors for use as consumable component parts in integrated disposable electrophysiological sensors that are used in monitoring electrical signals in various medical applications. The company also offers orthopedic implant components; thermoplastic injection molding services; and value added services, including the design, manufacture, and rehabilitation of injection molding tools. It serves original equipment manufacturers, and other contract manufacturing organizations, as well as defense industries. The company was formerly known as Arrhythmia Research Technology, Inc. and changed its name to Micron Solutions, Inc. in March 2017. Micron Solutions, Inc. is based in Fitchburg, Massachusetts.",
    "website": "http://www.micronsolutionsinc.com",
    "zipcode": "01420"
  },
  "MKEA.PA": {
    "city": "Paris",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Medical Devices",
    "long_name": "Mauna Kea Technologies SA",
    "market": "fr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MAUNA KEA TECH",
    "state": null,
    "summary": "Mauna Kea Technologies SA develops and markets medical devices for the diagnosis and treatment of cancers and other diseases in Europe, the Middle East, Africa, the United States, Latin America, China, and Japan. Its flagship product is Cellvizio, a multidisciplinary probe and needle-based confocal laser endomicroscopy platform, which provides physicians and researchers with images of tissues at the cellular level. The company was founded in 2000 and is headquartered in Paris, France.",
    "website": "http://www.maunakeatech.com",
    "zipcode": "75010"
  },
  "MKEAF": {
    "city": "Paris",
    "country": "France",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Mauna Kea Technologies SA",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MAUNA KEA TECHNOLOGIES",
    "state": null,
    "summary": "Mauna Kea Technologies SA develops and markets medical devices for the diagnosis and treatment of cancers and other diseases in Europe, the Middle East, Africa, the United States, Latin America, China, and Japan. Its flagship product is Cellvizio, a multidisciplinary probe and needle-based confocal laser endomicroscopy platform, which provides physicians and researchers with images of tissues at the cellular level. The company was founded in 2000 and is headquartered in Paris, France.",
    "website": "http://www.maunakeatech.com",
    "zipcode": "75010"
  },
  "MMTC": {
    "city": "San Clemente",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Micro Imaging Technology, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MICRO IMAGING TECH INC",
    "state": "CA",
    "summary": "Micro Imaging Technology, Inc., a development stage company, engages in the development of fluid monitoring systems for water monitoring, food processing, and clinical applications in the United States. The company is developing a non-biologically based system utilizing both proprietary hardware and software to determine the specific specie of an unknown microbe present in a fluid with a high degree of statistical probability. It would analyze a sample presented to it and compares its characteristics to a library of known microbe characteristics on file. The company was formerly known as Electropure, Inc. and changed its name to Micro Imaging Technology, Inc. in November 2005. Micro Imaging Technology, Inc. was founded in 1979 and is headquartered in San Clemente, California.",
    "website": "http://www.micro-identification.com",
    "zipcode": "92673"
  },
  "MN2.F": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Mentice AB (publ)",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MENTICE AB  SK -,20",
    "state": null,
    "summary": "Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. The company provides software modules in the areas of acute ischemic stroke intervention, aortic valve implantation, atrial septal defect and patent foramen ovale occlusion, below-the-knee intervention, cardiac rhythm management, carotid intervention, coronary angiography, coronary PRO, endovascular aortic repair, Iliac/SFA intervention, left atrial appendage occlusion, neurovascular intervention, peripheral angiography, prostatic artery embolization, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, and vascular trauma management. It offers flight simulations to physicians and clinical teams. The company's products are used to educate, train, and improve the practitioner's skills in different types of interventions and new clinical instruments. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.mentice.com",
    "zipcode": "411 03"
  },
  "MNTC.ST": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Mentice AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Mentice AB",
    "state": null,
    "summary": "Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. The company provides software modules in the areas of acute ischemic stroke intervention, aortic valve implantation, atrial septal defect and patent foramen ovale occlusion, below-the-knee intervention, cardiac rhythm management, carotid intervention, coronary angiography, coronary PRO, endovascular aortic repair, Iliac/SFA intervention, left atrial appendage occlusion, neurovascular intervention, peripheral angiography, prostatic artery embolization, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, and vascular trauma management. It offers flight simulations to physicians and clinical teams. The company's products are used to educate, train, and improve the practitioner's skills in different types of interventions and new clinical instruments. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.mentice.com",
    "zipcode": "411 03"
  },
  "MODD": {
    "city": "San Diego",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Modular Medical, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MODULAR MEDICAL INC",
    "state": "CA",
    "summary": "Modular Medical, Inc., a development stage medical device company, focuses on design, development, and commercialization of insulin pumps for insulin dependent people with diabetes. Its hardware technology allows people with diabetes to receive their daily insulin through continuous basal delivery and bolus delivery. The company is based in San Diego, California.",
    "website": "http://www.modular-medical.com",
    "zipcode": "92127"
  },
  "MOVE": {
    "city": "Pleasanton",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Movano Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Movano Inc.",
    "state": "CA",
    "summary": "Movano Inc., a technology company, develops a smart wearable and continuous glucose monitoring device. Its device enables individuals and their healthcare partners to measure and manage their health conditions. Movano Inc. was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. The company was incorporated in 2018 and is based in Pleasanton, California.",
    "website": "http://movano.com",
    "zipcode": "94588"
  },
  "MOVE.SW": {
    "city": "Castel San Pietro",
    "country": "Switzerland",
    "currency": "CHF",
    "exchange": "EBS",
    "industry": "Medical Devices",
    "long_name": "Medacta Group SA",
    "market": "ch_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "MEDACTA GROUP N",
    "state": null,
    "summary": "Medacta Group SA develops, manufactures, and distributes orthopedic and spinal surgery medical devices in Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.",
    "website": "http://www.medacta.com",
    "zipcode": "6874"
  },
  "MPM.F": {
    "city": "Fitchburg",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Micron Solutions, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MICRON SOLUTIONS  DL-,001",
    "state": "MA",
    "summary": "Micron Solutions, Inc., through its subsidiary, Micron Products, Inc., operates as a contract manufacturing organization that produces medical device components requiring precision machining and injection molding in the United States and internationally. The company also manufactures components, devices, and equipment for military, law enforcement, automotive, and consumer product applications. Its products include silver/silver chloride coated and conductive resin sensors for use as consumable component parts in integrated disposable electrophysiological sensors that are used in monitoring electrical signals in various medical applications. The company also offers orthopedic implant components; thermoplastic injection molding services; and value added services, including the design, manufacture, and rehabilitation of injection molding tools. It serves original equipment manufacturers, and other contract manufacturing organizations, as well as defense industries. The company was formerly known as Arrhythmia Research Technology, Inc. and changed its name to Micron Solutions, Inc. in March 2017. Micron Solutions, Inc. is based in Fitchburg, Massachusetts.",
    "website": "http://www.micronsolutionsinc.com",
    "zipcode": "01420"
  },
  "MSIU": {
    "city": "Wan Chai",
    "country": "Hong Kong",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Medical Supply International USA, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDICAL SUPPLY INTL USA INC",
    "state": null,
    "summary": "Medical Supply International USA, Inc., together with its subsidiaries, provides rehabilitation services and specialized hospital services in the healthcare industry in the People's Republic of China. It operates rehabilitative center, and maternity and specialized service hospital. The rehabilitative center serves patients who have survived from a serious injury or illness or an addiction and are seeking therapeutic or medical treatment. The company also operates outpatient clinic and offers other services, including private outpatients and health check-up services, and obstetrics and gynecology services. It offers 4-D ultrasound system applications for scanning for medical purposes, IPL system applications for treatment various kinds of skin disorder, and cosmetic surgery. The company was formerly known as Master Spirit International USA Inc. and changed its name to Medical Supply International USA, Inc. in October 2018. Medical Supply International USA, Inc. was founded in 2001 and is headquartered in Wan Chai, Hong Kong.",
    "website": null,
    "zipcode": null
  },
  "MSK.F": {
    "city": "Shanghai",
    "country": "China",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MicroPort Scientific Corporation",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "MICRP.SCIEN.REGS HD-00001",
    "state": null,
    "summary": "MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment provides coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment offers reconstructive joints, spine and trauma, and other professional implants and equipment. The company's Cardiac Rhythm Management Business segment develops, manufactures, and markets defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment provides products and services for neurovascular diseases, such as cerebral aneurysms, intracranial atherosclerotic diseases, carotid artery diseases, and other neurovasculature related diseases. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. The company's Heart Valve Business segment engages in the research and development, manufacture, and sale of VitaFlow Transcatheter aortic valve and delivery system for the treatment of valvular heart diseases. Its Surgical Robot Business segment provides research and technology integration in the fields of robot, intelligent control, and information to provide medical products. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.",
    "website": "http://www.microport.com",
    "zipcode": "201203"
  },
  "MSON": {
    "city": "Farmingdale",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Misonix, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "MISONIX, Inc.",
    "state": "NY",
    "summary": "Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.",
    "website": "http://www.misonix.com",
    "zipcode": "11735"
  },
  "MX1.AX": {
    "city": "Tonsley",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Micro-X Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MICRO-X FPO",
    "state": "SA",
    "summary": "Micro-X Limited designs, develops, and manufactures ultra-lightweight carbon nano tube based X-ray products for the healthcare and improvised explosive device imaging security markets in Australia. The company offers Carestream DRX Revolution Nano, an ultra-lightweight digital mobile X-ray system for bedside imaging for use in hospital wards and intensive care units; and Rover, a digital mobile X-Ray unit for deployed military hospitals. It is also developing Mobile Backscatter Imager for stand-off imaging of improvised explosive devices. The company was founded in 2011 and is based in Tonsley, Australia.",
    "website": "http://www.micro-x.com",
    "zipcode": "5042"
  },
  "MX9.F": {
    "city": "Farmingdale",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Misonix, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "MISONIX INC.  DL-,01",
    "state": "NY",
    "summary": "Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.",
    "website": "http://www.misonix.com",
    "zipcode": "11735"
  },
  "MYO": {
    "city": "Boston",
    "country": "United States",
    "currency": "USD",
    "exchange": "ASE",
    "industry": "Medical Devices",
    "long_name": "Myomo, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Myomo Inc.",
    "state": "MA",
    "summary": "Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.",
    "website": "http://www.myomo.com",
    "zipcode": "02114"
  },
  "MZEIQ": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Medizone International, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDIZONE INTERNATIONAL",
    "state": "MI",
    "summary": "Medizone International, Inc. develops, manufactures, and sells disinfection systems in the United States and internationally. It offers AsepticSure system, a disinfection system that is used in medical facilities, such as hospitals, clinics, physician's offices, outpatient surgical centers, and long-term care facilities; food industry; bio-safety labs; athletic facilities, such as gyms and locker rooms, as well as sports equipment; and mortuaries, bio-defense and response to pandemics, building remediation, tissue labs, sporting venues, and hotels, as well as clean rooms to disinfect hard and non-porous surfaces. The company was founded in 1986 and is based in Kalamazoo, Michigan. On May 8, 2018, Medizone International, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of Nevada.",
    "website": "http://www.medizoneint.com",
    "zipcode": "49007"
  },
  "N18A.F": {
    "city": "New York",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Nemaura Medical Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NEMAURA MED. INC. DL-,001",
    "state": "NY",
    "summary": "Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.",
    "website": "http://nemauramedical.com",
    "zipcode": "10019"
  },
  "N6A.F": {
    "city": "North Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "OncoSil Medical Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ONCOSIL MEDICAL LTD",
    "state": "NSW",
    "summary": "OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.",
    "website": "http://www.oncosil.com.au",
    "zipcode": "2060"
  },
  "NAOV": {
    "city": "Elmsford",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "NanoVibronix, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NanoVibronix, Inc.",
    "state": "NY",
    "summary": "NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.",
    "website": "http://www.nanovibronix.com",
    "zipcode": "10523"
  },
  "NARI": {
    "city": "Irvine",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Inari Medical, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Inari Medical, Inc.",
    "state": "CA",
    "summary": "Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.",
    "website": "http://www.inarimedical.com",
    "zipcode": "92618"
  },
  "NHNKY": {
    "city": "Tokyo",
    "country": "Japan",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Nihon Kohden Corporation",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "NIHON KOHDEN CORP",
    "state": null,
    "summary": "Nihon Kohden Corporation develops, produces, and sells medical electronic equipment in Japan and internationally. It provides physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring systems, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. The company also offers patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables and services, such as electrodes and sensors, and maintenance services. In addition, it provides treatment equipment, which include defibrillators, automated external defibrillators (AED), pacemakers, ventilators, anesthesia machines, cochlear implants, and related consumables and services, such as AED pads and batteries. Further, the company offers other medical equipment, including hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Nihon Kohden Corporation was founded in 1951 and is headquartered in Tokyo, Japan.",
    "website": "http://www.nihonkohden.com",
    "zipcode": "161-8560"
  },
  "NK8.F": {
    "city": "San Diego",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "NuVasive, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "NUVASIVE INC.  DL-,001",
    "state": "CA",
    "summary": "NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.",
    "website": "http://www.nuvasive.com",
    "zipcode": "92121"
  },
  "NM4.F": {
    "city": "Pleasanton",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Natus Medical Incorporated",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "NATUS MEDICAL INC. DL-001",
    "state": "CA",
    "summary": "Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was founded in 1987 and is headquartered in Pleasanton, California.",
    "website": "http://www.natus.com",
    "zipcode": "94566"
  },
  "NMRD": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Nemaura Medical Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Nemaura Medical Inc.",
    "state": "NY",
    "summary": "Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.",
    "website": "http://nemauramedical.com",
    "zipcode": "10019"
  },
  "NMTC": {
    "city": "Eden Prairie",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "NeuroOne Medical Technologies Corporation",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NeuroOne Medical Technologies C",
    "state": "MN",
    "summary": "NeuroOne Medical Technologies Corporation operates as a medical technology company. It focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. The company is based in Eden Prairie, Minnesota.",
    "website": "http://www.n1mtc.com",
    "zipcode": "55344"
  },
  "NNOX": {
    "city": "Neve Ilan",
    "country": "Israel",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Nano-X Imaging Ltd.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "NANO-X IMAGING LTD",
    "state": null,
    "summary": "Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.",
    "website": "http://www.nanox.vision",
    "zipcode": "9085000"
  },
  "NPCE": {
    "city": "Mountain View",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "NeuroPace, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Neuropace, Inc.",
    "state": "CA",
    "summary": "NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.",
    "website": "http://www.neuropace.com",
    "zipcode": "94043"
  },
  "NPW1.F": {
    "city": "Watford",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Smith & Nephew plc",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "SMITH + NEP.  DL -,20",
    "state": null,
    "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
    "website": "http://www.smith-nephew.com",
    "zipcode": "WD18 8YE"
  },
  "NPWA.F": {
    "city": "Watford",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Smith & Nephew plc",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "SMITH+NEPHEW ADR5 DL-20/2",
    "state": null,
    "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
    "website": "http://www.smith-nephew.com",
    "zipcode": "WD18 8YE"
  },
  "NSPR": {
    "city": "Tel Aviv",
    "country": "Israel",
    "currency": "USD",
    "exchange": "ASE",
    "industry": "Medical Devices",
    "long_name": "InspireMD, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "InspireMD Inc.",
    "state": null,
    "summary": "InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.",
    "website": "http://www.inspiremd.com",
    "zipcode": "6744832"
  },
  "NTI.AX": {
    "city": "Nedlands",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Neurotech International Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NEUROTECH FPO",
    "state": "WA",
    "summary": "Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism, a portable electroencephalographic medical device that uses neuro feedback to relax the minds of children with autism spectrum disorder. The company focuses on developing neuro-stimulation and neuro-diagnostic solutions that enable medical practitioners to monitor and play an active role in home-based therapies. It also engages in executing of medical research projects; and developing of technological devices and other solutions for the screening and treatment of neurological disorders. The company was incorporated in 2016 and is based in Nedlands, Australia.",
    "website": "http://www.neurotechinternational.com",
    "zipcode": "6009"
  },
  "NTUS": {
    "city": "Pleasanton",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Natus Medical Incorporated",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Natus Medical Incorporated",
    "state": "CA",
    "summary": "Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was founded in 1987 and is headquartered in Pleasanton, California.",
    "website": "http://www.natus.com",
    "zipcode": "94566"
  },
  "NUMD": {
    "city": "Salt Lake City",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Nu-Med Plus, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NU-MED PLUS INC",
    "state": "UT",
    "summary": "Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.",
    "website": "http://www.nu-medplus.com",
    "zipcode": "84111"
  },
  "NURECA.NS": {
    "city": "Chandigarh",
    "country": "India",
    "currency": "INR",
    "exchange": "NSI",
    "industry": "Medical Devices",
    "long_name": "Nureca Limited",
    "market": "in_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Nureca Limited",
    "state": null,
    "summary": "Nureca Limited, a B2C company, engages in the home healthcare and wellness products business primarily in India. It offers electric massagers, nebulizers, blood pressure monitors, glucometers, infrared thermometers for temperature scanning, fingertip pulse oximeters, weighing scales, home spa humidifiers and steamers, office electronics, rapid test kits, USB port car mobile chargers, and car mobile holder magnetic stands; and rehabilitation, mother and baby care, personal care and hygiene, nutrition, connected health care, and fitness products. The company offers its products under Dr Trust, Dr Physio, and Dr Trust brands. Its products provide consumers with tools to monitor chronic ailments and other diseases. The company sells its products through online channel partners comprising e-commerce companies, distributors, and retailers; and through its website, drtrust.in. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.",
    "website": "http://www.nureca.com",
    "zipcode": "160017"
  },
  "NUVA": {
    "city": "San Diego",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "NuVasive, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "NuVasive, Inc.",
    "state": "CA",
    "summary": "NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.",
    "website": "http://www.nuvasive.com",
    "zipcode": "92121"
  },
  "NUWE": {
    "city": "Eden Prairie",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Nuwellis, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Nuwellis, Inc.",
    "state": "MN",
    "summary": "Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.",
    "website": "http://www.nuwellis.com",
    "zipcode": "55344"
  },
  "NVCN": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Neovasc Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Neovasc Inc.",
    "state": "BC",
    "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
    "website": "http://www.neovasc.com",
    "zipcode": "V6V 2J7"
  },
  "NVCN.TO": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "TOR",
    "industry": "Medical Devices",
    "long_name": "Neovasc Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NEOVASC INC",
    "state": "BC",
    "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
    "website": "http://www.neovasc.com",
    "zipcode": "V6V 2J7"
  },
  "NVRO": {
    "city": "Redwood City",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Nevro Corp.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Nevro Corp.",
    "state": "CA",
    "summary": "Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. In addition, the company provides HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.",
    "website": "http://www.nevro.com",
    "zipcode": "94065"
  },
  "NWCI": {
    "city": "Branchburg",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "NewCardio, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NEWCARDIO INC",
    "state": "NJ",
    "summary": "NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.",
    "website": null,
    "zipcode": "08853"
  },
  "NXNN": {
    "city": "Dallas",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Nexeon MedSystems Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NEXEON MEDSYSTEMS INC",
    "state": "TX",
    "summary": "Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.",
    "website": "http://www.nexeonmedsystems.com",
    "zipcode": "75201"
  },
  "NXTMH.HE": {
    "city": "Helsinki",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "Nexstim Plc",
    "market": "fi_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Nexstim Oyj",
    "state": null,
    "summary": "Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression order or chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.",
    "website": "http://www.nexstim.com",
    "zipcode": "00510"
  },
  "NXTMS.ST": {
    "city": "Helsinki",
    "country": "Finland",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Nexstim Plc",
    "market": "se_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Nexstim Oyj",
    "state": null,
    "summary": "Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression order or chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.",
    "website": "http://www.nexstim.com",
    "zipcode": "00510"
  },
  "OBLN": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Obalon Therapeutics, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Obalon Therapeutics, Inc.",
    "state": "CA",
    "summary": "Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.",
    "website": "http://www.obalon.com",
    "zipcode": "92008-4410"
  },
  "OBSRV.OL": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Medical Devices",
    "long_name": "Observe Medical ASA",
    "market": "no_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OBSERVE MEDICAL",
    "state": null,
    "summary": "Observe Medical ASA develops and markets medical technology products for patients, healthcare professionals, and hospitals in Europe and the United States. The company offers Sippi, a digital urine measuring system that automatically delivers data to electronic patient journal systems. It also develops Sippcoat, a technology that hampers the formation of biofilms in urine collection and drainage systems. The company was founded in 2009 and is headquartered in Oslo, Norway.",
    "website": "http://observemedical.com",
    "zipcode": "0255"
  },
  "OC5.F": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "OC50.F": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD ADR 1/2/O.N.",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "OCLG": {
    "city": "Lafayette",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Oncologix Tech, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ONCOLOGIX TECH INC",
    "state": "LA",
    "summary": "Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.",
    "website": "http://www.oclghealth.com",
    "zipcode": "70508"
  },
  "ODYY": {
    "city": "Irvine",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Odyssey Group International, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ODYSSEY GROUP INTL INC",
    "state": "CA",
    "summary": "Odyssey Group International, Inc. focuses on development, acquisition, and commercialization of medical products and health related technologies. It intends to offer medical devices. The company has development projects in three technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat rare brain disorders. Odyssey Group International, Inc. was founded in 2014 and is based in Irvine, California.",
    "website": "http://theodysseygroupinternational.com",
    "zipcode": "92614"
  },
  "OFIX": {
    "city": "Lewisville",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Orthofix Medical Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Orthofix Medical Inc.",
    "state": "TX",
    "summary": "Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.",
    "website": "http://www.orthofix.com",
    "zipcode": "75056"
  },
  "OM": {
    "city": "San Jose",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Outset Medical, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Outset Medical, Inc.",
    "state": "CA",
    "summary": "Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.",
    "website": "http://www.outsetmedical.com",
    "zipcode": "95134"
  },
  "OM2.F": {
    "city": "Lewisville",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Orthofix Medical Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ORTHOFIX MED.INC.  DL-,10",
    "state": "TX",
    "summary": "Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.",
    "website": "http://www.orthofix.com",
    "zipcode": "75056"
  },
  "OM5A.F": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Observe Medical ASA",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OBSERVE MEDICAL ASA -,26",
    "state": null,
    "summary": "Observe Medical ASA develops and markets medical technology products for patients, healthcare professionals, and hospitals in Europe and the United States. The company offers Sippi, a digital urine measuring system that automatically delivers data to electronic patient journal systems. It also develops Sippcoat, a technology that hampers the formation of biofilms in urine collection and drainage systems. The company was founded in 2009 and is headquartered in Oslo, Norway.",
    "website": "http://observemedical.com",
    "zipcode": "0255"
  },
  "OMRX": {
    "city": "Naples",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Orthometrix, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ORTHOMETRIX INC",
    "state": "FL",
    "summary": "Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for research and clinical applications; patented motorized exercise systems for rehabilitation, physical therapy, and sports medicine based on patented vibration technology; human performance measurement systems for monitoring improvement in power and mobility; and extracorporeal shock wave therapy systems for non-invasive treatment of pain associated with plantar fasciitis. It also markets, sells, and services patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs, and wellness-conscious general public. The company offers bone and muscle diagnostic, bone and muscle research, rehabilitation/physical therapy, sports and fitness, and home products. It serves healthcare, veterinary, and sports and fitness markets in the United States and internationally. The company was formerly known as Norland Medical Systems, Inc. and changed its name to Orthometrix, Inc. in April 2002. Orthometrix, Inc. was founded in 1993 and is headquartered in Naples, Florida.",
    "website": null,
    "zipcode": "34110"
  },
  "OPTOCIRCUI.NS": {
    "city": "Bengaluru",
    "country": "India",
    "currency": "INR",
    "exchange": "NSI",
    "industry": "Medical Devices",
    "long_name": "Opto Circuits (India) Limited",
    "market": "in_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OPTO CIRCUITS IND",
    "state": null,
    "summary": "Opto Circuits (India) Limited manufactures and trades in invasive and non-invasive medical equipment in India and internationally. It operates through Sensors, Monitors, and Others segments. The company offers data management and connectivity products that connect to hospital information systems, electronic medical records, and other information systems; defibrillation systems to detect and identify arrhythmias; non-invasive vascular diagnostic systems to detect peripheral arterial disease; and respiratory and anesthesia monitoring products to identify and quantify inspired and expired CO2, O2, and N2O. It also provides non-invasive reusable and disposable sensors, extension and adapter cables, neo wraps, Y tapes, and Water Traps and ComfortCuffs, as well as batteries, defibrillation pads, electrodes, doppler probes, and other accessories and consumables; veterinary care products to diagnose, measure, and monitor parameters on animals; and vital signs patient monitoring equipment to measure and display a patient's vital signs. In addition, the company offers cardiac stents; catheters and related disposable products in the fields of urology, gastroenterology, and gynecology; PTA balloons to decrease the stimulus of chronic inflammation and the trigger for late thrombosis; and orthopedic implants, as well as surgical consumables, such as endernails and wound suction drainage systems. Further, it offers education and training, technical support, and professional services, as well as turnkey solutions in specialty ambulances, modular operation theatres, and cathlabs; and services in information technology, global positioning systems, and electronic design automation. The company serves physicians, general practitioners and specialists, clinics, and hospitals. Opto Circuits (India) Limited was founded in 1992 and is headquartered in Bengaluru, India.",
    "website": "http://www.optoindia.com",
    "zipcode": "560100"
  },
  "OPTOMED.HE": {
    "city": "Oulu",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "Optomed Oyj",
    "market": "fi_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Optomed Plc",
    "state": null,
    "summary": "Optomed Oyj, a medical technology company, provides handheld fundus cameras and eye-screening devices in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. It offers handheld fundus camera products, which are used in ophthalmology, pediatric care, endocrinology, neurology, and primary care. Its product portfolio consists of Optomed Smartscope Pro, Optomed Aurora, and Optomed Aava, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal; and desktops cameras, such as Optomed Polaris tabletop fundus cameras and Optomed Halo portable retinal cameras. The company also provides Optomed Avenue, a Software-as-a-Service (SaaS) platform that offers access to artificial intelligence services, screening process management tools, and remote image analyses; Avenue Eye Screen, a workflow management system for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Telemedicine, a remote analysis solution for faster access to medical consultation; Avenue Viewer, a patient data management solution for viewing, reporting, and archiving fundus images; and Avenue Sync, a software solution. In addition, it offers process management software for various cancer screenings; radiology information system, a software system for healthcare imaging units for managing medical images and associated data; and solution for digital pathology. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was founded in 2004 and is headquartered in Oulu, Finland.",
    "website": "http://www.optomed.com",
    "zipcode": "90230"
  },
  "ORTH.CN": {
    "city": "Kirkland",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Ortho Regenerative Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OrthoRegenTech",
    "state": "QC",
    "summary": "Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair. It also develops Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.",
    "website": "http://www.orthorti.com",
    "zipcode": "H9H 4R9"
  },
  "ORTIF": {
    "city": "Kirkland",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Ortho Regenerative Technologies Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ORTHO REGENERATIVE TECHNOLOGIES",
    "state": "QC",
    "summary": "Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair. It also develops Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.",
    "website": "http://www.orthorti.com",
    "zipcode": "H9H 4R9"
  },
  "OSL.AX": {
    "city": "North Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "OncoSil Medical Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ONCOSIL FPO",
    "state": "NSW",
    "summary": "OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.",
    "website": "http://www.oncosil.com.au",
    "zipcode": "2060"
  },
  "OSP.AX": {
    "city": "Minnetonka",
    "country": "United States",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Osprey Medical, Inc.",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "OSPREY MED CDI FORUS",
    "state": "MN",
    "summary": "Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.",
    "website": "http://www.ospreymed.com",
    "zipcode": "55343"
  },
  "OSSD.ST": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "OssDsign AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OssDsign AB",
    "state": null,
    "summary": "OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage, as well as nanosynthetic bone graft substitute for treating skeletal defect. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.",
    "website": "http://www.ossdsign.com",
    "zipcode": "754 50"
  },
  "OSSR.CO": {
    "city": "Reykjavik",
    "country": "Iceland",
    "currency": "DKK",
    "exchange": "CPH",
    "industry": "Medical Devices",
    "long_name": "Össur hf.",
    "market": "dk_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "ssur hf.",
    "state": null,
    "summary": "Ãssur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers prosthetics products, including artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, fingers, liners, and other components. The company also provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Ãssur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Ãssur hf. is a subsidiary of William Demant Invest A/S.",
    "website": "http://www.ossur.com",
    "zipcode": "110"
  },
  "OVN.AX": {
    "city": "Indooroopilly",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Oventus Medical Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OVENTUS FPO",
    "state": "QLD",
    "summary": "Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a customized 3D-printed nylon oral appliance for OSA patients; and ExVent, an alternative for CPAP-intolerant individuals. It also develops O2Vent. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.",
    "website": "http://o2vent.com",
    "zipcode": "4068"
  },
  "P75.F": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Pharmacolog i Uppsala AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PHARMACOLOG I UPPSALA AB",
    "state": null,
    "summary": "Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, an integrated system to monitor and safeguard discarded narcotics from surgical procedures; and PerpLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of end result. The company was founded in 2007 and is based in Uppsala, Sweden.",
    "website": "http://www.pharmacolog.com",
    "zipcode": "752 75"
  },
  "PAVM": {
    "city": "New York",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "PAVmed Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "PAVmed Inc.",
    "state": "NY",
    "summary": "PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.",
    "website": "http://www.pavmed.com",
    "zipcode": "10165"
  },
  "PAX.ST": {
    "city": "Karlshamn",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Paxman AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Paxman AB",
    "state": null,
    "summary": "Paxman AB (publ), together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. It serves various cancer centers and hospitals. Paxman AB (Publ) has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. The company was founded in 1996 and is headquartered in Karlshamn, Sweden.",
    "website": "http://www.paxman.se",
    "zipcode": "374 35"
  },
  "PBIO": {
    "city": "South Easton",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Pressure BioSciences, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PRESSURE BIOSCIENCES INC",
    "state": "MA",
    "summary": "Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. It serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. Pressure BioSciences, Inc. has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts.",
    "website": "http://www.pressurebiosciences.com",
    "zipcode": "02375"
  },
  "PECN": {
    "city": "North Billerica",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Photoelectron Corp.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PHOTOELECTRON CORP",
    "state": "MA",
    "summary": "Photoelectron Corporation, a technology company, engages in the development, manufacture, and marketing of miniature x-ray systems for multiple market applications. It creates and adapts miniature x-ray systems for various applications in healthcare and nonhealthcare related markets. The company offers micro-adaptive x-ray systems designed for x-ray fluorescence analysis, intravascular radiation therapy, brachytherapy, radiosurgery, intraoperative radiation therapy, and instrumentation to the industrial and medical markets through original equipment manufacturers. Photoelectron Corporation was founded in 1989 and is based in North Billerica, Massachusetts.",
    "website": null,
    "zipcode": "01862"
  },
  "PEN": {
    "city": "Alameda",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Penumbra, Inc.",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Penumbra, Inc.",
    "state": "CA",
    "summary": "Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; immersive virtual reality and display system that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.",
    "website": "http://www.penumbrainc.com",
    "zipcode": "94502"
  },
  "PETV": {
    "city": "Minneapolis",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "PetVivo Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PETVIVO HLDGS INC",
    "state": "MN",
    "summary": "PetVivo Holdings, Inc., a biomedical device company, engages in the licensing and commercializing medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products includes 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.",
    "website": "http://www.petvivo.com",
    "zipcode": "55439"
  },
  "PGUZ": {
    "city": "Palm Beach Gardens",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Pegasus Pharmaceuticals Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PEGASUS PHARMACEUTICALS INC",
    "state": "FL",
    "summary": "Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.",
    "website": "http://www.pegasusbiosciences.com",
    "zipcode": "33410"
  },
  "PHLOG-B.ST": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Pharmacolog i Uppsala AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Pharmacolog i Uppsala AB ser. B",
    "state": null,
    "summary": "Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, an integrated system to monitor and safeguard discarded narcotics from surgical procedures; and PerpLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of end result. The company was founded in 2007 and is based in Uppsala, Sweden.",
    "website": "http://www.pharmacolog.com",
    "zipcode": "752 75"
  },
  "PINK.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Perimeter Medical Imaging AI, Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PERIMETER MEDICAL IMAGING AI IN",
    "state": "ON",
    "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.perimetermed.com",
    "zipcode": "M5E 1E6"
  },
  "PLLWF": {
    "city": "Durham",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Polarean Imaging plc",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "POLAREAN IMAGING PLC",
    "state": "NC",
    "summary": "Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is headquartered in Durham, North Carolina.",
    "website": "http://www.polarean.com",
    "zipcode": "27713"
  },
  "PMDL": {
    "city": "San Diego",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Pace Medical, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PACE MEDICAL INC",
    "state": "CA",
    "summary": "Pace Medical, Inc. designs and markets cardiac pacing products for medical professions in the United States and internationally. The company offers Model 4580 MICRO-PACE, a programmable and dual-chamber temporary cardiac pacemaker for multi-mode and multi-parameter operation; Model EV4543, a single-chamber temporary cardiac pacemaker that is designed to provide acute therapeutic, prophylactic, and diagnostic pacing support; and The Bedside Model 4170, a single-chamber temporary cardiac pacemaker. It also provides REF 4800 pacing analyzer, an internally powered and software-programmable device designed for continuous operation in the acute cardiac-care environment as temporary cardiac pacemaker and a pacing analyzer; and autoclavable and single-use surgical/patient extension cables and adapters. The company was founded in 1985 and is based in San Diego, California.",
    "website": null,
    "zipcode": "92121"
  },
  "PMED.CN": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Predictmedix Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PredictmedixInc",
    "state": "ON",
    "summary": "Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for healthcare screenings and impairment detection. The company's AI products use facial, thermal, video, and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease, or mental illness. It also focuses on developing AI based screening, such as COVID19 solutions for the healthcare industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.predictmedix.com",
    "zipcode": "M5K 1G8"
  },
  "PMEDF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Predictmedix Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PREDICTMEDIX INC",
    "state": "ON",
    "summary": "Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for healthcare screenings and impairment detection. The company's AI products use facial, thermal, video, and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease, or mental illness. It also focuses on developing AI based screening, such as COVID19 solutions for the healthcare industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.predictmedix.com",
    "zipcode": "M5K 1G8"
  },
  "PODD": {
    "city": "Acton",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Insulet Corporation",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Insulet Corporation",
    "state": "MA",
    "summary": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.",
    "website": "http://www.insulet.com",
    "zipcode": "01720"
  },
  "POLX.L": {
    "city": "Durham",
    "country": "United States",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Polarean Imaging plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "POLAREAN IMAGING PLC ORD GBP0.0",
    "state": "NC",
    "summary": "Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.",
    "website": "http://www.polarean.com",
    "zipcode": "27713"
  },
  "POSC": {
    "city": "Westmont",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Positron Corporation",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "POSITRON CORP",
    "state": "IL",
    "summary": "Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers PET molecular imaging systems, clinical and support services, automated radiopharmaceutical systems, and radiopharmaceuticals and radioisotope processing and production. The company's Attrius system based on cardiac PET technology enables healthcare providers to more accurately diagnose heart disease, improve patient outcomes, and practice cost effective medicine. It is also focused on increasing Sr-82 supply through the processing of proton irradiated target material from domestic and foreign suppliers; and recycling Sr-82 from spent generators. Positron Corporation was founded in 1983 and is based in Westmont, Illinois.",
    "website": "http://www.positron.com",
    "zipcode": "60559"
  },
  "PROF": {
    "city": "Mississauga",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Profound Medical Corp.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Profound Medical Corp.",
    "state": "ON",
    "summary": "Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.",
    "website": "http://www.profoundmedical.com",
    "zipcode": "L4W 5K5"
  },
  "PSH.DE": {
    "city": "London",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORP.",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "PSH.F": {
    "city": "London",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORP.",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "PTQ.V": {
    "city": "Wilder",
    "country": "United States",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Protech Home Medical Corp.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PROTECH HOME MEDICAL CORP",
    "state": "KY",
    "summary": "Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.",
    "website": "http://www.protechhomemedical.com",
    "zipcode": "41076"
  },
  "PTQQF": {
    "city": "Wilder",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Protech Home Medical Corp.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PROTECH HOME MEDICAL CORP",
    "state": "KY",
    "summary": "Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.",
    "website": "http://www.protechhomemedical.com",
    "zipcode": "41076"
  },
  "PUS.MU": {
    "city": "Feldkirchen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "PULSION Medical Systems SE",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PULSION ST O.N.",
    "state": null,
    "summary": "PULSION Medical Systems SE engages in the development and sale of monitoring systems and disposables for diagnosis and treatment of patients worldwide. The company offers its principal products in the fields of anesthesia, surgical and internal intensive care medicine, and cardiology, as well as ophthalmology and tumor therapy. PULSION Medical Systems SE was founded in 1990 and is headquartered in Feldkirchen, Germany.",
    "website": "http://www.pulsion.com",
    "zipcode": "85622"
  },
  "PXMBF": {
    "city": "Karlshamn",
    "country": "Sweden",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Paxman AB (publ)",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PAXMAN AB",
    "state": null,
    "summary": "Paxman AB (publ), together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. It serves various cancer centers and hospitals. Paxman AB (Publ) has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. The company was founded in 1996 and is headquartered in Karlshamn, Sweden.",
    "website": "http://www.paxman.se",
    "zipcode": "374 35"
  },
  "PYNKF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Perimeter Medical Imaging AI, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PERIMETER MEDICAL IMAGING AI IN",
    "state": "ON",
    "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.perimetermed.com",
    "zipcode": "M5E 1E6"
  },
  "QD4.F": {
    "city": "Rosebery",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Quantum Health Group Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "QUANTUM HEALTH GROUP LTD.",
    "state": "NSW",
    "summary": "Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, the Philippines, and China. It operates in two segments, Medical and Environmental Services. The company distributes medical products in the field of radiology, oncology, aesthetics, and environmental health. It also manufactures energy saving heat pump technology used for heating and cooling systems internationally. The company was formerly known as Quantum Energy Limited. Quantum Health Group Limited was founded in 1975 and is headquartered in Rosebery, Australia.",
    "website": "http://www.qhealthcare.com.au",
    "zipcode": "2018"
  },
  "QLIFE.ST": {
    "city": "Helsingborg",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Qlife Holding AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "QLife Holding AB",
    "state": null,
    "summary": "Qlife Holding AB (publ), a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. It offers Egoo Home System, an integrated platform consisting of a small home device and disposable capsules each of that test for a specific biomarker, as well as a digital infrastructure that shares data with patient journal or hospital platform. The company has a research agreement with NordsjÃ¦llands Hospital to continue the validation of the Egoo Sars-CoV-2 virus test. The company was founded in 2019 and is based in Helsingborg, Sweden.",
    "website": "http://qlifeholding.com/en",
    "zipcode": "252 21"
  },
  "QTM.AX": {
    "city": "Rosebery",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Quantum Health Group Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "QUANTHEGRP FPO",
    "state": "NSW",
    "summary": "Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, the Philippines, and China. It operates in two segments, Medical and Environmental Services. The company distributes medical products in the field of radiology, oncology, aesthetics, and environmental health. It also manufactures energy saving heat pump technology used for heating and cooling systems internationally. The company was formerly known as Quantum Energy Limited. Quantum Health Group Limited was founded in 1975 and is headquartered in Rosebery, Australia.",
    "website": "http://www.qhealthcare.com.au",
    "zipcode": "2018"
  },
  "QTNA.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Titan Medical Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "TITAN MEDICAL INC.",
    "state": "ON",
    "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.titanmedicalinc.com",
    "zipcode": "M5H 3B7"
  },
  "QTRX": {
    "city": "Billerica",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Quanterix Corporation",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Quanterix Corporation",
    "state": "MA",
    "summary": "Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.",
    "website": "http://www.quanterix.com",
    "zipcode": "01821"
  },
  "QTVLF": {
    "city": "Singapore",
    "country": "Singapore",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "QT Vascular Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "QT VASCULAR LTD",
    "state": null,
    "summary": "QT Vascular Ltd., together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation; and Glider PTCA balloon catheter for the treatment of various complex lesions. It also provides Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for atraumatic dilatation in the treatment of blocked arteries; Chocolate Touch PTA balloon catheter to treat peripheral vascular disease; GliderfleX PTA balloon catheter for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature. It has operations in the United States, Europe, and Singapore. The company was incorporated in 2005 and is based in Singapore.",
    "website": "http://www.qtvascular.com",
    "zipcode": "609966"
  },
  "R0V.MU": {
    "city": "Vantaa",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "Revenio Group Oyj",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "REVENIO GROUP CORP. EO 15",
    "state": null,
    "summary": "Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally. The company offers ic100 and ic200 tonometers; Icare HOME, a device for self-measurement of eye pressure; Icare TONOVET Plus tonometers for animals; fundus imaging devices comprising EIDON, DRS, and DRSplus; MAIA, a microperimeter to measure the effectiveness of drugs for retinal disease treatment; COMPASS, which provides fundus perimetry with true-color confocal retinal images; and Ventica, to examine the variability in tidal breathing in children. It is also developing Cutica, a hyperspectral camera for dermatologists to detect skin cancers. Revenio Group Oyj is based in Vantaa, Finland.",
    "website": "http://www.reveniogroup.fi",
    "zipcode": "01510"
  },
  "R3I1.F": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Advanced Oncotherapy plc",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ADVANCED ONCOTHER. LS-,25",
    "state": null,
    "summary": "Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.",
    "website": "http://www.avoplc.com",
    "zipcode": "W1S 1TE"
  },
  "RCEL": {
    "city": "Valencia",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "AVITA Medical, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Avita Therapeutics, Inc.",
    "state": "CA",
    "summary": "AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.",
    "website": "http://www.avitamedical.com",
    "zipcode": "91355"
  },
  "RDGL": {
    "city": "Richland",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Vivos Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VIVOS INC",
    "state": "WA",
    "summary": "Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 is headquartered in Richland, Washington.",
    "website": "http://www.radiogel.com",
    "zipcode": "99352"
  },
  "REG1V.HE": {
    "city": "Vantaa",
    "country": "Finland",
    "currency": "EUR",
    "exchange": "HEL",
    "industry": "Medical Devices",
    "long_name": "Revenio Group Oyj",
    "market": "fi_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Revenio Group Corporation",
    "state": null,
    "summary": "Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments for the early detection of glaucoma, diabetic retinopathy, and macular degeneration in Finland, Italy, rest of Europe, the United States, and internationally. The company offers ic100 and ic200 tonometers; Icare HOME, a device for self-measurement of eye pressure; Icare TONOVET Plus tonometers for animals; fundus imaging devices comprising EIDON, DRS, and DRSplus; MAIA, a microperimeter to measure the effectiveness of drugs for retinal disease treatment; COMPASS, which provides fundus perimetry with true-color confocal retinal images; and Ventica, to examine the variability in tidal breathing in children. It is also developing Cutica, a hyperspectral camera for dermatologists to detect skin cancers. Revenio Group Oyj is based in Vantaa, Finland.",
    "website": "http://www.reveniogroup.fi",
    "zipcode": "01510"
  },
  "RFCS": {
    "city": "Dallas",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Refocus Group, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "REFOCUS GROUP INC",
    "state": "TX",
    "summary": "Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.",
    "website": "http://www.refocus-group.com",
    "zipcode": "75231"
  },
  "RHNMF": {
    "city": "Richmond",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Rhinomed Limited",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RHINOMED LIMITED",
    "state": "VIC",
    "summary": "Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; and Pronto for nasal congestion and sleep disturbance issues. It also engages in developing applications for the delivery of medical cannabis and conditions, including anxiety, pain, allergies, nausea, anxiety, and coughs and colds; and nasal swab to test the presence of upper respiratory tract diseases, including influenza, and coronavirus strains. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.",
    "website": "http://www.rhinomed.global",
    "zipcode": "3121"
  },
  "RHT.AX": {
    "city": "Burswood",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Resonance Health Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RESONANCE FPO",
    "state": "WA",
    "summary": "Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship products include FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration; and FerriSmart, an automated software medical device to manage patients with iron overload disorders, such as thalassemia, sickle cell disease, hereditary haemochromatosis, anaemias, and cancers. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; HepaFat-AI, an artificial intelligence software tool, which is used for the automated assessment of liver fat from MRI data; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; researchers; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.",
    "website": "http://www.resonancehealth.com",
    "zipcode": "6100"
  },
  "RJV.F": {
    "city": "Crows Nest",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "SomnoMed Limited",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SOMNOMED LTD.",
    "state": "NSW",
    "summary": "SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.",
    "website": "http://somnomed.com/au/",
    "zipcode": "2065"
  },
  "RMED": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "USD",
    "exchange": "ASE",
    "industry": "Medical Devices",
    "long_name": "Ra Medical Systems, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Ra Medical Systems, Inc.",
    "state": "CA",
    "summary": "Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.",
    "website": "http://www.ramed.com",
    "zipcode": "92011"
  },
  "RMSL": {
    "city": "Orlando",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "REMSleep Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "REMSLEEP HOLDINGS INC",
    "state": "FL",
    "summary": "REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. It offers DeltaWave CPAP interface device to treat patients with sleep apnea. The company serves home care dealers, private sleep labs, Internet providers, product end users, physicians, medical group, and hospitals, as well as medical associations. REMSleep Holdings, Inc. was founded in 2007 and is headquartered in Orlando, Florida.",
    "website": "http://www.remsleeptech.com",
    "zipcode": "32789"
  },
  "RNO.AX": {
    "city": "Richmond",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Rhinomed Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RHINOMED FPO",
    "state": "VIC",
    "summary": "Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; and Pronto for nasal congestion and sleep disturbance issues. It also engages in developing applications for the delivery of medical cannabis and conditions, including anxiety, pain, allergies, nausea, anxiety, and coughs and colds; and nasal swab to test the presence of upper respiratory tract diseases, including influenza, and coronavirus strains. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.",
    "website": "http://www.rhinomed.global",
    "zipcode": "3121"
  },
  "RSH.AX": {
    "city": "Melbourne",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Respiri Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RESPIRI FPO",
    "state": "VIC",
    "summary": "Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.",
    "website": "http://www.respiri.co",
    "zipcode": "3004"
  },
  "RSLS": {
    "city": "San Clemente",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "ReShape Lifesciences Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RESHAPE LIFESCIENCES INC",
    "state": "CA",
    "summary": "ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.",
    "website": "http://www.reshapelifesciences.com",
    "zipcode": "92673"
  },
  "RSN.SG": {
    "city": "Burswood",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Resonance Health Limited",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Resonance Health Ltd. Registere",
    "state": "WA",
    "summary": "Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship products include FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration; and FerriSmart, an automated software medical device to manage patients with iron overload disorders, such as thalassemia, sickle cell disease, hereditary haemochromatosis, anaemias, and cancers. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; HepaFat-AI, an artificial intelligence software tool, which is used for the automated assessment of liver fat from MRI data; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; researchers; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.",
    "website": "http://www.resonancehealth.com",
    "zipcode": "6100"
  },
  "RT2.F": {
    "city": "Deerfield",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Surgalign Holdings, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SURGALIGN HLDGS  DL-,001",
    "state": "IL",
    "summary": "Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.",
    "website": "http://www.surgalign.com",
    "zipcode": "60015"
  },
  "RTSL": {
    "city": "Dallas",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Rapid Therapeutic Science Laboratories, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RAPID THERAPEUTIC SCIENCE LBRTS",
    "state": "TX",
    "summary": "Rapid Therapeutic Science Laboratories, Inc. holds a sublicense agreement to access to certain technology regarding the RxoidTM metered dose inhaler (TMDI). The TMDI is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.",
    "website": null,
    "zipcode": "75240"
  },
  "RUA.L": {
    "city": "Irvine",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Rua Life Sciences Plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "RUA LIFE SCIENCES PLC ORD 5P",
    "state": null,
    "summary": "Rua Life Sciences Plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to Rua Life Sciences Plc in June 2020. Rua Life Sciences Plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.",
    "website": "http://www.rualifesciences.com",
    "zipcode": "KA11 5AN"
  },
  "RWLK": {
    "city": "Yokneam Illit",
    "country": "Israel",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "ReWalk Robotics Ltd.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ReWalk Robotics Ltd.",
    "state": null,
    "summary": "ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.",
    "website": "http://www.rewalk.com",
    "zipcode": "2069203"
  },
  "S0Z.F": {
    "city": "Santa Barbara",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Sientra, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SIENTRA INC.  DL-,01",
    "state": "CA",
    "summary": "Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.",
    "website": "http://sientra.com",
    "zipcode": "93117"
  },
  "S1YK34.SA": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Stryker Corporation",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "STRYKER CORPDRN",
    "state": "MI",
    "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",
    "website": "http://www.stryker.com",
    "zipcode": "49002"
  },
  "S21.F": {
    "city": "LinkÃ¶ping",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "S2Medical AB (publ)",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "S2MEDICAL AB B",
    "state": null,
    "summary": "S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in LinkÃ¶ping, Sweden.",
    "website": "http://www.s2m.se",
    "zipcode": "582 73"
  },
  "S2M.ST": {
    "city": "LinkÃ¶ping",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "S2Medical AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "S2Medical AB ser. B",
    "state": null,
    "summary": "S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in LinkÃ¶ping, Sweden.",
    "website": "http://www.s2m.se",
    "zipcode": "582 73"
  },
  "SBS.DE": {
    "city": "Birkenfeld",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Stratec SE",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "STRATEC SE  NA O.N.",
    "state": null,
    "summary": "Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.",
    "website": "http://www.stratec.com",
    "zipcode": "75217"
  },
  "SBS.F": {
    "city": "Birkenfeld",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Stratec SE",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "STRATEC SE  NA O.N.",
    "state": null,
    "summary": "Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.",
    "website": "http://www.stratec.com",
    "zipcode": "75217"
  },
  "SCIB.ST": {
    "city": "Stockholm",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "SciBase Holding AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Scibase Holding AB",
    "state": null,
    "summary": "SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.",
    "website": "http://www.scibase.com",
    "zipcode": "172 63"
  },
  "SDC": {
    "city": "Nashville",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "SmileDirectClub, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SmileDirectClub, Inc.",
    "state": "TN",
    "summary": "SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, Spain, and Austria. It offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.",
    "website": "http://www.smiledirectclub.com",
    "zipcode": "37219"
  },
  "SDC.MX": {
    "city": "Nashville",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "SmileDirectClub, Inc.",
    "market": "mx_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SMILEDIRECTCLUB INC",
    "state": "TN",
    "summary": "SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, Spain, and Austria. It offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.",
    "website": "http://www.smiledirectclub.com",
    "zipcode": "37219"
  },
  "SDOS.ST": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "ScandiDos AB (publ)",
    "market": "se_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ScandiDos AB",
    "state": null,
    "summary": "ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation; and Delta4 Trolley, an ergonomic solution. The company is headquartered in Uppsala, Sweden.",
    "website": "http://scandidos.com",
    "zipcode": "751 83"
  },
  "SECT-B.ST": {
    "city": "LinkÃ¶ping",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Sectra AB (publ)",
    "market": "se_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "SECTRA AB ser B",
    "state": null,
    "summary": "Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company's Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society's critical operations. The company's Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in LinkÃ¶ping, Sweden.",
    "website": "http://www.sectra.com",
    "zipcode": "583 30"
  },
  "SEOVF": {
    "city": "London",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORPORATION",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "SEQUA.BR": {
    "city": "Gent",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "BRU",
    "industry": "Medical Devices",
    "long_name": "Sequana Medical NV",
    "market": "be_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SEQUANA MEDICAL",
    "state": null,
    "summary": "Sequana Medical NV, a commercial stage medical device company, focuses on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure in Switzerland, Germany, and internationally. Its products include alfapump, a treatment solution for the management of liver refractory ascites and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with volume overload due to heart failure. The company was founded in 2006 and is headquartered in Ghent, Belgium.",
    "website": "http://www.sequanamedical.com",
    "zipcode": "9052"
  },
  "SEZI.ST": {
    "city": "Uppsala",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Senzime AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Senzime AB",
    "state": null,
    "summary": "Senzime AB (publ) develps and markets patient monitoring systems to monitor patients under anesthesia in Europe and the United States. The company offers TetraGraph, a TOF-monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; CliniSenz Analyzer, which detects early signs of complications; and Onzurf Probe for sampling from the surface of an organ. Senzime AB (publ) was founded in 1999 and is based in Uppsala, Sweden.",
    "website": "http://www.senzime.com",
    "zipcode": "756 51"
  },
  "SHOM": {
    "city": "Greer",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Southern Home Medical, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SOUTHERN HOME MED INC",
    "state": "SC",
    "summary": "Southern Home Medical, Inc. provides healthcare services to medical institutions in the United States. It supplies breathing equipment for patients with respiratory conditions; and oxygen concentrators, portable oxygen tanks, hospital beds, alternating pressure mattresses, patient lifts, tracheotomy supplies, commodes, walkers, and wheelchairs. The company also provides medical staffing needs to hospitals, rehab centers, nursing homes, mental health centers, and other medical facilities. It supports hospitals, rehab centers, nursing homes, and other medical facilities. Southern Home Medical, Inc. is based in Greer, South Carolina.",
    "website": "http://www.southernhomemedical.com",
    "zipcode": "29651"
  },
  "SIBN": {
    "city": "Santa Clara",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "SI-BONE, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SI-BONE, Inc.",
    "state": "CA",
    "summary": "SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.",
    "website": "http://si-bone.com",
    "zipcode": "95050"
  },
  "SIEN": {
    "city": "Santa Barbara",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Sientra, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Sientra, Inc.",
    "state": "CA",
    "summary": "Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.",
    "website": "http://sientra.com",
    "zipcode": "93117"
  },
  "SILK": {
    "city": "Sunnyvale",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Silk Road Medical, Inc",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Silk Road Medical, Inc.",
    "state": "CA",
    "summary": "Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.",
    "website": "http://silkroadmed.com",
    "zipcode": "94089"
  },
  "SINT": {
    "city": "Salt Lake City",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Sintx Technologies, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SiNtx Technologies, Inc.",
    "state": "UT",
    "summary": "Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.",
    "website": "http://www.sintx.com",
    "zipcode": "84119"
  },
  "SMLR": {
    "city": "Santa Clara",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Semler Scientific, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SEMLER SCIENTIFIC INC",
    "state": "CA",
    "summary": "Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.",
    "website": "http://www.semlerscientific.com",
    "zipcode": "95051"
  },
  "SN.L": {
    "city": "Watford",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Smith & Nephew plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "SMITH & NEPHEW PLC ORD USD0.20",
    "state": null,
    "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
    "website": "http://www.smith-nephew.com",
    "zipcode": "WD18 8YE"
  },
  "SNDD": {
    "city": "Lafayette",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "RedHawk Holdings Corp.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "REDHAWK HOLDINGS CORP",
    "state": "LA",
    "summary": "RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom. It operates in three segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. The company manufactures and sells Sharps and Needle Destruction Devices; carotid artery digital non-contact thermometers; and Centri Controlled Entry System, a full body X-ray scanner. It also distributes WoundClot, a bleeding control medical device; Berrcom JXB178 infrared non-contact thermometers; and Zonis. In addition, RedHawk Holdings Corp. sells a line of face masks and face shields, including a level 1 single use disposable mask, a three layer level 3 cotton masks, and KN95 and N95 masks; an anti-fog and anti-static splash protection face shield; and a line of ultraviolet sanitation lights, including tabletop and handheld devices, as well as branded generic pharmaceuticals, such as Paracetamol, Glipizide, and Omeprazole. The company serves retail pharmacies, hospitals, physicians' offices, private and public healthcare clinics, corrections facilities, schools, veterinary clinics, emergency services, first responders, municipalities, and long term care facilities. In addition, it is involved in the commercial and residential property investment and leasing activities; sale of point of entry full-body security systems; and provision of specialized financial services. The company was formerly known as Independence Energy Corp. and changed its name to RedHawk Holdings Corp. in October 2015. RedHawk Holdings Corp. was incorporated in 2005 and is headquartered in Lafayette, Louisiana.",
    "website": "http://www.redhawkholdingscorp.com",
    "zipcode": "70508"
  },
  "SNDZ": {
    "city": "Fountain Hills",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Sunridge International, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SUNRIDGE INTERNATIONAL",
    "state": "AZ",
    "summary": "Sunridge International, Inc. manufactures and markets patented vacuum fixation devices and suction rings for the treatment of open angle and pigmentary glaucoma worldwide. It serves medical supply companies and health care providers. The company was founded in 1997 and is based in Fountain Hills, Arizona.",
    "website": null,
    "zipcode": "85268"
  },
  "SNN": {
    "city": "Watford",
    "country": "United Kingdom",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Smith & Nephew plc",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Smith & Nephew SNATS, Inc.",
    "state": null,
    "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
    "website": "http://www.smith-nephew.com",
    "zipcode": "WD18 8YE"
  },
  "SNNUF": {
    "city": "Watford",
    "country": "United Kingdom",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Smith & Nephew plc",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "SMITH & NEPHEW",
    "state": null,
    "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
    "website": "http://www.smith-nephew.com",
    "zipcode": "WD18 8YE"
  },
  "SNWV": {
    "city": "Suwanee",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "SANUWAVE Health, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SANUWAVE HEALTH INC",
    "state": "GA",
    "summary": "SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States, Europe, Canada, Asia, and the Asia Pacific. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device that has completed its Phase III clinical studies for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.",
    "website": "http://www.sanuwave.com",
    "zipcode": "30024"
  },
  "SOLY": {
    "city": "Houston",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Soliton, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Soliton, Inc.",
    "state": "TX",
    "summary": "Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.",
    "website": "http://www.soliton.com",
    "zipcode": "77081"
  },
  "SOM.AX": {
    "city": "Crows Nest",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "SomnoMed Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SOMNOMED FPO",
    "state": "NSW",
    "summary": "SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.",
    "website": "http://somnomed.com/au/",
    "zipcode": "2065"
  },
  "SOMNF": {
    "city": "Crows Nest",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "SomnoMed Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SOMNOMED LIMITED",
    "state": "NSW",
    "summary": "SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.",
    "website": "http://somnomed.com/au/",
    "zipcode": "2065"
  },
  "SPEC.ST": {
    "city": "Lund",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "SpectraCure AB (publ)",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SpectraCure AB",
    "state": null,
    "summary": "SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.",
    "website": "http://www.spectracure.com",
    "zipcode": "222 29"
  },
  "SPNE": {
    "city": "Carlsbad",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "SeaSpine Holdings Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SeaSpine Holdings Corporation",
    "state": "CA",
    "summary": "SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and demineralized bone matrices. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive surgery, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical spine. The company has development and licensing agreement with restor3d, Inc. and 7D Surgical, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.",
    "website": "http://www.seaspine.com",
    "zipcode": "92008"
  },
  "SRDX": {
    "city": "Eden Prairie",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Surmodics, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Surmodics, Inc.",
    "state": "MN",
    "summary": "Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.",
    "website": "http://www.surmodics.com",
    "zipcode": "55344"
  },
  "SRGA": {
    "city": "Deerfield",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Surgalign Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Surgalign Holdings, Inc.",
    "state": "IL",
    "summary": "Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.",
    "website": "http://www.surgalign.com",
    "zipcode": "60015"
  },
  "SRTS": {
    "city": "Boca Raton",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Sensus Healthcare, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Sensus Healthcare, Inc.",
    "state": "FL",
    "summary": "Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary modulated robotic brachytherapy oncology therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.",
    "website": "http://www.sensushealthcare.com",
    "zipcode": "33487"
  },
  "SSKN": {
    "city": "Horsham",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "STRATA Skin Sciences, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Strata Skin Sciences, Inc.",
    "state": "PA",
    "summary": "STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.",
    "website": "http://www.strataskinsciences.com",
    "zipcode": "19044"
  },
  "SSUR": {
    "city": "Brooklyn",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "StatSure Diagnostic Systems, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "STATSURE DIAGNOSTIC SYSTEMS INC",
    "state": "NY",
    "summary": "StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices. The company was founded in 1986 and is based in Brooklyn, New York.",
    "website": "http://www.statsurediagnostics.com",
    "zipcode": "11230"
  },
  "STIL.ST": {
    "city": "TorshÃ¤lla",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Stille AB",
    "market": "se_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Stille AB",
    "state": null,
    "summary": "Stille AB manufactures and sells surgical instruments in Sweden and internationally. The company offers artery and ligature clamps; artery forceps; bone cutters and rongeurs; clamps; curettes, raspatories, elevators, etc.; forceps; micro instruments; needle holder, wire twistings, and holding forceps; osteotomes, chisels, etc.; reactors and skin hooks; scissors; and other products. It also provides operating tables for ERCP / abdominal fluoroscopy, neuro / spine, pain management, urology, and vascular surgeries. The company was founded in 1841 and is headquartered in TorshÃ¤lla, Sweden. Stille AB is a subsidiary of Linc AB.",
    "website": "http://www.stille.se",
    "zipcode": "644 30"
  },
  "STRR": {
    "city": "Old Greenwich",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Star Equity Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Star Equity Holdings, Inc.",
    "state": "CT",
    "summary": "Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to cardiologists, internal medicine physicians, family practice physicians, hospitals, IDNs, and federal institutions. It also develops, sells, and maintains solid-state gamma cameras; imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages and finances real estate assets and investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.",
    "website": "http://www.starequity.com",
    "zipcode": "06870"
  },
  "STRRP": {
    "city": "Old Greenwich",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Star Equity Holdings, Inc.",
    "market": "us_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "Star Equity Holdings, Inc. - Se",
    "state": "CT",
    "summary": "Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to cardiologists, internal medicine physicians, family practice physicians, hospitals, IDNs, and federal institutions. It also develops, sells, and maintains solid-state gamma cameras; imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages and finances real estate assets and investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.",
    "website": "http://www.starequity.com",
    "zipcode": "06870"
  },
  "STSEY": {
    "city": "Birkenfeld",
    "country": "Germany",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Stratec SE",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "STRATEC SE UNSPN ADS EACH REP 0",
    "state": null,
    "summary": "Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.",
    "website": "http://www.stratec.com",
    "zipcode": "75217"
  },
  "SU6.F": {
    "city": "Eden Prairie",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Surmodics, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SURMODICS  DL-,05",
    "state": "MN",
    "summary": "Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.",
    "website": "http://www.surmodics.com",
    "zipcode": "55344"
  },
  "SUN.L": {
    "city": "Leeds",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Devices",
    "long_name": "Surgical Innovations Group plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "SURGICAL INNOVATIONS GROUP PLC ",
    "state": null,
    "summary": "Surgical Innovations Group plc designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company's SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. Its OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company's Distribution segment distributes medical products through Elemental Healthcare Ltd. It also designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.",
    "website": "http://www.sigroupplc.com",
    "zipcode": "LS16 6QZ"
  },
  "SVA.V": {
    "city": "London",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORP.",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "SWAV": {
    "city": "Santa Clara",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "ShockWave Medical, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "ShockWave Medical, Inc.",
    "state": "CA",
    "summary": "ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.",
    "website": "http://www.shockwavemedical.com",
    "zipcode": "95054"
  },
  "SWNM": {
    "city": "Tampa",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Southwestern Medical Solutions, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "SOUTHWESTERN MEDICAL SOLUTIONS ",
    "state": "FL",
    "summary": "Southwestern Medical Solutions, Inc. engages in the research and development of medical devices. The company offers LabGuard Accucheck, a device for on-site collection/analysis and testing to provide results for on-site diagnostic testing/screening market. The company was incorporated in 2003 and is based in Tampa, Florida.",
    "website": null,
    "zipcode": "33618"
  },
  "SYK": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Stryker Corporation",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Stryker Corporation",
    "state": "MI",
    "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",
    "website": "http://www.stryker.com",
    "zipcode": "49002"
  },
  "SYK.DE": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Stryker Corporation",
    "market": "de_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "STRYKER CORP.  DL-,10",
    "state": "MI",
    "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",
    "website": "http://www.stryker.com",
    "zipcode": "49002"
  },
  "SYK.F": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Stryker Corporation",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "STRYKER CORP.  DL-,10",
    "state": "MI",
    "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",
    "website": "http://www.stryker.com",
    "zipcode": "49002"
  },
  "SYK.MX": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Stryker Corporation",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "STRYKER CORP",
    "state": "MI",
    "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",
    "website": "http://www.stryker.com",
    "zipcode": "49002"
  },
  "SYK.VI": {
    "city": "Kalamazoo",
    "country": "United States",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "Stryker Corporation",
    "market": "at_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "STRYKER CORP",
    "state": "MI",
    "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",
    "website": "http://www.stryker.com",
    "zipcode": "49002"
  },
  "TCLIF": {
    "city": "Malakoff",
    "country": "France",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Theraclion SA",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERACLION",
    "state": null,
    "summary": "Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was incorporated in 2004 and is based in Malakoff, France.",
    "website": "http://www.theraclion.com",
    "zipcode": "92240"
  },
  "TCMD": {
    "city": "Minneapolis",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Tactile Systems Technology, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Tactile Systems Technology, Inc",
    "state": "MN",
    "summary": "Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.",
    "website": "http://www.tactilemedical.com",
    "zipcode": "55416"
  },
  "TD5A.F": {
    "city": "San Diego",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Tandem Diabetes Care, Inc.",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "TANDEM DIABETES NEW -,001",
    "state": "CA",
    "summary": "Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.",
    "website": "http://www.tandemdiabetes.com",
    "zipcode": "92121"
  },
  "TELA": {
    "city": "Malvern",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "TELA Bio, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "TELA Bio, Inc.",
    "state": "PA",
    "summary": "TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.",
    "website": "http://www.telabio.com",
    "zipcode": "19355"
  },
  "TEST.V": {
    "city": "Calgary",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "FluroTech Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "FLUROTECH LTD",
    "state": "AB",
    "summary": "FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech's specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada.",
    "website": "http://www.flurotech.com",
    "zipcode": "T2L 1Y1"
  },
  "THMO": {
    "city": "Rancho Cordova",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "ThermoGenesis Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ThermoGenesis Holdings, Inc.",
    "state": "CA",
    "summary": "ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem, and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.",
    "website": "http://www.thermogenesis.com",
    "zipcode": "95742"
  },
  "THRBF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Therma Bright Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "THERMA BRIGHT INC",
    "state": "ON",
    "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
    "website": "http://thermabright.com",
    "zipcode": "M4M 3P1"
  },
  "THRM.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Therma Bright Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "THERMA BRIGHT INC",
    "state": "ON",
    "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
    "website": "http://thermabright.com",
    "zipcode": "M4M 3P1"
  },
  "THRP.F": {
    "city": "Rancho Cordova",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ThermoGenesis Holdings, Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERMOGENESIS  DL-,001",
    "state": "CA",
    "summary": "ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem, and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.",
    "website": "http://www.thermogenesis.com",
    "zipcode": "95742"
  },
  "TJ9.F": {
    "city": "Brisbane",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cutera, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CUTERA INC.  DL-,001",
    "state": "CA",
    "summary": "Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, myQ, and skincare products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.",
    "website": "http://cutera.com",
    "zipcode": "94005"
  },
  "TLIS": {
    "city": "Menlo Park",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Talis Biomedical Corporation",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Talis Biomedical Corporation",
    "state": "CA",
    "summary": "Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.",
    "website": "http://talis.bio",
    "zipcode": "94025"
  },
  "TLT.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Theralase Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERALASE TECHNOLOGIES INC.",
    "state": "ON",
    "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
    "website": "http://www.theralase.com",
    "zipcode": "M4B 3G4"
  },
  "TLTFF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Theralase Technologies Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERALASE TECHNOLOGIES INC",
    "state": "ON",
    "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
    "website": "http://www.theralase.com",
    "zipcode": "M4B 3G4"
  },
  "TMCI": {
    "city": "Ponte Vedra",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Treace Medical Concepts, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Treace Medical Concepts, Inc.",
    "state": "FL",
    "summary": "Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.",
    "website": "http://www.treace.com",
    "zipcode": "32081"
  },
  "TMD.TO": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "TOR",
    "industry": "Medical Devices",
    "long_name": "Titan Medical Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "TITAN MEDICAL INC",
    "state": "ON",
    "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.titanmedicalinc.com",
    "zipcode": "M5H 3B7"
  },
  "TMDI": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Titan Medical Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Titan Medical Inc.",
    "state": "ON",
    "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.titanmedicalinc.com",
    "zipcode": "M5H 3B7"
  },
  "TMDX": {
    "city": "Andover",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "TransMedics Group, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "TransMedics Group, Inc.",
    "state": "MA",
    "summary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.",
    "website": "http://www.transmedics.com",
    "zipcode": "01810"
  },
  "TNDM": {
    "city": "San Diego",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Tandem Diabetes Care, Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Tandem Diabetes Care, Inc.",
    "state": "CA",
    "summary": "Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.",
    "website": "http://www.tandemdiabetes.com",
    "zipcode": "92121"
  },
  "TRU.AX": {
    "city": "Auckland",
    "country": "New Zealand",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "TruScreen Group Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "TRUSCREEN FPO NZX",
    "state": null,
    "summary": "Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in New Zealand and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.",
    "website": "http://truscreen.com",
    "zipcode": "1010"
  },
  "TRU.NZ": {
    "city": "Auckland",
    "country": "New Zealand",
    "currency": "NZD",
    "exchange": "NZE",
    "industry": "Medical Devices",
    "long_name": "TruScreen Group Limited",
    "market": "nz_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "TruScreen Group Limited Ordinar",
    "state": null,
    "summary": "Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in New Zealand and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.",
    "website": "http://truscreen.com",
    "zipcode": "1010"
  },
  "TTX.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Theralase Technologies Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERALASE TECHNOLOGIE.INC",
    "state": "ON",
    "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
    "website": "http://www.theralase.com",
    "zipcode": "M4B 3G4"
  },
  "UAHC": {
    "city": "Chicago",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "United American Healthcare Corporation",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "UNITED AMERICAN HEALTHCARE INC",
    "state": "IL",
    "summary": "United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.",
    "website": "http://www.uahc.com",
    "zipcode": "60601"
  },
  "UBI.AX": {
    "city": "Rowville",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Universal Biosensors, Inc.",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "UNI BIOSEN CDI 1:1",
    "state": "VIC",
    "summary": "Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It offers SENTIA Wine Analyzer to test Free Sulphur Dioxide; prothrombin time international normalized ratio coagulation test strips; Sentia Free Sulphite test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.",
    "website": "http://www.universalbiosensors.com",
    "zipcode": "3178"
  },
  "UCM.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Uscom Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "USCOM FPO",
    "state": "NSW",
    "summary": "Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides Ventitest, a ventilator testing device; Ventitest sensor to test lung function; and The SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.",
    "website": "http://www.uscom.com.au",
    "zipcode": "2000"
  },
  "ULGX": {
    "city": "Minneapolis",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Urologix, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "UROLOGIX",
    "state": "MN",
    "summary": "Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.",
    "website": "http://www.urologix.com",
    "zipcode": "55447"
  },
  "UNIVPHOTO.NS": {
    "city": "New Delhi",
    "country": "India",
    "currency": "INR",
    "exchange": "NSI",
    "industry": "Medical Devices",
    "long_name": "Universus Photo Imagings Limited",
    "market": "in_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Universus Imagings Ltd",
    "state": null,
    "summary": "Universus Photo Imagings Limited manufactures, sells, and trades in photographic and other imaging products. It offers photographic papers, NTR films, medical X-ray films, etc. The company was formerly known as Jindal Photo Imaging Limited and changed its name to Universus Photo Imagings Limited in December 2019. Universus Photo Imagings Limited was incorporated in 2011 and is based in New Delhi, India.",
    "website": "http://www.universusphotoimagings.com",
    "zipcode": "110 070"
  },
  "VA21.F": {
    "city": "Exeter",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Vapotherm, Inc.",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "VAPOTHERM INC. DL-,001",
    "state": "NH",
    "summary": "Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.",
    "website": "http://www.vapotherm.com",
    "zipcode": "03833"
  },
  "VAPO": {
    "city": "Exeter",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Vapotherm, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Vapotherm, Inc.",
    "state": "NH",
    "summary": "Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.",
    "website": "http://www.vapotherm.com",
    "zipcode": "03833"
  },
  "VERO": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Venus Concept Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Venus Concept Inc.",
    "state": "ON",
    "summary": "Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and treatment of ingrown hair; and Venus Fiore that is used for the treatment of vaginal canal, labia skin tightening, and mons pubis. The company also offers Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin; Venus Freeze Plus, a noninvasive device used in dermatologic and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides; Venus Bliss, a device is used for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance. In addition, it provides NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system; and ARTAS and ARTAS iX, a robotic systems to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.",
    "website": "http://www.venusconcept.com",
    "zipcode": "M2J 4Y8"
  },
  "VG2B.F": {
    "city": "Redwood City",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Avinger, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "AVINGER INC.  DL-,001",
    "state": "CA",
    "summary": "Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.",
    "website": "http://www.avinger.com",
    "zipcode": "94063"
  },
  "VI4.F": {
    "city": "Salt Lake City",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Varex Imaging Corporation",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "VAREX IMAGING CORP DL-,01",
    "state": "UT",
    "summary": "Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys (a component of X-ray units that holds X-ray film cassettes). This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.",
    "website": "http://www.vareximaging.com",
    "zipcode": "84104"
  },
  "VICA": {
    "city": "Glasgow",
    "country": "United Kingdom",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Rafina Innovations Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RAFINA INNOVATIONS INC",
    "state": null,
    "summary": "Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.",
    "website": "http://rafina-innovations.com",
    "zipcode": "G51 1HJ"
  },
  "VIJ.F": {
    "city": "Lafayette",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Viemed Healthcare, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "VIEMED HLTHCARE INC. O.N.",
    "state": "LA",
    "summary": "Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.",
    "website": "http://www.viemed.com",
    "zipcode": "70508"
  },
  "VIRO.CO": {
    "city": "BirkerÃ¸d",
    "country": "Denmark",
    "currency": "DKK",
    "exchange": "CPH",
    "industry": "Medical Devices",
    "long_name": "ViroGates A/S",
    "market": "dk_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ViroGates A/S",
    "state": null,
    "summary": "ViroGates A/S, a medical technology company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the suPAR (soluble urokinase plasminogen activator receptor) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex to help triage patients in the emergency setting and COVID-19 patients. In addition, its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was founded in 2000 and is headquartered in BirkerÃ¸d, Denmark. ViroGates A/S was formerly a subsidiary of Medicon Valley.",
    "website": "http://www.virogates.com",
    "zipcode": "3460"
  },
  "VITR.ST": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Vitrolife AB (publ)",
    "market": "se_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "Vitrolife AB",
    "state": null,
    "summary": "Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.vitrolife.com",
    "zipcode": "421 32"
  },
  "VIVE": {
    "city": "Englewood",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Viveve Medical, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "Viveve Medical, Inc.",
    "state": "CO",
    "summary": "Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. The company was founded in 2005 and is headquartered in Englewood, Colorado.",
    "website": "http://www.viveve.com",
    "zipcode": "80112"
  },
  "VMD": {
    "city": "Lafayette",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Viemed Healthcare, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Viemed Healthcare, Inc.",
    "state": "LA",
    "summary": "Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.",
    "website": "http://www.viemed.com",
    "zipcode": "70508"
  },
  "VMD.TO": {
    "city": "Lafayette",
    "country": "United States",
    "currency": "CAD",
    "exchange": "TOR",
    "industry": "Medical Devices",
    "long_name": "Viemed Healthcare, Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "VIEMED HEALTHCARE INC",
    "state": "LA",
    "summary": "Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.",
    "website": "http://www.viemed.com",
    "zipcode": "70508"
  },
  "VMTHF": {
    "city": "Hangzhou",
    "country": "China",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Venus Medtech (Hangzhou) Inc.",
    "market": "us_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "VENUS MEDTECH (HANGZHOU) INC",
    "state": null,
    "summary": "Venus Medtech (Hangzhou) Inc. develops and sells transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of cerebral damage during TAVR and other structural heart procedures. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.",
    "website": "http://www.venusmedtech.com",
    "zipcode": null
  },
  "VPT.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "VentriPoint Diagnostics Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VENTRIPOINT DIAGNOSTICS LTD",
    "state": "ON",
    "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
    "website": "http://www.ventripoint.com",
    "zipcode": "M2N 5Y7"
  },
  "VPTDF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "VentriPoint Diagnostics Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VENTRIPOINT DIAGNOSTICS LTD",
    "state": "ON",
    "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
    "website": "http://www.ventripoint.com",
    "zipcode": "M2N 5Y7"
  },
  "VRAY": {
    "city": "Oakwood",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "ViewRay, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ViewRay, Inc.",
    "state": "OH",
    "summary": "ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.",
    "website": "http://www.viewray.com",
    "zipcode": "44146"
  },
  "VREX": {
    "city": "Salt Lake City",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Varex Imaging Corporation",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Varex Imaging Corporation",
    "state": "UT",
    "summary": "Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys (a component of X-ray units that holds X-ray film cassettes). This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.",
    "website": "http://www.vareximaging.com",
    "zipcode": "84104"
  },
  "VRSEF": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Verisante Technology Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VERISANTE TECHNOLOGY INC",
    "state": "BC",
    "summary": "Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.",
    "website": "http://www.verisante.com",
    "zipcode": "V6V 3B7"
  },
  "VRSYF": {
    "city": "Ottawa",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "VMS Rehab Systems, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VMS REHAB SYSTEMS",
    "state": "ON",
    "summary": "VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses. It develops and tests generic tadalafil products. The company also sells orthopedic wedge seat cushions for relieving the discomfort and/or pain caused by other lower body medical issues, including pilonidal disease, piles disease, and hemorrhoids to home healthcare retail networks in Canada. VMS Rehab Systems, Inc. was founded in 1998 and is based in Ottawa, Canada.",
    "website": "http://www.vmsrehabsystemsinc.com",
    "zipcode": "K1R 7X6"
  },
  "VTFN.F": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Vitrolife AB (publ)",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "VITROLIFE AB  SK 0,2",
    "state": null,
    "summary": "Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.vitrolife.com",
    "zipcode": "421 32"
  },
  "VTI.AX": {
    "city": "Alpharetta",
    "country": "United States",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Visioneering Technologies, Inc.",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VISIONTECH CDI FORUS",
    "state": "GA",
    "summary": "Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. It offers NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.",
    "website": "http://vtivision.com",
    "zipcode": "30009"
  },
  "VVOS": {
    "city": "Highlands Ranch",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Vivos Therapeutics, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Vivos Therapeutics, Inc.",
    "state": "CO",
    "summary": "Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (SDB) comprising mild-to-moderate obstructive sleep apnea (OSA). The company's solutions cover proprietary alternatives for treating mild-to-moderate OSA; craniofacial and anatomical anomalies that are associated with mild-to-moderate OSA. Its treatment for OSA involves specially designed and customized oral appliances and treatment protocols. The company, through its Vivos Integrated Healthcare Network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate OSA. Vivos Therapeutics, Inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. It caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers, and patients in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2007 and is based in Highlands Ranch, Colorado.",
    "website": "http://www.vivoslife.com",
    "zipcode": "80129"
  },
  "VYCO": {
    "city": "Boca Raton",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Vycor Medical, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VYCOR MEDICAL  INC",
    "state": "FL",
    "summary": "Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria, and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida.",
    "website": "http://www.vycormedical.com",
    "zipcode": "33487"
  },
  "WCUI": {
    "city": "Hoffman Estates",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Wellness Center USA, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "WELLNESS CTR USA INC",
    "state": "IL",
    "summary": "Wellness Center USA, Inc. engages in the healthcare and medical businesses in the United States and internationally. It operates through Medical Devices, and Authentication and Encryption Products and Services segments. The company is primarily involved in the marketing and distribution of online sports and nutrition supplements. It also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices, including Psoria-Light that is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, the company offers Intelligent Microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence services comprising proprietary, unprecedented, and actionable technology for industries, companies, and agencies. Wellness Center USA, Inc. was founded in 2010 and is based in Tuscon, Arizona.",
    "website": "http://www.wellnesscenterusa.com",
    "zipcode": "60169"
  },
  "WGB.F": {
    "city": "Plano",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Integer Holdings Corporation",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "INTEGER HLDGS  DL-,001",
    "state": "TX",
    "summary": "Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.",
    "website": "http://www.integer.net",
    "zipcode": "75024"
  },
  "WLSI": {
    "city": "Holland",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Wellstar International, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "WELLSTAR INTERNATIONAL INC",
    "state": "OH",
    "summary": "Wellstar International, Inc. does not have significant operations. Previously, the company, through its subsidiary, Trillennium Medical Imaging, Inc., engaged in developing and licensing advanced thermal imaging technology in the consumer health care markets. Its technology enabled a diagnostic screening procedure for the early breast cancer detection; the differential diagnosis of pain dysfunctions, such as reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders; and the detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. Wellstar International, Inc. was founded in 1997 and is based in Holland, Ohio.",
    "website": null,
    "zipcode": "43528"
  },
  "WTKN": {
    "city": "Orlando",
    "country": "United States",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "WellTek Incorporated",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "WELLTEK INCORP",
    "state": "FL",
    "summary": "WellTek Incorporated operates as a health, fitness, and wellness company that provides solutions to address obesity, and chronic neck and back pain in the United States. It engages in the manufacture, market, and distribution of medical, rehabilitation, and exercise equipment. The company also involves in building a network of medical back and neck rehabilitation centers offering a proprietary program to managed care companies, self-insured employer groups, and federal government agencies. In addition, it operates a social networking site, which allows in reaching, engaging, and influencing health and wellness conscious consumers with new and existing brand assets, technologies, products, and services. WellTek Incorporated was founded in 2003 and is headquartered in Orlando, Florida.",
    "website": "http://www.welltekinc.com",
    "zipcode": "32801"
  },
  "XAIR": {
    "city": "Garden City",
    "country": "United States",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Beyond Air, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Beyond Air, Inc.",
    "state": "NY",
    "summary": "Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.",
    "website": "http://www.beyondair.net",
    "zipcode": "11530"
  },
  "XEJ.F": {
    "city": "Sunnyvale",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Accuray Incorporated",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ACCURAY INC.  DL -,001",
    "state": "CA",
    "summary": "Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.",
    "website": "http://www.accuray.com",
    "zipcode": "94089"
  },
  "XENT": {
    "city": "Menlo Park",
    "country": "United States",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Intersect ENT, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Intersect ENT, Inc.",
    "state": "CA",
    "summary": "Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL and PROPEL Mini, which are steroid releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.",
    "website": "http://www.intersectent.com",
    "zipcode": "94025"
  },
  "XMS.F": {
    "city": "Belgrade",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Xtant Medical Holdings, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "XTANT MEDICAL HLDGS",
    "state": "MT",
    "summary": "Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.",
    "website": "http://www.xtantmedical.com",
    "zipcode": "59714"
  },
  "XTNT": {
    "city": "Belgrade",
    "country": "United States",
    "currency": "USD",
    "exchange": "ASE",
    "industry": "Medical Devices",
    "long_name": "Xtant Medical Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Xtant Medical Holdings, Inc.",
    "state": "MT",
    "summary": "Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.",
    "website": "http://www.xtantmedical.com",
    "zipcode": "59714"
  },
  "XVIPF": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Xvivo Perfusion AB (publ)",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "XVIVO PERFUSION AB",
    "state": null,
    "summary": "Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.xvivoperfusion.com",
    "zipcode": "400 14"
  },
  "XVIVO.ST": {
    "city": "Gothenburg",
    "country": "Sweden",
    "currency": "SEK",
    "exchange": "STO",
    "industry": "Medical Devices",
    "long_name": "Xvivo Perfusion AB (publ)",
    "market": "se_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Xvivo Perfusion AB",
    "state": null,
    "summary": "Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.",
    "website": "http://www.xvivoperfusion.com",
    "zipcode": "400 14"
  },
  "Z1BH34.SA": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Medical Devices",
    "long_name": "Zimmer Biomet Holdings, Inc.",
    "market": "br_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ZIMMER BIOMEDRN",
    "state": "IN",
    "summary": "Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.zimmerbiomet.com",
    "zipcode": "46580"
  },
  "ZBH": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "USD",
    "exchange": "NYQ",
    "industry": "Medical Devices",
    "long_name": "Zimmer Biomet Holdings, Inc.",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "Zimmer Biomet Holdings, Inc.",
    "state": "IN",
    "summary": "Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.zimmerbiomet.com",
    "zipcode": "46580"
  },
  "ZBH.MX": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Medical Devices",
    "long_name": "Zimmer Biomet Holdings, Inc.",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ZIMMER BIOMET HOLDINGS INC",
    "state": "IN",
    "summary": "Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.zimmerbiomet.com",
    "zipcode": "46580"
  },
  "ZBH.SW": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "CHF",
    "exchange": "EBS",
    "industry": "Medical Devices",
    "long_name": "Zimmer Biomet Holdings, Inc.",
    "market": "ch_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ZIMMER HLD",
    "state": "IN",
    "summary": "Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.zimmerbiomet.com",
    "zipcode": "46580"
  },
  "ZIM.F": {
    "city": "Warsaw",
    "country": "United States",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Zimmer Biomet Holdings, Inc.",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "ZIMMER BIOMET HLDGS DL-01",
    "state": "IN",
    "summary": "Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.",
    "website": "http://www.zimmerbiomet.com",
    "zipcode": "46580"
  },
  "ZMSPF": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Zecotek Photonics Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ZECOTEK PHOTONICS INC",
    "state": "BC",
    "summary": "Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets in Canada. The company operates through three divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Its imaging systems include lutetium fine silicate scintillation crystals; solid-state micro-pixel avalanche photo diode photo detectors and transistors; and integrated detector modules. The company also develops glasses-free 3D displays; and 3D auto-stereoscopic displays, and 3D printers and related technologies. The company was formerly known as Zecotek Medical Systems Inc. and changed its name to Zecotek Photonics Inc. in November 2007. Zecotek Photonics Inc. was incorporated in 1983 and is headquartered in Richmond, Canada.",
    "website": "http://www.zecotek.com",
    "zipcode": "V6W 0A5"
  },
  "ZYXI": {
    "city": "Englewood",
    "country": "United States",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Zynex, Inc.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Zynex, Inc.",
    "state": "CO",
    "summary": "Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.",
    "website": "http://www.zynex.com",
    "zipcode": "80112"
  }
}
